{
    "Category": "",
    "Instances": [
        {
            "Input.cid": "bisect-0",
            "Input.complex": "Because drotrecogin alfa (activated) may affect the APTT assays, drotrecogin alfa (activated) present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because</span></span> drotrecogin alfa (activated) may affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin</span></span> <mark>assays. Drotrecos</mark> alfa <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(activated)</span></span> <mark>is therefore</mark> present in plasma samples <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>to</mark> interfere with one-stage coagulation assays based on <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT (such as factor VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>XI assays).</span></span> <mark>XI).</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because drotrecogin</span></span> <mark>Drotrecogin</mark> alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin alfa (activated) present</span></span> <mark>assays. exception</mark> in plasma <span class='tooltip' style='color:red'>^<span class='tooltiptext'>samples</span></span> <mark>samples, it</mark> may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage coagulation assays</span></span> <mark>one-step methods therefore clotting factors</mark> based <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>IX</mark> the APTT (such as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>factor</span></span> <mark>modernize</mark> VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and XI assays).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because</span></span> <mark>Since</mark> drotrecogin alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT assays, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drotrecogin alfa (activated) present in plasma samples may</span></span> <mark>drotrescogin can</mark> interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage</span></span> <mark>one - stage</mark> coagulation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays</span></span> <mark>tests</mark> based on the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>APTT</span></span> <mark>APTT.</mark> (such as factor VIII, IX, and XI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays).</span></span> <mark>tests).</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because drotrecogin</span></span> <mark>Drotrecogin</mark> alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin alfa (activated) present</span></span> <mark>assays. Present</mark> in plasma <span class='tooltip' style='color:red'>^<span class='tooltiptext'>samples</span></span> <mark>samples, it</mark> may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage coagulation assays</span></span> <mark>one-step methods of clotting factors</mark> based on the APTT (such as factor VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and XI assays).",
            "Input.simple-5": "Because drotrecogin alfa (activated) may affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin</span></span> <mark>assays. Disorient</mark> alfa <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(activated)</span></span> present in plasma samples may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage</span></span> <mark>one - stage</mark> coagulation assays based on <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT (such as factor VIII, IX, and XI assays).",
            "Answer.end_timestamp": 1619724695.789,
            "Answer.fluency-1": 49,
            "Answer.fluency-2": 63,
            "Answer.fluency-3": 74,
            "Answer.fluency-4": 50,
            "Answer.fluency-5": 75,
            "Answer.start_timestamp": 1619724639.63,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-0",
            "Input.complex": "Because drotrecogin alfa (activated) may affect the APTT assays, drotrecogin alfa (activated) present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because</span></span> drotrecogin alfa (activated) may affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin</span></span> <mark>assays. Drotrecos</mark> alfa <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(activated)</span></span> <mark>is therefore</mark> present in plasma samples <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>to</mark> interfere with one-stage coagulation assays based on <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT (such as factor VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>XI assays).</span></span> <mark>XI).</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because drotrecogin</span></span> <mark>Drotrecogin</mark> alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin alfa (activated) present</span></span> <mark>assays. exception</mark> in plasma <span class='tooltip' style='color:red'>^<span class='tooltiptext'>samples</span></span> <mark>samples, it</mark> may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage coagulation assays</span></span> <mark>one-step methods therefore clotting factors</mark> based <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>IX</mark> the APTT (such as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>factor</span></span> <mark>modernize</mark> VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and XI assays).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because</span></span> <mark>Since</mark> drotrecogin alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT assays, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drotrecogin alfa (activated) present in plasma samples may</span></span> <mark>drotrescogin can</mark> interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage</span></span> <mark>one - stage</mark> coagulation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays</span></span> <mark>tests</mark> based on the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>APTT</span></span> <mark>APTT.</mark> (such as factor VIII, IX, and XI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays).</span></span> <mark>tests).</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because drotrecogin</span></span> <mark>Drotrecogin</mark> alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin alfa (activated) present</span></span> <mark>assays. Present</mark> in plasma <span class='tooltip' style='color:red'>^<span class='tooltiptext'>samples</span></span> <mark>samples, it</mark> may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage coagulation assays</span></span> <mark>one-step methods of clotting factors</mark> based on the APTT (such as factor VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and XI assays).",
            "Input.simple-5": "Because drotrecogin alfa (activated) may affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin</span></span> <mark>assays. Disorient</mark> alfa <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(activated)</span></span> present in plasma samples may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage</span></span> <mark>one - stage</mark> coagulation assays based on <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT (such as factor VIII, IX, and XI assays).",
            "Answer.end_timestamp": 1619727362.177,
            "Answer.fluency-1": 38,
            "Answer.fluency-2": 70,
            "Answer.fluency-3": 89,
            "Answer.fluency-4": 78,
            "Answer.fluency-5": 57,
            "Answer.start_timestamp": 1619727323.821,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-0",
            "Input.complex": "Because drotrecogin alfa (activated) may affect the APTT assays, drotrecogin alfa (activated) present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because</span></span> drotrecogin alfa (activated) may affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin</span></span> <mark>assays. Drotrecos</mark> alfa <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(activated)</span></span> <mark>is therefore</mark> present in plasma samples <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>to</mark> interfere with one-stage coagulation assays based on <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT (such as factor VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>XI assays).</span></span> <mark>XI).</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because drotrecogin</span></span> <mark>Drotrecogin</mark> alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin alfa (activated) present</span></span> <mark>assays. exception</mark> in plasma <span class='tooltip' style='color:red'>^<span class='tooltiptext'>samples</span></span> <mark>samples, it</mark> may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage coagulation assays</span></span> <mark>one-step methods therefore clotting factors</mark> based <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>IX</mark> the APTT (such as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>factor</span></span> <mark>modernize</mark> VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and XI assays).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because</span></span> <mark>Since</mark> drotrecogin alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT assays, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drotrecogin alfa (activated) present in plasma samples may</span></span> <mark>drotrescogin can</mark> interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage</span></span> <mark>one - stage</mark> coagulation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays</span></span> <mark>tests</mark> based on the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>APTT</span></span> <mark>APTT.</mark> (such as factor VIII, IX, and XI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays).</span></span> <mark>tests).</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because drotrecogin</span></span> <mark>Drotrecogin</mark> alfa (activated) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin alfa (activated) present</span></span> <mark>assays. Present</mark> in plasma <span class='tooltip' style='color:red'>^<span class='tooltiptext'>samples</span></span> <mark>samples, it</mark> may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage coagulation assays</span></span> <mark>one-step methods of clotting factors</mark> based on the APTT (such as factor VIII, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IX,</span></span> <mark>IX</mark> and XI assays).",
            "Input.simple-5": "Because drotrecogin alfa (activated) may affect the APTT <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assays, drotrecogin</span></span> <mark>assays. Disorient</mark> alfa <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(activated)</span></span> present in plasma samples may interfere with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>one-stage</span></span> <mark>one - stage</mark> coagulation assays based on <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> APTT (such as factor VIII, IX, and XI assays).",
            "Answer.end_timestamp": 1619727885.349,
            "Answer.fluency-1": 72,
            "Answer.fluency-2": 63,
            "Answer.fluency-3": 90,
            "Answer.fluency-4": 73,
            "Answer.fluency-5": 50,
            "Answer.start_timestamp": 1619727873.864,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-1",
            "Input.complex": "In addition to the above point regarding production movements, figures obtained from the cooperating exporting producer were unclear in respect of capacity utilisation.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "In addition to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>above point regarding production movements,</span></span> <mark>above, the</mark> figures obtained from the cooperating exporting producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>are not clear. They relate to</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition</span></span> <mark>The facts established were not whether</mark> to the above <span class='tooltip' style='color:red'>^<span class='tooltiptext'>point regarding production movements, figures obtained from</span></span> <mark>mobile production. The data provided by</mark> the cooperating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>exporting</span></span> <mark>about</mark> producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>with an effective the</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization rate was also not clear.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition</span></span> <mark>The facts established were not limited</mark> to the above <span class='tooltip' style='color:red'>^<span class='tooltiptext'>point regarding production movements, figures obtained from</span></span> <mark>mobile production. The data provided by</mark> the cooperating exporting producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>with regard to the</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization rate was also not clear.</mark>",
            "Input.simple-4": "In addition to the above point regarding production <span class='tooltip' style='color:red'>^<span class='tooltiptext'>movements, figures</span></span> <mark>movements. Figures</mark> obtained from the cooperating exporting producer were unclear in respect of capacity utilisation.",
            "Input.simple-5": "In addition to the above point regarding production movements, figures obtained from the cooperating exporting producer were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unclear in respect of</span></span> <mark>unclear. This applies to</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>use.</mark>",
            "Answer.end_timestamp": 1619724273.572,
            "Answer.fluency-1": 59,
            "Answer.fluency-2": 85,
            "Answer.fluency-3": 54,
            "Answer.fluency-4": 66,
            "Answer.fluency-5": 79,
            "Answer.start_timestamp": 1619724262.979,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-1",
            "Input.complex": "In addition to the above point regarding production movements, figures obtained from the cooperating exporting producer were unclear in respect of capacity utilisation.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "In addition to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>above point regarding production movements,</span></span> <mark>above, the</mark> figures obtained from the cooperating exporting producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>are not clear. They relate to</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition</span></span> <mark>The facts established were not whether</mark> to the above <span class='tooltip' style='color:red'>^<span class='tooltiptext'>point regarding production movements, figures obtained from</span></span> <mark>mobile production. The data provided by</mark> the cooperating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>exporting</span></span> <mark>about</mark> producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>with an effective the</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization rate was also not clear.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition</span></span> <mark>The facts established were not limited</mark> to the above <span class='tooltip' style='color:red'>^<span class='tooltiptext'>point regarding production movements, figures obtained from</span></span> <mark>mobile production. The data provided by</mark> the cooperating exporting producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>with regard to the</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization rate was also not clear.</mark>",
            "Input.simple-4": "In addition to the above point regarding production <span class='tooltip' style='color:red'>^<span class='tooltiptext'>movements, figures</span></span> <mark>movements. Figures</mark> obtained from the cooperating exporting producer were unclear in respect of capacity utilisation.",
            "Input.simple-5": "In addition to the above point regarding production movements, figures obtained from the cooperating exporting producer were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unclear in respect of</span></span> <mark>unclear. This applies to</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>use.</mark>",
            "Answer.end_timestamp": 1619724320.971,
            "Answer.fluency-1": 55,
            "Answer.fluency-2": 80,
            "Answer.fluency-3": 53,
            "Answer.fluency-4": 77,
            "Answer.fluency-5": 66,
            "Answer.start_timestamp": 1619724316.479,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-1",
            "Input.complex": "In addition to the above point regarding production movements, figures obtained from the cooperating exporting producer were unclear in respect of capacity utilisation.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "In addition to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>above point regarding production movements,</span></span> <mark>above, the</mark> figures obtained from the cooperating exporting producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>are not clear. They relate to</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition</span></span> <mark>The facts established were not whether</mark> to the above <span class='tooltip' style='color:red'>^<span class='tooltiptext'>point regarding production movements, figures obtained from</span></span> <mark>mobile production. The data provided by</mark> the cooperating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>exporting</span></span> <mark>about</mark> producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>with an effective the</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization rate was also not clear.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition</span></span> <mark>The facts established were not limited</mark> to the above <span class='tooltip' style='color:red'>^<span class='tooltiptext'>point regarding production movements, figures obtained from</span></span> <mark>mobile production. The data provided by</mark> the cooperating exporting producer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were unclear in respect of</span></span> <mark>with regard to the</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>utilization rate was also not clear.</mark>",
            "Input.simple-4": "In addition to the above point regarding production <span class='tooltip' style='color:red'>^<span class='tooltiptext'>movements, figures</span></span> <mark>movements. Figures</mark> obtained from the cooperating exporting producer were unclear in respect of capacity utilisation.",
            "Input.simple-5": "In addition to the above point regarding production movements, figures obtained from the cooperating exporting producer were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unclear in respect of</span></span> <mark>unclear. This applies to</mark> capacity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>utilisation.</span></span> <mark>use.</mark>",
            "Answer.end_timestamp": 1619730148.788,
            "Answer.fluency-1": 28,
            "Answer.fluency-2": 53,
            "Answer.fluency-3": 15,
            "Answer.fluency-4": 39,
            "Answer.fluency-5": 79,
            "Answer.start_timestamp": 1619730136.415,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-2",
            "Input.complex": "Since PROCOMVAX has not been studied in persons who have malignancies or are otherwise immunocompromised, the extent of the immune response in such persons is unknown.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in persons who have malignancies or are otherwise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <mark>therefore</mark> unknown.",
            "Input.simple-2": "Since PROCOMVAX has not been studied in persons who have malignancies or are otherwise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in such persons is unknown.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons who have malignancies or are otherwise immunocompromised, the extent</span></span> <mark>people with malignant tumors recognized years montelukast</mark> of <mark>another origin. The level substances</mark> the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unknown.</span></span> <mark>not known.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons who have malignancies</span></span> <mark>people with malignant tumors</mark> or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are otherwise immunocompromised, the extent</span></span> <mark>immune deficiency of another origin. The level</mark> of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unknown.</span></span> <mark>not known.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons</span></span> <mark>people</mark> who have malignancies or are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>otherwise immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is unknown.",
            "Answer.end_timestamp": 1619726334.156,
            "Answer.fluency-1": 62,
            "Answer.fluency-2": 70,
            "Answer.fluency-3": 85,
            "Answer.fluency-4": 61,
            "Answer.fluency-5": 50,
            "Answer.start_timestamp": 1619726311.165,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-2",
            "Input.complex": "Since PROCOMVAX has not been studied in persons who have malignancies or are otherwise immunocompromised, the extent of the immune response in such persons is unknown.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in persons who have malignancies or are otherwise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <mark>therefore</mark> unknown.",
            "Input.simple-2": "Since PROCOMVAX has not been studied in persons who have malignancies or are otherwise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in such persons is unknown.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons who have malignancies or are otherwise immunocompromised, the extent</span></span> <mark>people with malignant tumors recognized years montelukast</mark> of <mark>another origin. The level substances</mark> the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unknown.</span></span> <mark>not known.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons who have malignancies</span></span> <mark>people with malignant tumors</mark> or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are otherwise immunocompromised, the extent</span></span> <mark>immune deficiency of another origin. The level</mark> of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unknown.</span></span> <mark>not known.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons</span></span> <mark>people</mark> who have malignancies or are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>otherwise immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is unknown.",
            "Answer.end_timestamp": 1619724342.495,
            "Answer.fluency-1": 99,
            "Answer.fluency-2": 75,
            "Answer.fluency-3": 25,
            "Answer.fluency-4": 75,
            "Answer.fluency-5": 100,
            "Answer.start_timestamp": 1619724179.134,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-2",
            "Input.complex": "Since PROCOMVAX has not been studied in persons who have malignancies or are otherwise immunocompromised, the extent of the immune response in such persons is unknown.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in persons who have malignancies or are otherwise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <mark>therefore</mark> unknown.",
            "Input.simple-2": "Since PROCOMVAX has not been studied in persons who have malignancies or are otherwise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in such persons is unknown.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons who have malignancies or are otherwise immunocompromised, the extent</span></span> <mark>people with malignant tumors recognized years montelukast</mark> of <mark>another origin. The level substances</mark> the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unknown.</span></span> <mark>not known.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons who have malignancies</span></span> <mark>people with malignant tumors</mark> or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are otherwise immunocompromised, the extent</span></span> <mark>immune deficiency of another origin. The level</mark> of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>unknown.</span></span> <mark>not known.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> PROCOMVAX has not been studied in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>persons</span></span> <mark>people</mark> who have malignancies or are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>otherwise immunocompromised, the</span></span> <mark>immunocompromised. The</mark> extent of the immune response in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such persons</span></span> <mark>these people</mark> is unknown.",
            "Answer.end_timestamp": 1619733518.025,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 64,
            "Answer.fluency-3": 45,
            "Answer.fluency-4": 63,
            "Answer.fluency-5": 79,
            "Answer.start_timestamp": 1619733505.566,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-3",
            "Input.complex": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in 1997, they were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>Although the</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased</span></span> <mark>declined</mark> between 1998 and 2000 and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again</span></span> between 2000 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the IP,</span></span> <mark>2000,</mark> it should be noted that while imports from the country concerned only started in 1997, they were already significant in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1998 and were at</span></span> <mark>1998. They reached</mark> a level of 32 million pieces in the IP.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports of RBMs from</mark> Indonesia decreased <span class='tooltip' style='color:red'>^<span class='tooltiptext'>between 1998 and 2000</span></span> <mark>in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>IP. However, imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of TEA of RBMs from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased between 1998 and 2000</span></span> <mark>dose in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>IP. without imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and were at a level of</span></span> <mark>reason amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-5": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Answer.end_timestamp": 1619727202.729,
            "Answer.fluency-1": 28,
            "Answer.fluency-2": 66,
            "Answer.fluency-3": 58,
            "Answer.fluency-4": 73,
            "Answer.fluency-5": 51,
            "Answer.start_timestamp": 1619727169.194,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-3",
            "Input.complex": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in 1997, they were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>Although the</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased</span></span> <mark>declined</mark> between 1998 and 2000 and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again</span></span> between 2000 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the IP,</span></span> <mark>2000,</mark> it should be noted that while imports from the country concerned only started in 1997, they were already significant in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1998 and were at</span></span> <mark>1998. They reached</mark> a level of 32 million pieces in the IP.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports of RBMs from</mark> Indonesia decreased <span class='tooltip' style='color:red'>^<span class='tooltiptext'>between 1998 and 2000</span></span> <mark>in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>IP. However, imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of TEA of RBMs from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased between 1998 and 2000</span></span> <mark>dose in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>IP. without imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and were at a level of</span></span> <mark>reason amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-5": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Answer.end_timestamp": 1619724189.759,
            "Answer.fluency-1": 41,
            "Answer.fluency-2": 65,
            "Answer.fluency-3": 25,
            "Answer.fluency-4": 65,
            "Answer.fluency-5": 54,
            "Answer.start_timestamp": 1619724183.898,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-3",
            "Input.complex": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in 1997, they were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>Although the</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased</span></span> <mark>declined</mark> between 1998 and 2000 and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again</span></span> between 2000 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the IP,</span></span> <mark>2000,</mark> it should be noted that while imports from the country concerned only started in 1997, they were already significant in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1998 and were at</span></span> <mark>1998. They reached</mark> a level of 32 million pieces in the IP.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports of RBMs from</mark> Indonesia decreased <span class='tooltip' style='color:red'>^<span class='tooltiptext'>between 1998 and 2000</span></span> <mark>in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>IP. However, imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if import</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of TEA of RBMs from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased between 1998 and 2000</span></span> <mark>dose in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>IP. without imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and were at a level of</span></span> <mark>reason amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-5": "Even if import volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Answer.end_timestamp": 1619724471.363,
            "Answer.fluency-1": 78,
            "Answer.fluency-2": 77,
            "Answer.fluency-3": 85,
            "Answer.fluency-4": 94,
            "Answer.fluency-5": 85,
            "Answer.start_timestamp": 1619724457.002,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-4",
            "Input.complex": "Because insufficient information is available regarding the use of ramipril during breastfeeding (see section 5. 2), ramipril is not recommended.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "Because insufficient information is available regarding the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Ramipril</mark> is not recommended.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>lack of sufficient information on</mark> the use of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ramipril</span></span> <mark>pharmacist</mark> during <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breastfeeding</span></span> <mark>submit</mark> (see <span class='tooltip' style='color:red'>^<span class='tooltiptext'>section</span></span> <mark>aid</mark> 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Therefore, sent</mark> is not recommended.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>lack of sufficient information on</mark> the use of ramipril during <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breastfeeding</span></span> <mark>breast-feeding</mark> (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2),</span></span> <mark>2). Therefore,</mark> ramipril is not recommended.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>a lack of information about</mark> the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Therefore, it</mark> is not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>recommended.</span></span> <mark>recommended to use it.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient</span></span> <mark>Too little</mark> information is available regarding the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). It</mark> is <mark>therefore</mark> not recommended.",
            "Answer.end_timestamp": 1619724450.365,
            "Answer.fluency-1": 76,
            "Answer.fluency-2": 61,
            "Answer.fluency-3": 50,
            "Answer.fluency-4": 75,
            "Answer.fluency-5": 50,
            "Answer.start_timestamp": 1619724161.542,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-4",
            "Input.complex": "Because insufficient information is available regarding the use of ramipril during breastfeeding (see section 5. 2), ramipril is not recommended.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "Because insufficient information is available regarding the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Ramipril</mark> is not recommended.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>lack of sufficient information on</mark> the use of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ramipril</span></span> <mark>pharmacist</mark> during <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breastfeeding</span></span> <mark>submit</mark> (see <span class='tooltip' style='color:red'>^<span class='tooltiptext'>section</span></span> <mark>aid</mark> 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Therefore, sent</mark> is not recommended.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>lack of sufficient information on</mark> the use of ramipril during <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breastfeeding</span></span> <mark>breast-feeding</mark> (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2),</span></span> <mark>2). Therefore,</mark> ramipril is not recommended.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>a lack of information about</mark> the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Therefore, it</mark> is not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>recommended.</span></span> <mark>recommended to use it.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient</span></span> <mark>Too little</mark> information is available regarding the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). It</mark> is <mark>therefore</mark> not recommended.",
            "Answer.end_timestamp": 1619724141.386,
            "Answer.fluency-1": 74,
            "Answer.fluency-2": 82,
            "Answer.fluency-3": 77,
            "Answer.fluency-4": 90,
            "Answer.fluency-5": 86,
            "Answer.start_timestamp": 1619724088.806,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-4",
            "Input.complex": "Because insufficient information is available regarding the use of ramipril during breastfeeding (see section 5. 2), ramipril is not recommended.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "Because insufficient information is available regarding the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Ramipril</mark> is not recommended.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>lack of sufficient information on</mark> the use of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ramipril</span></span> <mark>pharmacist</mark> during <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breastfeeding</span></span> <mark>submit</mark> (see <span class='tooltip' style='color:red'>^<span class='tooltiptext'>section</span></span> <mark>aid</mark> 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Therefore, sent</mark> is not recommended.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>lack of sufficient information on</mark> the use of ramipril during <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breastfeeding</span></span> <mark>breast-feeding</mark> (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2),</span></span> <mark>2). Therefore,</mark> ramipril is not recommended.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient information</span></span> <mark>There</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>available regarding</span></span> <mark>a lack of information about</mark> the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). Therefore, it</mark> is not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>recommended.</span></span> <mark>recommended to use it.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because insufficient</span></span> <mark>Too little</mark> information is available regarding the use of ramipril during breastfeeding (see section 5. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2), ramipril</span></span> <mark>2). It</mark> is <mark>therefore</mark> not recommended.",
            "Answer.end_timestamp": 1619724809.592,
            "Answer.fluency-1": 78,
            "Answer.fluency-2": 89,
            "Answer.fluency-3": 84,
            "Answer.fluency-4": 93,
            "Answer.fluency-5": 88,
            "Answer.start_timestamp": 1619724794.115,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-5",
            "Input.complex": "Using facts available and in the absence of any other reliable information available for the country, it was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Using facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using facts available and in the absence of any</span></span> <mark>As no</mark> other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reliable</span></span> <mark>private</mark> information <mark>allergic</mark> available for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>this</mark> country, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> <mark>the treatment available had to be used. It</mark> was considered appropriate to base the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determination</span></span> <mark>calculations</mark> on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>contained</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>complaint.</span></span> <mark>rats</mark>",
            "Input.simple-3": "Using facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using facts available and in the absence of any</span></span> <mark>As no</mark> other reliable information <mark>was</mark> available for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>this</mark> country, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> <mark>the facts available had to be used. It</mark> was considered appropriate to base the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determination</span></span> <mark>calculations</mark> on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>contained</mark> in the complaint.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using</span></span> <mark>Based on the</mark> facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>presented</mark> in the complaint.",
            "Answer.end_timestamp": 1619727270.509,
            "Answer.fluency-1": 46,
            "Answer.fluency-2": 66,
            "Answer.fluency-3": 80,
            "Answer.fluency-4": 60,
            "Answer.fluency-5": 38,
            "Answer.start_timestamp": 1619727243.675,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-5",
            "Input.complex": "Using facts available and in the absence of any other reliable information available for the country, it was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Using facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using facts available and in the absence of any</span></span> <mark>As no</mark> other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reliable</span></span> <mark>private</mark> information <mark>allergic</mark> available for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>this</mark> country, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> <mark>the treatment available had to be used. It</mark> was considered appropriate to base the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determination</span></span> <mark>calculations</mark> on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>contained</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>complaint.</span></span> <mark>rats</mark>",
            "Input.simple-3": "Using facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using facts available and in the absence of any</span></span> <mark>As no</mark> other reliable information <mark>was</mark> available for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>this</mark> country, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> <mark>the facts available had to be used. It</mark> was considered appropriate to base the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determination</span></span> <mark>calculations</mark> on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>contained</mark> in the complaint.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using</span></span> <mark>Based on the</mark> facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>presented</mark> in the complaint.",
            "Answer.end_timestamp": 1619724457.584,
            "Answer.fluency-1": 90,
            "Answer.fluency-2": 96,
            "Answer.fluency-3": 94,
            "Answer.fluency-4": 99,
            "Answer.fluency-5": 90,
            "Answer.start_timestamp": 1619724426.539,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-5",
            "Input.complex": "Using facts available and in the absence of any other reliable information available for the country, it was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Using facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using facts available and in the absence of any</span></span> <mark>As no</mark> other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reliable</span></span> <mark>private</mark> information <mark>allergic</mark> available for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>this</mark> country, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> <mark>the treatment available had to be used. It</mark> was considered appropriate to base the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determination</span></span> <mark>calculations</mark> on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>contained</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>complaint.</span></span> <mark>rats</mark>",
            "Input.simple-3": "Using facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information submitted in the complaint.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using facts available and in the absence of any</span></span> <mark>As no</mark> other reliable information <mark>was</mark> available for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>this</mark> country, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> <mark>the facts available had to be used. It</mark> was considered appropriate to base the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determination</span></span> <mark>calculations</mark> on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>contained</mark> in the complaint.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Using</span></span> <mark>Based on the</mark> facts available and in the absence of any other reliable information available for the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>country, it</span></span> <mark>country. It</mark> was considered appropriate to base the determination on the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>presented</mark> in the complaint.",
            "Answer.end_timestamp": 1619730209.053,
            "Answer.fluency-1": 79,
            "Answer.fluency-2": 59,
            "Answer.fluency-3": 35,
            "Answer.fluency-4": 54,
            "Answer.fluency-5": 72,
            "Answer.start_timestamp": 1619730198.693,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-6",
            "Input.complex": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present case, those in Section II. 2 can be applied to a certain extent.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. Those</mark> in Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II.</span></span> <mark>2.</mark> 2 can be applied to a certain extent.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> <mark>Admittedly,</mark> the principles <mark>set out</mark> in Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II. 1</span></span> <mark>II, point 1,</mark> of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning the</mark> sale <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>in the context of</mark> an unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding</span></span> <mark>offer</mark> procedure are not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>applicable</span></span> <mark>valid</mark> in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. However, the principles set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section II. 2 can be applied</span></span> <mark>section II, point 2, of this communication would apply,</mark> to a certain extent.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> <mark>Admittedly,</mark> the principles <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>set ends different</mark> Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II. 1</span></span> <mark>II, point 1,</mark> of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning the</mark> sale <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>in the tested of</mark> an unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding</span></span> <mark>preclude</mark> procedure are not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>applicable</span></span> <mark>valid</mark> in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. However, the principles set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section II. 2 can be applied</span></span> <mark>section II, point 2, of this communication would apply,</mark> to a certain extent.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> principles <mark>set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section</span></span> <mark>section</mark> II. 1 of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning</mark> sale through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an</span></span> unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding procedure</span></span> <mark>tenders</mark> are not applicable in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the present case, those in</span></span> <mark>this case. However,</mark> Section II. 2 can <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be applied</span></span> <mark>apply</mark> to a certain extent.",
            "Input.simple-5": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present case, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those in Section</span></span> <mark>s.</mark> II. 2 can be applied to a certain extent.",
            "Answer.end_timestamp": 1619724826.085,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 49,
            "Answer.fluency-3": 75,
            "Answer.fluency-4": 75,
            "Answer.fluency-5": 51,
            "Answer.start_timestamp": 1619724738.621,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-6",
            "Input.complex": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present case, those in Section II. 2 can be applied to a certain extent.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. Those</mark> in Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II.</span></span> <mark>2.</mark> 2 can be applied to a certain extent.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> <mark>Admittedly,</mark> the principles <mark>set out</mark> in Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II. 1</span></span> <mark>II, point 1,</mark> of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning the</mark> sale <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>in the context of</mark> an unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding</span></span> <mark>offer</mark> procedure are not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>applicable</span></span> <mark>valid</mark> in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. However, the principles set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section II. 2 can be applied</span></span> <mark>section II, point 2, of this communication would apply,</mark> to a certain extent.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> <mark>Admittedly,</mark> the principles <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>set ends different</mark> Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II. 1</span></span> <mark>II, point 1,</mark> of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning the</mark> sale <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>in the tested of</mark> an unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding</span></span> <mark>preclude</mark> procedure are not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>applicable</span></span> <mark>valid</mark> in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. However, the principles set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section II. 2 can be applied</span></span> <mark>section II, point 2, of this communication would apply,</mark> to a certain extent.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> principles <mark>set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section</span></span> <mark>section</mark> II. 1 of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning</mark> sale through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an</span></span> unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding procedure</span></span> <mark>tenders</mark> are not applicable in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the present case, those in</span></span> <mark>this case. However,</mark> Section II. 2 can <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be applied</span></span> <mark>apply</mark> to a certain extent.",
            "Input.simple-5": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present case, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those in Section</span></span> <mark>s.</mark> II. 2 can be applied to a certain extent.",
            "Answer.end_timestamp": 1619724544.491,
            "Answer.fluency-1": 97,
            "Answer.fluency-2": 86,
            "Answer.fluency-3": 97,
            "Answer.fluency-4": 91,
            "Answer.fluency-5": 99,
            "Answer.start_timestamp": 1619724532.224,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-6",
            "Input.complex": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present case, those in Section II. 2 can be applied to a certain extent.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. Those</mark> in Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II.</span></span> <mark>2.</mark> 2 can be applied to a certain extent.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> <mark>Admittedly,</mark> the principles <mark>set out</mark> in Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II. 1</span></span> <mark>II, point 1,</mark> of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning the</mark> sale <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>in the context of</mark> an unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding</span></span> <mark>offer</mark> procedure are not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>applicable</span></span> <mark>valid</mark> in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. However, the principles set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section II. 2 can be applied</span></span> <mark>section II, point 2, of this communication would apply,</mark> to a certain extent.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> <mark>Admittedly,</mark> the principles <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>set ends different</mark> Section <span class='tooltip' style='color:red'>^<span class='tooltiptext'>II. 1</span></span> <mark>II, point 1,</mark> of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning the</mark> sale <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>in the tested of</mark> an unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding</span></span> <mark>preclude</mark> procedure are not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>applicable</span></span> <mark>valid</mark> in the present <span class='tooltip' style='color:red'>^<span class='tooltiptext'>case, those</span></span> <mark>case. However, the principles set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section II. 2 can be applied</span></span> <mark>section II, point 2, of this communication would apply,</mark> to a certain extent.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> principles <mark>set out</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Section</span></span> <mark>section</mark> II. 1 of the communication <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regarding</span></span> <mark>concerning</mark> sale through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an</span></span> unconditional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bidding procedure</span></span> <mark>tenders</mark> are not applicable in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the present case, those in</span></span> <mark>this case. However,</mark> Section II. 2 can <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be applied</span></span> <mark>apply</mark> to a certain extent.",
            "Input.simple-5": "Although the principles in Section II. 1 of the communication regarding sale through an unconditional bidding procedure are not applicable in the present case, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those in Section</span></span> <mark>s.</mark> II. 2 can be applied to a certain extent.",
            "Answer.end_timestamp": 1619727925.49,
            "Answer.fluency-1": 55,
            "Answer.fluency-2": 90,
            "Answer.fluency-3": 73,
            "Answer.fluency-4": 42,
            "Answer.fluency-5": 61,
            "Answer.start_timestamp": 1619727914.054,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-7",
            "Input.complex": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of trade, the rules applicable to wines imported from the United States of America should be extended in the light of the progress of the negotiations.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade,</span></span> <mark>trade. Therefore,</mark> the rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States</span></span> <mark>US</mark> of America should be extended in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with the United States of America will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be completed</mark> before the end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rules</span></span> <mark>currently</mark> applicable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>rules for</mark> wines imported from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the United States of America should</span></span> <mark>this country are to</mark> be extended in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with the United States of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>America</span></span> <mark>product</mark> will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be completed</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>advisable</mark> end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rules</span></span> <mark>currently</mark> applicable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>rules questionnaire</mark> wines imported from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the United States of America should</span></span> <mark>Lamivudine country are to</mark> be extended in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-4": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of trade, the rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States of America</span></span> <mark>US. These rules</mark> should be extended in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-5": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, the</span></span> <mark>trade. The</mark> rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States</span></span> <mark>US</mark> of America should be extended in the light of the progress of the negotiations.",
            "Answer.end_timestamp": 1619726215.642,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 50,
            "Answer.fluency-3": 75,
            "Answer.fluency-4": 88,
            "Answer.fluency-5": 75,
            "Answer.start_timestamp": 1619726156.759,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-7",
            "Input.complex": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of trade, the rules applicable to wines imported from the United States of America should be extended in the light of the progress of the negotiations.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade,</span></span> <mark>trade. Therefore,</mark> the rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States</span></span> <mark>US</mark> of America should be extended in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with the United States of America will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be completed</mark> before the end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rules</span></span> <mark>currently</mark> applicable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>rules for</mark> wines imported from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the United States of America should</span></span> <mark>this country are to</mark> be extended in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with the United States of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>America</span></span> <mark>product</mark> will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be completed</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>advisable</mark> end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rules</span></span> <mark>currently</mark> applicable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>rules questionnaire</mark> wines imported from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the United States of America should</span></span> <mark>Lamivudine country are to</mark> be extended in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-4": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of trade, the rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States of America</span></span> <mark>US. These rules</mark> should be extended in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-5": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, the</span></span> <mark>trade. The</mark> rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States</span></span> <mark>US</mark> of America should be extended in the light of the progress of the negotiations.",
            "Answer.end_timestamp": 1619724642.25,
            "Answer.fluency-1": 79,
            "Answer.fluency-2": 89,
            "Answer.fluency-3": 84,
            "Answer.fluency-4": 90,
            "Answer.fluency-5": 90,
            "Answer.start_timestamp": 1619724497.699,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-7",
            "Input.complex": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of trade, the rules applicable to wines imported from the United States of America should be extended in the light of the progress of the negotiations.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade,</span></span> <mark>trade. Therefore,</mark> the rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States</span></span> <mark>US</mark> of America should be extended in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with the United States of America will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be completed</mark> before the end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rules</span></span> <mark>currently</mark> applicable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>rules for</mark> wines imported from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the United States of America should</span></span> <mark>this country are to</mark> be extended in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with the United States of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>America</span></span> <mark>product</mark> will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be completed</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>advisable</mark> end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rules</span></span> <mark>currently</mark> applicable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>rules questionnaire</mark> wines imported from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the United States of America should</span></span> <mark>Lamivudine country are to</mark> be extended in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-4": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of trade, the rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States of America</span></span> <mark>US. These rules</mark> should be extended in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-5": "Since the bilateral negotiations in progress with the United States of America will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, the</span></span> <mark>trade. The</mark> rules applicable to wines imported from the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>United States</span></span> <mark>US</mark> of America should be extended in the light of the progress of the negotiations.",
            "Answer.end_timestamp": 1619724604.126,
            "Answer.fluency-1": 96,
            "Answer.fluency-2": 90,
            "Answer.fluency-3": 99,
            "Answer.fluency-4": 84,
            "Answer.fluency-5": 92,
            "Answer.start_timestamp": 1619724574.777,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-8",
            "Input.complex": "When the offer for sale is submitted to the intervention agency the intervention centre to which the seller intends to deliver the product and where the product is located at the time of the offer must be stated.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "When the offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale</span></span> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>presented</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency,</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. It must also specify</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>When the</span></span> <mark>The</mark> offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale is submitted</span></span> <mark>to sell must be addressed</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency, specifying</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. The offer must indicate the place</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>When the</span></span> <mark>The</mark> offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale is submitted</span></span> <mark>to account must be addressed</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency, specifying</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>intervention centre</span></span> <mark>drugs center</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which</span></span> <mark>strengthen</mark> the seller <span class='tooltip' style='color:red'>^<span class='tooltiptext'>intends</span></span> <mark>installation</mark> to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. The offer must indicate the place</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-4": "When the offer for sale is submitted to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency,</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and where</span></span> <mark>product. Where</mark> the product is located at the time of the offer must be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stated.</span></span> <mark>indicated.</mark>",
            "Input.simple-5": "When the offer for sale is submitted to the intervention agency the intervention centre to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and where</span></span> <mark>product. Where</mark> the product is located at the time of the offer must be stated.",
            "Answer.end_timestamp": 1619727322.567,
            "Answer.fluency-1": 40,
            "Answer.fluency-2": 51,
            "Answer.fluency-3": 64,
            "Answer.fluency-4": 76,
            "Answer.fluency-5": 60,
            "Answer.start_timestamp": 1619727282.984,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-8",
            "Input.complex": "When the offer for sale is submitted to the intervention agency the intervention centre to which the seller intends to deliver the product and where the product is located at the time of the offer must be stated.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "When the offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale</span></span> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>presented</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency,</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. It must also specify</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>When the</span></span> <mark>The</mark> offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale is submitted</span></span> <mark>to sell must be addressed</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency, specifying</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. The offer must indicate the place</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>When the</span></span> <mark>The</mark> offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale is submitted</span></span> <mark>to account must be addressed</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency, specifying</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>intervention centre</span></span> <mark>drugs center</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which</span></span> <mark>strengthen</mark> the seller <span class='tooltip' style='color:red'>^<span class='tooltiptext'>intends</span></span> <mark>installation</mark> to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. The offer must indicate the place</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-4": "When the offer for sale is submitted to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency,</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and where</span></span> <mark>product. Where</mark> the product is located at the time of the offer must be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stated.</span></span> <mark>indicated.</mark>",
            "Input.simple-5": "When the offer for sale is submitted to the intervention agency the intervention centre to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and where</span></span> <mark>product. Where</mark> the product is located at the time of the offer must be stated.",
            "Answer.end_timestamp": 1619724530.752,
            "Answer.fluency-1": 84,
            "Answer.fluency-2": 96,
            "Answer.fluency-3": 85,
            "Answer.fluency-4": 98,
            "Answer.fluency-5": 90,
            "Answer.start_timestamp": 1619724517.867,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-8",
            "Input.complex": "When the offer for sale is submitted to the intervention agency the intervention centre to which the seller intends to deliver the product and where the product is located at the time of the offer must be stated.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "When the offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale</span></span> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>submitted</span></span> <mark>presented</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency,</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. It must also specify</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>When the</span></span> <mark>The</mark> offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale is submitted</span></span> <mark>to sell must be addressed</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency, specifying</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. The offer must indicate the place</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>When the</span></span> <mark>The</mark> offer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for sale is submitted</span></span> <mark>to account must be addressed</mark> to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency, specifying</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>intervention centre</span></span> <mark>drugs center</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which</span></span> <mark>strengthen</mark> the seller <span class='tooltip' style='color:red'>^<span class='tooltiptext'>intends</span></span> <mark>installation</mark> to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and</span></span> <mark>product. The offer must indicate the place</mark> where the product is located at the time of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>offer must be stated.</span></span> <mark>offer.</mark>",
            "Input.simple-4": "When the offer for sale is submitted to the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agency</span></span> <mark>agency,</mark> the intervention <span class='tooltip' style='color:red'>^<span class='tooltiptext'>centre</span></span> <mark>center</mark> to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and where</span></span> <mark>product. Where</mark> the product is located at the time of the offer must be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stated.</span></span> <mark>indicated.</mark>",
            "Input.simple-5": "When the offer for sale is submitted to the intervention agency the intervention centre to which the seller intends to deliver the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product and where</span></span> <mark>product. Where</mark> the product is located at the time of the offer must be stated.",
            "Answer.end_timestamp": 1619730155.129,
            "Answer.fluency-1": 76,
            "Answer.fluency-2": 62,
            "Answer.fluency-3": 38,
            "Answer.fluency-4": 54,
            "Answer.fluency-5": 65,
            "Answer.start_timestamp": 1619730138.586,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-9",
            "Input.complex": "As the purpose of this type of review is to assess the likelihood of dumping should measures be removed, it was not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an anti-dumping investigation carried out under Article 5 of the basic Regulation.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "As the purpose of this type of review is to assess the likelihood of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an anti-dumping investigation carried out under Article 5 of the basic Regulation.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the purpose of this</span></span> <mark>This</mark> type of review <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>aims</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assess</span></span> <mark>determine</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>likelihood</span></span> <mark>risk</mark> of dumping should measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be removed, it</span></span> <mark>Tian repealed. It</mark> was <mark>therefore</mark> not considered necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or appropriate</span></span> <mark>determined Admittedly</mark> to calculate <mark>the</mark> dumping margins or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allowances</span></span> <mark>the adjustments</mark> with the precision that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>would be necessary in</span></span> an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>Regulation</mark> investigation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>carried out</span></span> <mark>would require</mark> under Article 5 of the basic Regulation.",
            "Input.simple-3": "As the purpose of this type of review is to assess the likelihood of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>anti - dumping</mark> investigation carried out under Article 5 of the basic Regulation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> purpose of this type of review is to assess the likelihood of dumping should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>measures</span></span> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>dumping</span></span> <mark>the</mark> margins or allowances with the precision <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that would be</span></span> necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>for</mark> an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>anti - dumping</mark> investigation carried out under Article 5 of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basic</span></span> <mark>Basic</mark> Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the purpose of this</span></span> <mark>This</mark> type of review <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>aims</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assess</span></span> <mark>determine</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>likelihood</span></span> <mark>risk</mark> of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>repealed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate <mark>the</mark> dumping margins or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allowances</span></span> <mark>the adjustments</mark> with the precision that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>would be necessary in</span></span> an anti-dumping investigation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>carried out</span></span> <mark>would require</mark> under Article 5 of the basic Regulation.",
            "Answer.end_timestamp": 1619731798.143,
            "Answer.fluency-1": 57,
            "Answer.fluency-2": 42,
            "Answer.fluency-3": 77,
            "Answer.fluency-4": 62,
            "Answer.fluency-5": 45,
            "Answer.start_timestamp": 1619731779.065,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-9",
            "Input.complex": "As the purpose of this type of review is to assess the likelihood of dumping should measures be removed, it was not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an anti-dumping investigation carried out under Article 5 of the basic Regulation.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "As the purpose of this type of review is to assess the likelihood of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an anti-dumping investigation carried out under Article 5 of the basic Regulation.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the purpose of this</span></span> <mark>This</mark> type of review <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>aims</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assess</span></span> <mark>determine</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>likelihood</span></span> <mark>risk</mark> of dumping should measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be removed, it</span></span> <mark>Tian repealed. It</mark> was <mark>therefore</mark> not considered necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or appropriate</span></span> <mark>determined Admittedly</mark> to calculate <mark>the</mark> dumping margins or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allowances</span></span> <mark>the adjustments</mark> with the precision that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>would be necessary in</span></span> an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>Regulation</mark> investigation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>carried out</span></span> <mark>would require</mark> under Article 5 of the basic Regulation.",
            "Input.simple-3": "As the purpose of this type of review is to assess the likelihood of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>anti - dumping</mark> investigation carried out under Article 5 of the basic Regulation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> purpose of this type of review is to assess the likelihood of dumping should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>measures</span></span> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>dumping</span></span> <mark>the</mark> margins or allowances with the precision <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that would be</span></span> necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>for</mark> an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>anti - dumping</mark> investigation carried out under Article 5 of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basic</span></span> <mark>Basic</mark> Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the purpose of this</span></span> <mark>This</mark> type of review <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>aims</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assess</span></span> <mark>determine</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>likelihood</span></span> <mark>risk</mark> of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>repealed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate <mark>the</mark> dumping margins or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allowances</span></span> <mark>the adjustments</mark> with the precision that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>would be necessary in</span></span> an anti-dumping investigation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>carried out</span></span> <mark>would require</mark> under Article 5 of the basic Regulation.",
            "Answer.end_timestamp": 1619724454.354,
            "Answer.fluency-1": 66,
            "Answer.fluency-2": 80,
            "Answer.fluency-3": 69,
            "Answer.fluency-4": 85,
            "Answer.fluency-5": 79,
            "Answer.start_timestamp": 1619724440.741,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-9",
            "Input.complex": "As the purpose of this type of review is to assess the likelihood of dumping should measures be removed, it was not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an anti-dumping investigation carried out under Article 5 of the basic Regulation.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "As the purpose of this type of review is to assess the likelihood of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an anti-dumping investigation carried out under Article 5 of the basic Regulation.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the purpose of this</span></span> <mark>This</mark> type of review <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>aims</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assess</span></span> <mark>determine</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>likelihood</span></span> <mark>risk</mark> of dumping should measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be removed, it</span></span> <mark>Tian repealed. It</mark> was <mark>therefore</mark> not considered necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or appropriate</span></span> <mark>determined Admittedly</mark> to calculate <mark>the</mark> dumping margins or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allowances</span></span> <mark>the adjustments</mark> with the precision that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>would be necessary in</span></span> an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>Regulation</mark> investigation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>carried out</span></span> <mark>would require</mark> under Article 5 of the basic Regulation.",
            "Input.simple-3": "As the purpose of this type of review is to assess the likelihood of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was not considered necessary or appropriate to calculate dumping margins or allowances with the precision that would be necessary in an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>anti - dumping</mark> investigation carried out under Article 5 of the basic Regulation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> purpose of this type of review is to assess the likelihood of dumping should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>measures</span></span> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>removed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>dumping</span></span> <mark>the</mark> margins or allowances with the precision <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that would be</span></span> necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>for</mark> an <span class='tooltip' style='color:red'>^<span class='tooltiptext'>anti-dumping</span></span> <mark>anti - dumping</mark> investigation carried out under Article 5 of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basic</span></span> <mark>Basic</mark> Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the purpose of this</span></span> <mark>This</mark> type of review <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>aims</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>assess</span></span> <mark>determine</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>likelihood</span></span> <mark>risk</mark> of dumping should measures be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>removed, it</span></span> <mark>repealed. It</mark> was <mark>therefore</mark> not considered necessary or appropriate to calculate <mark>the</mark> dumping margins or <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allowances</span></span> <mark>the adjustments</mark> with the precision that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>would be necessary in</span></span> an anti-dumping investigation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>carried out</span></span> <mark>would require</mark> under Article 5 of the basic Regulation.",
            "Answer.end_timestamp": 1619727872.828,
            "Answer.fluency-1": 48,
            "Answer.fluency-2": 64,
            "Answer.fluency-3": 78,
            "Answer.fluency-4": 64,
            "Answer.fluency-5": 90,
            "Answer.start_timestamp": 1619727860.76,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-10",
            "Input.complex": "Whilst studies in rats and mice have not produced any evidence of teratogenic effect, the safety in pregnant and lactating sows has not been established.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst studies</span></span> <mark>Studies</mark> in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect,</span></span> <mark>effect. However,</mark> the safety <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>of</mark> pregnant and lactating sows has not been established.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst</span></span> <mark>No teratogenic effect has part demonstrated sows</mark> studies <mark>conducted</mark> in rats <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and mice have not produced any evidence of teratogenic effect, the</span></span> <mark>However mice. The</mark> safety <mark>of the product</mark> in pregnant <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>or</mark> lactating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>sows has</span></span> <mark>sows, however, consult</mark> not been established.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst studies</span></span> <mark>Studies</mark> in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect,</span></span> <mark>effect. However,</mark> the safety <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>of</mark> pregnant and lactating sows has not been established.",
            "Input.simple-4": "Whilst studies in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect, the</span></span> <mark>effect. The</mark> safety in pregnant and lactating sows has not been established.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst</span></span> <mark>No teratogenic effect has been demonstrated in</mark> studies <mark>conducted</mark> in rats and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mice have not produced any evidence of teratogenic effect, the</span></span> <mark>mice. The</mark> safety <mark>of the product</mark> in pregnant <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>or</mark> lactating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>sows</span></span> <mark>sows, however,</mark> has not been established.",
            "Answer.end_timestamp": 1619756199.484,
            "Answer.fluency-1": 77,
            "Answer.fluency-2": 75,
            "Answer.fluency-3": 58,
            "Answer.fluency-4": 86,
            "Answer.fluency-5": 70,
            "Answer.start_timestamp": 1619756186.552,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-10",
            "Input.complex": "Whilst studies in rats and mice have not produced any evidence of teratogenic effect, the safety in pregnant and lactating sows has not been established.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst studies</span></span> <mark>Studies</mark> in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect,</span></span> <mark>effect. However,</mark> the safety <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>of</mark> pregnant and lactating sows has not been established.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst</span></span> <mark>No teratogenic effect has part demonstrated sows</mark> studies <mark>conducted</mark> in rats <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and mice have not produced any evidence of teratogenic effect, the</span></span> <mark>However mice. The</mark> safety <mark>of the product</mark> in pregnant <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>or</mark> lactating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>sows has</span></span> <mark>sows, however, consult</mark> not been established.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst studies</span></span> <mark>Studies</mark> in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect,</span></span> <mark>effect. However,</mark> the safety <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>of</mark> pregnant and lactating sows has not been established.",
            "Input.simple-4": "Whilst studies in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect, the</span></span> <mark>effect. The</mark> safety in pregnant and lactating sows has not been established.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst</span></span> <mark>No teratogenic effect has been demonstrated in</mark> studies <mark>conducted</mark> in rats and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mice have not produced any evidence of teratogenic effect, the</span></span> <mark>mice. The</mark> safety <mark>of the product</mark> in pregnant <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>or</mark> lactating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>sows</span></span> <mark>sows, however,</mark> has not been established.",
            "Answer.end_timestamp": 1619727242.429,
            "Answer.fluency-1": 67,
            "Answer.fluency-2": 53,
            "Answer.fluency-3": 34,
            "Answer.fluency-4": 61,
            "Answer.fluency-5": 78,
            "Answer.start_timestamp": 1619727225.253,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-10",
            "Input.complex": "Whilst studies in rats and mice have not produced any evidence of teratogenic effect, the safety in pregnant and lactating sows has not been established.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst studies</span></span> <mark>Studies</mark> in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect,</span></span> <mark>effect. However,</mark> the safety <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>of</mark> pregnant and lactating sows has not been established.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst</span></span> <mark>No teratogenic effect has part demonstrated sows</mark> studies <mark>conducted</mark> in rats <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and mice have not produced any evidence of teratogenic effect, the</span></span> <mark>However mice. The</mark> safety <mark>of the product</mark> in pregnant <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>or</mark> lactating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>sows has</span></span> <mark>sows, however, consult</mark> not been established.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst studies</span></span> <mark>Studies</mark> in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect,</span></span> <mark>effect. However,</mark> the safety <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in</span></span> <mark>of</mark> pregnant and lactating sows has not been established.",
            "Input.simple-4": "Whilst studies in rats and mice have not produced any evidence of teratogenic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>effect, the</span></span> <mark>effect. The</mark> safety in pregnant and lactating sows has not been established.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst</span></span> <mark>No teratogenic effect has been demonstrated in</mark> studies <mark>conducted</mark> in rats and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mice have not produced any evidence of teratogenic effect, the</span></span> <mark>mice. The</mark> safety <mark>of the product</mark> in pregnant <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>or</mark> lactating <span class='tooltip' style='color:red'>^<span class='tooltiptext'>sows</span></span> <mark>sows, however,</mark> has not been established.",
            "Answer.end_timestamp": 1619724405.697,
            "Answer.fluency-1": 58,
            "Answer.fluency-2": 43,
            "Answer.fluency-3": 80,
            "Answer.fluency-4": 68,
            "Answer.fluency-5": 59,
            "Answer.start_timestamp": 1619724392.986,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-11",
            "Input.complex": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be deleted, it is included in the standard contractual clauses for the sake of clarification and to avoid the need for the parties to negotiate indemnification clauses individually.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>deleted, it</span></span> <mark>deleted. It</mark> is included in the standard contractual clauses for the sake of clarification and to avoid the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification</span></span> <mark>indemmanification</mark> clauses individually.",
            "Input.simple-2": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be deleted, it is included in the standard contractual clauses for the sake of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>clarification and to avoid</span></span> <mark>clarification. This avoids</mark> the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification clauses individually.</span></span> <mark>individually clauses.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual</span></span> <mark>Mutual</mark> indemnification between the parties is not a requirement for the adequacy of the protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of</mark> the data subjects and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> therefore be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>deleted,</span></span> <mark>deleted. However,</mark> it is included in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> standard contractual clauses for the sake of clarification and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to avoid</span></span> <mark>avoids</mark> the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification clauses</span></span> individually.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual indemnification</span></span> <mark>The provision on a reciprocal right to compensation</mark> between the parties is not a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>requirement</span></span> <mark>prerequisite</mark> for the adequacy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>implementation</mark> the <mark>level of</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>are</mark> the data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>subjects</span></span> <mark>subjects,</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may therefore be deleted,</span></span> <mark>the parties can avoid this provision. In the interest identify clarity, however,</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> included in the standard contractual clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for the sake of clarification</span></span> and to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>avoid the need for</span></span> <mark>save</mark> the parties <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to negotiate indemnification</span></span> <mark>from negotiating compensation</mark> clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>individually.</span></span> <mark>in individual cases.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual indemnification</span></span> <mark>The provision on a reciprocal right to compensation</mark> between the parties is not a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>requirement</span></span> <mark>prerequisite</mark> for the adequacy of the <mark>level of</mark> protection for the data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>subjects</span></span> <mark>subjects,</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may therefore be deleted,</span></span> <mark>the parties can delete this provision. In the interest of clarity, however,</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> included in the standard contractual clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for the sake of clarification</span></span> and to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>avoid the need for</span></span> <mark>save</mark> the parties <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to negotiate indemnification</span></span> <mark>from negotiating compensation</mark> clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>individually.</span></span> <mark>in individual cases.</mark>",
            "Answer.end_timestamp": 1619724174.809,
            "Answer.fluency-1": 51,
            "Answer.fluency-2": 73,
            "Answer.fluency-3": 38,
            "Answer.fluency-4": 66,
            "Answer.fluency-5": 53,
            "Answer.start_timestamp": 1619724164.359,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-11",
            "Input.complex": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be deleted, it is included in the standard contractual clauses for the sake of clarification and to avoid the need for the parties to negotiate indemnification clauses individually.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>deleted, it</span></span> <mark>deleted. It</mark> is included in the standard contractual clauses for the sake of clarification and to avoid the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification</span></span> <mark>indemmanification</mark> clauses individually.",
            "Input.simple-2": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be deleted, it is included in the standard contractual clauses for the sake of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>clarification and to avoid</span></span> <mark>clarification. This avoids</mark> the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification clauses individually.</span></span> <mark>individually clauses.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual</span></span> <mark>Mutual</mark> indemnification between the parties is not a requirement for the adequacy of the protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of</mark> the data subjects and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> therefore be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>deleted,</span></span> <mark>deleted. However,</mark> it is included in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> standard contractual clauses for the sake of clarification and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to avoid</span></span> <mark>avoids</mark> the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification clauses</span></span> individually.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual indemnification</span></span> <mark>The provision on a reciprocal right to compensation</mark> between the parties is not a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>requirement</span></span> <mark>prerequisite</mark> for the adequacy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>implementation</mark> the <mark>level of</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>are</mark> the data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>subjects</span></span> <mark>subjects,</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may therefore be deleted,</span></span> <mark>the parties can avoid this provision. In the interest identify clarity, however,</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> included in the standard contractual clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for the sake of clarification</span></span> and to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>avoid the need for</span></span> <mark>save</mark> the parties <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to negotiate indemnification</span></span> <mark>from negotiating compensation</mark> clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>individually.</span></span> <mark>in individual cases.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual indemnification</span></span> <mark>The provision on a reciprocal right to compensation</mark> between the parties is not a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>requirement</span></span> <mark>prerequisite</mark> for the adequacy of the <mark>level of</mark> protection for the data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>subjects</span></span> <mark>subjects,</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may therefore be deleted,</span></span> <mark>the parties can delete this provision. In the interest of clarity, however,</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> included in the standard contractual clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for the sake of clarification</span></span> and to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>avoid the need for</span></span> <mark>save</mark> the parties <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to negotiate indemnification</span></span> <mark>from negotiating compensation</mark> clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>individually.</span></span> <mark>in individual cases.</mark>",
            "Answer.end_timestamp": 1619724486.973,
            "Answer.fluency-1": 95,
            "Answer.fluency-2": 83,
            "Answer.fluency-3": 90,
            "Answer.fluency-4": 98,
            "Answer.fluency-5": 86,
            "Answer.start_timestamp": 1619724473.06,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-11",
            "Input.complex": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be deleted, it is included in the standard contractual clauses for the sake of clarification and to avoid the need for the parties to negotiate indemnification clauses individually.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>deleted, it</span></span> <mark>deleted. It</mark> is included in the standard contractual clauses for the sake of clarification and to avoid the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification</span></span> <mark>indemmanification</mark> clauses individually.",
            "Input.simple-2": "Although mutual indemnification between the parties is not a requirement for the adequacy of the protection for the data subjects and may therefore be deleted, it is included in the standard contractual clauses for the sake of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>clarification and to avoid</span></span> <mark>clarification. This avoids</mark> the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification clauses individually.</span></span> <mark>individually clauses.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual</span></span> <mark>Mutual</mark> indemnification between the parties is not a requirement for the adequacy of the protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of</mark> the data subjects and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may</span></span> <mark>can</mark> therefore be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>deleted,</span></span> <mark>deleted. However,</mark> it is included in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> standard contractual clauses for the sake of clarification and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to avoid</span></span> <mark>avoids</mark> the need for the parties to negotiate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>indemnification clauses</span></span> individually.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual indemnification</span></span> <mark>The provision on a reciprocal right to compensation</mark> between the parties is not a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>requirement</span></span> <mark>prerequisite</mark> for the adequacy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>implementation</mark> the <mark>level of</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>are</mark> the data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>subjects</span></span> <mark>subjects,</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may therefore be deleted,</span></span> <mark>the parties can avoid this provision. In the interest identify clarity, however,</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> included in the standard contractual clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for the sake of clarification</span></span> and to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>avoid the need for</span></span> <mark>save</mark> the parties <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to negotiate indemnification</span></span> <mark>from negotiating compensation</mark> clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>individually.</span></span> <mark>in individual cases.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although mutual indemnification</span></span> <mark>The provision on a reciprocal right to compensation</mark> between the parties is not a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>requirement</span></span> <mark>prerequisite</mark> for the adequacy of the <mark>level of</mark> protection for the data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>subjects</span></span> <mark>subjects,</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>may therefore be deleted,</span></span> <mark>the parties can delete this provision. In the interest of clarity, however,</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> included in the standard contractual clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for the sake of clarification</span></span> and to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>avoid the need for</span></span> <mark>save</mark> the parties <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to negotiate indemnification</span></span> <mark>from negotiating compensation</mark> clauses <span class='tooltip' style='color:red'>^<span class='tooltiptext'>individually.</span></span> <mark>in individual cases.</mark>",
            "Answer.end_timestamp": 1619727958.091,
            "Answer.fluency-1": 29,
            "Answer.fluency-2": 50,
            "Answer.fluency-3": 83,
            "Answer.fluency-4": 63,
            "Answer.fluency-5": 50,
            "Answer.start_timestamp": 1619727939.506,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-12",
            "Input.complex": "Unless the plasma is pooled and frozen within 48 hours of collecting the blood, the sterility of each unit shall be tested by culturing not less than 10 ml.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>must</mark> be tested by culturing <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not</span></span> less than 10 ml.",
            "Input.simple-2": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit shall be tested by culturing not less than 10 ml.",
            "Input.simple-3": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>must</mark> be tested by culturing <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not less than</span></span> <mark>at least</mark> 10 ml.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Unless the plasma</span></span> <mark>Plasma</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pooled</span></span> <mark>mixed</mark> and frozen within 48 hours <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of collecting the blood,</span></span> <mark>following blood collection. In this case,</mark> the sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>should</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tested by culturing not less than</span></span> <mark>verified with cultures of at least</mark> 10 ml.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Unless the plasma</span></span> <mark>Plasma</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pooled</span></span> <mark>be</mark> and frozen within 48 hours <mark>following</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>collecting the blood,</span></span> <mark>collection. In this immune</mark> the sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>another</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tested by culturing not less than</span></span> <mark>verified with cultures of at least</mark> 10 ml.",
            "Answer.end_timestamp": 1619727377.175,
            "Answer.fluency-1": 63,
            "Answer.fluency-2": 83,
            "Answer.fluency-3": 60,
            "Answer.fluency-4": 39,
            "Answer.fluency-5": 81,
            "Answer.start_timestamp": 1619727363.311,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-12",
            "Input.complex": "Unless the plasma is pooled and frozen within 48 hours of collecting the blood, the sterility of each unit shall be tested by culturing not less than 10 ml.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>must</mark> be tested by culturing <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not</span></span> less than 10 ml.",
            "Input.simple-2": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit shall be tested by culturing not less than 10 ml.",
            "Input.simple-3": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>must</mark> be tested by culturing <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not less than</span></span> <mark>at least</mark> 10 ml.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Unless the plasma</span></span> <mark>Plasma</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pooled</span></span> <mark>mixed</mark> and frozen within 48 hours <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of collecting the blood,</span></span> <mark>following blood collection. In this case,</mark> the sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>should</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tested by culturing not less than</span></span> <mark>verified with cultures of at least</mark> 10 ml.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Unless the plasma</span></span> <mark>Plasma</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pooled</span></span> <mark>be</mark> and frozen within 48 hours <mark>following</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>collecting the blood,</span></span> <mark>collection. In this immune</mark> the sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>another</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tested by culturing not less than</span></span> <mark>verified with cultures of at least</mark> 10 ml.",
            "Answer.end_timestamp": 1619724453.862,
            "Answer.fluency-1": 43,
            "Answer.fluency-2": 67,
            "Answer.fluency-3": 51,
            "Answer.fluency-4": 76,
            "Answer.fluency-5": 49,
            "Answer.start_timestamp": 1619724448.946,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-12",
            "Input.complex": "Unless the plasma is pooled and frozen within 48 hours of collecting the blood, the sterility of each unit shall be tested by culturing not less than 10 ml.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>must</mark> be tested by culturing <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not</span></span> less than 10 ml.",
            "Input.simple-2": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit shall be tested by culturing not less than 10 ml.",
            "Input.simple-3": "Unless the plasma is pooled and frozen within 48 hours of collecting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>blood, the</span></span> <mark>blood. The</mark> sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>must</mark> be tested by culturing <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not less than</span></span> <mark>at least</mark> 10 ml.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Unless the plasma</span></span> <mark>Plasma</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pooled</span></span> <mark>mixed</mark> and frozen within 48 hours <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of collecting the blood,</span></span> <mark>following blood collection. In this case,</mark> the sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>should</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tested by culturing not less than</span></span> <mark>verified with cultures of at least</mark> 10 ml.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Unless the plasma</span></span> <mark>Plasma</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pooled</span></span> <mark>be</mark> and frozen within 48 hours <mark>following</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>collecting the blood,</span></span> <mark>collection. In this immune</mark> the sterility of each unit <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shall</span></span> <mark>another</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tested by culturing not less than</span></span> <mark>verified with cultures of at least</mark> 10 ml.",
            "Answer.end_timestamp": 1619727859.755,
            "Answer.fluency-1": 48,
            "Answer.fluency-2": 69,
            "Answer.fluency-3": 82,
            "Answer.fluency-4": 67,
            "Answer.fluency-5": 51,
            "Answer.start_timestamp": 1619727841.094,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-13",
            "Input.complex": "Since it would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the toll, tolls are collected as a whole at the entrance of the tunnel.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Since it would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll,</span></span> <mark>toll. As a result,</mark> tolls are collected as a whole at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it would be expensive and disruptive to have</span></span> <mark>The installation of</mark> a toll <span class='tooltip' style='color:red'>^<span class='tooltiptext'>booth</span></span> <mark>system</mark> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>each end</span></span> <mark>both ends</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tunnel for</span></span> <mark>tunnel, allowing</mark> each <mark>of the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>States concerned</mark> to collect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> <mark>its</mark> share of the toll, <mark>would be expensive and would have disruptive effects. Therefore,</mark> tolls are collected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as a whole</span></span> <mark>globally</mark> at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it</span></span> <mark>It</mark> would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll, tolls are</span></span> <mark>toll. The toll is therefore</mark> collected as a whole at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it</span></span> <mark>It</mark> would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll,</span></span> <mark>toll. Therefore, the</mark> tolls are collected as a whole at the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>entrance of the tunnel.</span></span> <mark>entrance.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it would be expensive and disruptive to have</span></span> <mark>The installation of</mark> a toll <span class='tooltip' style='color:red'>^<span class='tooltiptext'>booth at each end</span></span> <mark>system material ml ends</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tunnel for</span></span> <mark>tunnel, starting</mark> each <mark>of the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>States concerned</mark> to collect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> <mark>its</mark> share of the toll, <mark>would be expensive and taxable have disruptive effects. Therefore,</mark> tolls are collected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as a whole</span></span> <mark>globally</mark> at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Answer.end_timestamp": 1619724399.674,
            "Answer.fluency-1": 57,
            "Answer.fluency-2": 69,
            "Answer.fluency-3": 37,
            "Answer.fluency-4": 53,
            "Answer.fluency-5": 84,
            "Answer.start_timestamp": 1619724383.032,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-13",
            "Input.complex": "Since it would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the toll, tolls are collected as a whole at the entrance of the tunnel.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Since it would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll,</span></span> <mark>toll. As a result,</mark> tolls are collected as a whole at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it would be expensive and disruptive to have</span></span> <mark>The installation of</mark> a toll <span class='tooltip' style='color:red'>^<span class='tooltiptext'>booth</span></span> <mark>system</mark> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>each end</span></span> <mark>both ends</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tunnel for</span></span> <mark>tunnel, allowing</mark> each <mark>of the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>States concerned</mark> to collect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> <mark>its</mark> share of the toll, <mark>would be expensive and would have disruptive effects. Therefore,</mark> tolls are collected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as a whole</span></span> <mark>globally</mark> at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it</span></span> <mark>It</mark> would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll, tolls are</span></span> <mark>toll. The toll is therefore</mark> collected as a whole at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it</span></span> <mark>It</mark> would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll,</span></span> <mark>toll. Therefore, the</mark> tolls are collected as a whole at the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>entrance of the tunnel.</span></span> <mark>entrance.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it would be expensive and disruptive to have</span></span> <mark>The installation of</mark> a toll <span class='tooltip' style='color:red'>^<span class='tooltiptext'>booth at each end</span></span> <mark>system material ml ends</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tunnel for</span></span> <mark>tunnel, starting</mark> each <mark>of the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>States concerned</mark> to collect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> <mark>its</mark> share of the toll, <mark>would be expensive and taxable have disruptive effects. Therefore,</mark> tolls are collected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as a whole</span></span> <mark>globally</mark> at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Answer.end_timestamp": 1619724409.696,
            "Answer.fluency-1": 98,
            "Answer.fluency-2": 85,
            "Answer.fluency-3": 97,
            "Answer.fluency-4": 92,
            "Answer.fluency-5": 97,
            "Answer.start_timestamp": 1619724398.64,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-13",
            "Input.complex": "Since it would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the toll, tolls are collected as a whole at the entrance of the tunnel.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Since it would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll,</span></span> <mark>toll. As a result,</mark> tolls are collected as a whole at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it would be expensive and disruptive to have</span></span> <mark>The installation of</mark> a toll <span class='tooltip' style='color:red'>^<span class='tooltiptext'>booth</span></span> <mark>system</mark> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>each end</span></span> <mark>both ends</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tunnel for</span></span> <mark>tunnel, allowing</mark> each <mark>of the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>States concerned</mark> to collect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> <mark>its</mark> share of the toll, <mark>would be expensive and would have disruptive effects. Therefore,</mark> tolls are collected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as a whole</span></span> <mark>globally</mark> at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it</span></span> <mark>It</mark> would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll, tolls are</span></span> <mark>toll. The toll is therefore</mark> collected as a whole at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it</span></span> <mark>It</mark> would be expensive and disruptive to have a toll booth at each end of the tunnel for each Member State to collect their share of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>toll,</span></span> <mark>toll. Therefore, the</mark> tolls are collected as a whole at the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>entrance of the tunnel.</span></span> <mark>entrance.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since it would be expensive and disruptive to have</span></span> <mark>The installation of</mark> a toll <span class='tooltip' style='color:red'>^<span class='tooltiptext'>booth at each end</span></span> <mark>system material ml ends</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>tunnel for</span></span> <mark>tunnel, starting</mark> each <mark>of the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>States concerned</mark> to collect <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> <mark>its</mark> share of the toll, <mark>would be expensive and taxable have disruptive effects. Therefore,</mark> tolls are collected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as a whole</span></span> <mark>globally</mark> at the entrance <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>to</mark> the tunnel.",
            "Answer.end_timestamp": 1619730220.478,
            "Answer.fluency-1": 86,
            "Answer.fluency-2": 46,
            "Answer.fluency-3": 62,
            "Answer.fluency-4": 77,
            "Answer.fluency-5": 62,
            "Answer.start_timestamp": 1619730210.111,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-14",
            "Input.complex": "Although the definition of feedingstuffs does not preclude water being considered as feedingstuff, it is not included in the non-exhaustive list of main feed materials.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuffs does not</span></span> <mark>feed period in</mark> preclude water <mark>from</mark> being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it is not included in</span></span> <mark>feed. However,</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>unit</mark> list <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>based the</mark> main feed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>materials.</span></span> <mark>materials does not include the water.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff,</span></span> <mark>feeding. However,</mark> it is not included in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>non - exhaustive</mark> list of main feed materials.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuffs</span></span> <mark>feed</mark> does not preclude water <mark>from</mark> being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it is not included in</span></span> <mark>feed. However,</mark> the non-exhaustive list of <mark>the</mark> main feed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>materials.</span></span> <mark>materials does not include the water.</mark>",
            "Input.simple-4": "Although the definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff,</span></span> <mark>feeding. However,</mark> it is not included in the non-exhaustive list of main feed materials.",
            "Input.simple-5": "Although the definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it</span></span> <mark>feedstuff. It</mark> is not included in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>non - exhaustive</mark> list of main feed materials.",
            "Answer.end_timestamp": 1619724901.923,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 75,
            "Answer.fluency-3": 50,
            "Answer.fluency-4": 25,
            "Answer.fluency-5": 88,
            "Answer.start_timestamp": 1619724831.32,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-14",
            "Input.complex": "Although the definition of feedingstuffs does not preclude water being considered as feedingstuff, it is not included in the non-exhaustive list of main feed materials.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuffs does not</span></span> <mark>feed period in</mark> preclude water <mark>from</mark> being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it is not included in</span></span> <mark>feed. However,</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>unit</mark> list <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>based the</mark> main feed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>materials.</span></span> <mark>materials does not include the water.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff,</span></span> <mark>feeding. However,</mark> it is not included in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>non - exhaustive</mark> list of main feed materials.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuffs</span></span> <mark>feed</mark> does not preclude water <mark>from</mark> being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it is not included in</span></span> <mark>feed. However,</mark> the non-exhaustive list of <mark>the</mark> main feed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>materials.</span></span> <mark>materials does not include the water.</mark>",
            "Input.simple-4": "Although the definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff,</span></span> <mark>feeding. However,</mark> it is not included in the non-exhaustive list of main feed materials.",
            "Input.simple-5": "Although the definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it</span></span> <mark>feedstuff. It</mark> is not included in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>non - exhaustive</mark> list of main feed materials.",
            "Answer.end_timestamp": 1619724483.843,
            "Answer.fluency-1": 83,
            "Answer.fluency-2": 80,
            "Answer.fluency-3": 93,
            "Answer.fluency-4": 86,
            "Answer.fluency-5": 90,
            "Answer.start_timestamp": 1619724449.453,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-14",
            "Input.complex": "Although the definition of feedingstuffs does not preclude water being considered as feedingstuff, it is not included in the non-exhaustive list of main feed materials.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuffs does not</span></span> <mark>feed period in</mark> preclude water <mark>from</mark> being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it is not included in</span></span> <mark>feed. However,</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>unit</mark> list <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>based the</mark> main feed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>materials.</span></span> <mark>materials does not include the water.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff,</span></span> <mark>feeding. However,</mark> it is not included in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>non - exhaustive</mark> list of main feed materials.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> definition of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuffs</span></span> <mark>feed</mark> does not preclude water <mark>from</mark> being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it is not included in</span></span> <mark>feed. However,</mark> the non-exhaustive list of <mark>the</mark> main feed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>materials.</span></span> <mark>materials does not include the water.</mark>",
            "Input.simple-4": "Although the definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff,</span></span> <mark>feeding. However,</mark> it is not included in the non-exhaustive list of main feed materials.",
            "Input.simple-5": "Although the definition of feedingstuffs does not preclude water being considered as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>feedingstuff, it</span></span> <mark>feedstuff. It</mark> is not included in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>non-exhaustive</span></span> <mark>non - exhaustive</mark> list of main feed materials.",
            "Answer.end_timestamp": 1619724359.041,
            "Answer.fluency-1": 41,
            "Answer.fluency-2": 69,
            "Answer.fluency-3": 54,
            "Answer.fluency-4": 32,
            "Answer.fluency-5": 56,
            "Answer.start_timestamp": 1619724352.815,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-15",
            "Input.complex": "As weight loss may be accompanied by improved metabolic control in diabetes, patients who are taking a medicinal product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>medicinal</span></span> <mark>medical</mark> product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-2": "As weight loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a medicinal product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be</span></span> <mark>sent</mark> accompanied by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>improved</span></span> <mark>data</mark> metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients who are taking a medicinal product for diabetes</span></span> <mark>diabetics. Patients on referred medication</mark> should <mark>therefore</mark> consult <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>contractual</mark> doctor or pharmacist before starting treatment with alli.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>medicinal product</span></span> <mark>medicine</mark> for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients who are taking a medicinal product for diabetes</span></span> <mark>diabetics. Patients on anti-diabetic medication</mark> should <mark>therefore</mark> consult a doctor or pharmacist before starting treatment with alli.",
            "Answer.end_timestamp": 1619726116.548,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 50,
            "Answer.fluency-3": 75,
            "Answer.fluency-4": 75,
            "Answer.fluency-5": -1,
            "Answer.start_timestamp": 1619726082.095,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-15",
            "Input.complex": "As weight loss may be accompanied by improved metabolic control in diabetes, patients who are taking a medicinal product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>medicinal</span></span> <mark>medical</mark> product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-2": "As weight loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a medicinal product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be</span></span> <mark>sent</mark> accompanied by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>improved</span></span> <mark>data</mark> metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients who are taking a medicinal product for diabetes</span></span> <mark>diabetics. Patients on referred medication</mark> should <mark>therefore</mark> consult <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>contractual</mark> doctor or pharmacist before starting treatment with alli.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>medicinal product</span></span> <mark>medicine</mark> for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients who are taking a medicinal product for diabetes</span></span> <mark>diabetics. Patients on anti-diabetic medication</mark> should <mark>therefore</mark> consult a doctor or pharmacist before starting treatment with alli.",
            "Answer.end_timestamp": 1619727224.054,
            "Answer.fluency-1": 49,
            "Answer.fluency-2": 73,
            "Answer.fluency-3": 59,
            "Answer.fluency-4": 28,
            "Answer.fluency-5": 52,
            "Answer.start_timestamp": 1619727203.995,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-15",
            "Input.complex": "As weight loss may be accompanied by improved metabolic control in diabetes, patients who are taking a medicinal product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>medicinal</span></span> <mark>medical</mark> product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-2": "As weight loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a medicinal product for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be</span></span> <mark>sent</mark> accompanied by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>improved</span></span> <mark>data</mark> metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients who are taking a medicinal product for diabetes</span></span> <mark>diabetics. Patients on referred medication</mark> should <mark>therefore</mark> consult <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>contractual</mark> doctor or pharmacist before starting treatment with alli.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients</span></span> <mark>diabetes. Patients</mark> who are taking a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>medicinal product</span></span> <mark>medicine</mark> for diabetes should consult a doctor or pharmacist before starting treatment with alli.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As weight</span></span> <mark>Weight</mark> loss may be accompanied by improved metabolic control in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>diabetes, patients who are taking a medicinal product for diabetes</span></span> <mark>diabetics. Patients on anti-diabetic medication</mark> should <mark>therefore</mark> consult a doctor or pharmacist before starting treatment with alli.",
            "Answer.end_timestamp": 1619725082.323,
            "Answer.fluency-1": 64,
            "Answer.fluency-2": 51,
            "Answer.fluency-3": 61,
            "Answer.fluency-4": 77,
            "Answer.fluency-5": 38,
            "Answer.start_timestamp": 1619725057.293,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-16",
            "Input.complex": "Since Kivexa contains abacavir some patients taking Kivexa may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. Therefore,</mark> some patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking Kivexa</span></span> <mark>who take kvexa</mark> may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. So,</mark> some <span class='tooltip' style='color:red'>^<span class='tooltiptext'>patients</span></span> <mark>seller</mark> taking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Kivexa may</span></span> <mark>pass alfa therefore</mark> develop a hypersensitivity reaction <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(serious allergic</span></span> <mark>(severe after</mark> reaction).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. So,</mark> some patients taking Kivexa may <mark>therefore</mark> develop a hypersensitivity reaction <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(serious</span></span> <mark>(severe</mark> allergic reaction).",
            "Input.simple-4": "Since Kivexa contains abacavir some patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking Kivexa</span></span> <mark>taking. These patients</mark> may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir some patients taking Kivexa may develop</span></span> <mark>abacavir. As</mark> a <mark>result, patients who take Kivex can develop</mark> hypersensitivity reaction (serious allergic reaction).",
            "Answer.end_timestamp": 1619724207.039,
            "Answer.fluency-1": 84,
            "Answer.fluency-2": 68,
            "Answer.fluency-3": 84,
            "Answer.fluency-4": 68,
            "Answer.fluency-5": 87,
            "Answer.start_timestamp": 1619724136.99,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-16",
            "Input.complex": "Since Kivexa contains abacavir some patients taking Kivexa may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. Therefore,</mark> some patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking Kivexa</span></span> <mark>who take kvexa</mark> may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. So,</mark> some <span class='tooltip' style='color:red'>^<span class='tooltiptext'>patients</span></span> <mark>seller</mark> taking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Kivexa may</span></span> <mark>pass alfa therefore</mark> develop a hypersensitivity reaction <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(serious allergic</span></span> <mark>(severe after</mark> reaction).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. So,</mark> some patients taking Kivexa may <mark>therefore</mark> develop a hypersensitivity reaction <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(serious</span></span> <mark>(severe</mark> allergic reaction).",
            "Input.simple-4": "Since Kivexa contains abacavir some patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking Kivexa</span></span> <mark>taking. These patients</mark> may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir some patients taking Kivexa may develop</span></span> <mark>abacavir. As</mark> a <mark>result, patients who take Kivex can develop</mark> hypersensitivity reaction (serious allergic reaction).",
            "Answer.end_timestamp": 1619727796.203,
            "Answer.fluency-1": 33,
            "Answer.fluency-2": 54,
            "Answer.fluency-3": 71,
            "Answer.fluency-4": 50,
            "Answer.fluency-5": 64,
            "Answer.start_timestamp": 1619727605.422,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-16",
            "Input.complex": "Since Kivexa contains abacavir some patients taking Kivexa may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. Therefore,</mark> some patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking Kivexa</span></span> <mark>who take kvexa</mark> may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. So,</mark> some <span class='tooltip' style='color:red'>^<span class='tooltiptext'>patients</span></span> <mark>seller</mark> taking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Kivexa may</span></span> <mark>pass alfa therefore</mark> develop a hypersensitivity reaction <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(serious allergic</span></span> <mark>(severe after</mark> reaction).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir</span></span> <mark>abacavir. So,</mark> some patients taking Kivexa may <mark>therefore</mark> develop a hypersensitivity reaction <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(serious</span></span> <mark>(severe</mark> allergic reaction).",
            "Input.simple-4": "Since Kivexa contains abacavir some patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking Kivexa</span></span> <mark>taking. These patients</mark> may develop a hypersensitivity reaction (serious allergic reaction).",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since</span></span> Kivexa contains <span class='tooltip' style='color:red'>^<span class='tooltiptext'>abacavir some patients taking Kivexa may develop</span></span> <mark>abacavir. As</mark> a <mark>result, patients who take Kivex can develop</mark> hypersensitivity reaction (serious allergic reaction).",
            "Answer.end_timestamp": 1619724792.227,
            "Answer.fluency-1": 82,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 86,
            "Answer.fluency-4": 93,
            "Answer.fluency-5": 84,
            "Answer.start_timestamp": 1619724782.083,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-17",
            "Input.complex": "Among a range of proposals to strengthen shareholders' rights and modernise the board of directors, it provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Among a range of proposals to strengthen shareholders' rights and modernise the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>The Member contains</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proposals</span></span> <mark>order</mark> to strengthen <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shareholders' rights and modernise</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>board</span></span> <mark>rights</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors,</span></span> <mark>the shareholder and to modernize the</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provides for</span></span> <mark>of directors. For example,</mark> an initiative <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aimed at encouraging an appropriate regulatory regime</span></span> <mark>is announced affect promote a scheme</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors' remuneration</span></span> <mark>executive pay</mark> in the Member States.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>The communication contains</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of proposals to strengthen <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shareholders'</span></span> <mark>the</mark> rights <mark>of the shareholder</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>modernise</span></span> <mark>to modernize</mark> the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it provides for</span></span> <mark>directors. For example,</mark> an initiative <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aimed at encouraging an appropriate regulatory regime</span></span> <mark>is announced to promote a scheme</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors' remuneration</span></span> <mark>executive pay</mark> in the Member States.",
            "Input.simple-4": "Among a range of proposals to strengthen shareholders' rights and modernise the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>It proposes</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of proposals <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to strengthen</span></span> <mark>aimed at strengthening</mark> shareholders' rights and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>modernise</span></span> <mark>modernizing</mark> the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' <span class='tooltip' style='color:red'>^<span class='tooltiptext'>remuneration</span></span> <mark>salaries</mark> in the Member States.",
            "Answer.end_timestamp": 1619724458.736,
            "Answer.fluency-1": 28,
            "Answer.fluency-2": 48,
            "Answer.fluency-3": 38,
            "Answer.fluency-4": 67,
            "Answer.fluency-5": 53,
            "Answer.start_timestamp": 1619724455.083,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-17",
            "Input.complex": "Among a range of proposals to strengthen shareholders' rights and modernise the board of directors, it provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Among a range of proposals to strengthen shareholders' rights and modernise the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>The Member contains</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proposals</span></span> <mark>order</mark> to strengthen <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shareholders' rights and modernise</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>board</span></span> <mark>rights</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors,</span></span> <mark>the shareholder and to modernize the</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provides for</span></span> <mark>of directors. For example,</mark> an initiative <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aimed at encouraging an appropriate regulatory regime</span></span> <mark>is announced affect promote a scheme</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors' remuneration</span></span> <mark>executive pay</mark> in the Member States.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>The communication contains</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of proposals to strengthen <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shareholders'</span></span> <mark>the</mark> rights <mark>of the shareholder</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>modernise</span></span> <mark>to modernize</mark> the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it provides for</span></span> <mark>directors. For example,</mark> an initiative <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aimed at encouraging an appropriate regulatory regime</span></span> <mark>is announced to promote a scheme</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors' remuneration</span></span> <mark>executive pay</mark> in the Member States.",
            "Input.simple-4": "Among a range of proposals to strengthen shareholders' rights and modernise the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>It proposes</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of proposals <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to strengthen</span></span> <mark>aimed at strengthening</mark> shareholders' rights and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>modernise</span></span> <mark>modernizing</mark> the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' <span class='tooltip' style='color:red'>^<span class='tooltiptext'>remuneration</span></span> <mark>salaries</mark> in the Member States.",
            "Answer.end_timestamp": 1619724516.353,
            "Answer.fluency-1": 95,
            "Answer.fluency-2": 86,
            "Answer.fluency-3": 95,
            "Answer.fluency-4": 83,
            "Answer.fluency-5": 96,
            "Answer.start_timestamp": 1619724506.782,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-17",
            "Input.complex": "Among a range of proposals to strengthen shareholders' rights and modernise the board of directors, it provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Among a range of proposals to strengthen shareholders' rights and modernise the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>The Member contains</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proposals</span></span> <mark>order</mark> to strengthen <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shareholders' rights and modernise</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>board</span></span> <mark>rights</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors,</span></span> <mark>the shareholder and to modernize the</mark> it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provides for</span></span> <mark>of directors. For example,</mark> an initiative <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aimed at encouraging an appropriate regulatory regime</span></span> <mark>is announced affect promote a scheme</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors' remuneration</span></span> <mark>executive pay</mark> in the Member States.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>The communication contains</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of proposals to strengthen <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shareholders'</span></span> <mark>the</mark> rights <mark>of the shareholder</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>modernise</span></span> <mark>to modernize</mark> the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it provides for</span></span> <mark>directors. For example,</mark> an initiative <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aimed at encouraging an appropriate regulatory regime</span></span> <mark>is announced to promote a scheme</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors' remuneration</span></span> <mark>executive pay</mark> in the Member States.",
            "Input.simple-4": "Among a range of proposals to strengthen shareholders' rights and modernise the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' remuneration in the Member States.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Among</span></span> <mark>It proposes</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>range</span></span> <mark>series</mark> of proposals <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to strengthen</span></span> <mark>aimed at strengthening</mark> shareholders' rights and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>modernise</span></span> <mark>modernizing</mark> the board of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>directors, it</span></span> <mark>directors. It</mark> provides for an initiative aimed at encouraging an appropriate regulatory regime for directors' <span class='tooltip' style='color:red'>^<span class='tooltiptext'>remuneration</span></span> <mark>salaries</mark> in the Member States.",
            "Answer.end_timestamp": 1619728045.803,
            "Answer.fluency-1": 46,
            "Answer.fluency-2": 61,
            "Answer.fluency-3": 82,
            "Answer.fluency-4": 63,
            "Answer.fluency-5": 79,
            "Answer.start_timestamp": 1619727989.198,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-18",
            "Input.complex": "Not only does the protection of investors require timely public disclosure of inside information by issuers, it also requires such disclosure to be as fast and as synchronised as possible between all categories of investors in all Member States.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Not only does the</span></span> <mark>Investor</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of investors</span></span> <mark>does not only</mark> require <span class='tooltip' style='color:red'>^<span class='tooltiptext'>timely public disclosure of</span></span> <mark>issuers to disclose</mark> inside information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by issuers, it</span></span> <mark>on time. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such disclosure to</span></span> <mark>that this publication</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as fast</span></span> <mark>million rapid</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all <span class='tooltip' style='color:red'>^<span class='tooltiptext'>categories</span></span> <mark>list</mark> of investors in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>all</span></span> <mark>in entrance</mark> Member States.",
            "Input.simple-2": "Not only does the protection of investors require timely public disclosure of inside information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>that</mark> disclosure <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> be as fast and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all Member States.",
            "Input.simple-3": "Not only does the protection of investors require <mark>a</mark> timely public disclosure of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inside</span></span> <mark>internal</mark> information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>that</mark> disclosure <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> be as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fast</span></span> <mark>quickly</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all Member States.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Not only does the</span></span> <mark>Investor</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of investors</span></span> <mark>does not only</mark> require <span class='tooltip' style='color:red'>^<span class='tooltiptext'>timely public disclosure of</span></span> <mark>issuers to disclose</mark> inside information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by issuers, it</span></span> <mark>on time. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such disclosure to</span></span> <mark>that this publication</mark> be as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fast</span></span> <mark>rapid</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all <mark>the</mark> Member States.",
            "Input.simple-5": "Not only does the protection of investors require timely public disclosure of inside information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires such disclosure to be as fast and as synchronised as possible between all categories of investors in all Member States.",
            "Answer.end_timestamp": 1619724482.67,
            "Answer.fluency-1": 60,
            "Answer.fluency-2": 87,
            "Answer.fluency-3": 43,
            "Answer.fluency-4": 73,
            "Answer.fluency-5": 63,
            "Answer.start_timestamp": 1619724476.226,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-18",
            "Input.complex": "Not only does the protection of investors require timely public disclosure of inside information by issuers, it also requires such disclosure to be as fast and as synchronised as possible between all categories of investors in all Member States.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Not only does the</span></span> <mark>Investor</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of investors</span></span> <mark>does not only</mark> require <span class='tooltip' style='color:red'>^<span class='tooltiptext'>timely public disclosure of</span></span> <mark>issuers to disclose</mark> inside information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by issuers, it</span></span> <mark>on time. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such disclosure to</span></span> <mark>that this publication</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as fast</span></span> <mark>million rapid</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all <span class='tooltip' style='color:red'>^<span class='tooltiptext'>categories</span></span> <mark>list</mark> of investors in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>all</span></span> <mark>in entrance</mark> Member States.",
            "Input.simple-2": "Not only does the protection of investors require timely public disclosure of inside information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>that</mark> disclosure <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> be as fast and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all Member States.",
            "Input.simple-3": "Not only does the protection of investors require <mark>a</mark> timely public disclosure of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inside</span></span> <mark>internal</mark> information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>that</mark> disclosure <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> be as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fast</span></span> <mark>quickly</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all Member States.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Not only does the</span></span> <mark>Investor</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of investors</span></span> <mark>does not only</mark> require <span class='tooltip' style='color:red'>^<span class='tooltiptext'>timely public disclosure of</span></span> <mark>issuers to disclose</mark> inside information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by issuers, it</span></span> <mark>on time. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such disclosure to</span></span> <mark>that this publication</mark> be as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fast</span></span> <mark>rapid</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all <mark>the</mark> Member States.",
            "Input.simple-5": "Not only does the protection of investors require timely public disclosure of inside information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires such disclosure to be as fast and as synchronised as possible between all categories of investors in all Member States.",
            "Answer.end_timestamp": 1619724840.892,
            "Answer.fluency-1": 85,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 89,
            "Answer.fluency-4": 93,
            "Answer.fluency-5": 81,
            "Answer.start_timestamp": 1619724828.993,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-18",
            "Input.complex": "Not only does the protection of investors require timely public disclosure of inside information by issuers, it also requires such disclosure to be as fast and as synchronised as possible between all categories of investors in all Member States.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Not only does the</span></span> <mark>Investor</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of investors</span></span> <mark>does not only</mark> require <span class='tooltip' style='color:red'>^<span class='tooltiptext'>timely public disclosure of</span></span> <mark>issuers to disclose</mark> inside information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by issuers, it</span></span> <mark>on time. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such disclosure to</span></span> <mark>that this publication</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as fast</span></span> <mark>million rapid</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all <span class='tooltip' style='color:red'>^<span class='tooltiptext'>categories</span></span> <mark>list</mark> of investors in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>all</span></span> <mark>in entrance</mark> Member States.",
            "Input.simple-2": "Not only does the protection of investors require timely public disclosure of inside information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>that</mark> disclosure <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> be as fast and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all Member States.",
            "Input.simple-3": "Not only does the protection of investors require <mark>a</mark> timely public disclosure of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inside</span></span> <mark>internal</mark> information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>that</mark> disclosure <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> be as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fast</span></span> <mark>quickly</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all Member States.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Not only does the</span></span> <mark>Investor</mark> protection <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of investors</span></span> <mark>does not only</mark> require <span class='tooltip' style='color:red'>^<span class='tooltiptext'>timely public disclosure of</span></span> <mark>issuers to disclose</mark> inside information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by issuers, it</span></span> <mark>on time. It</mark> also requires <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such disclosure to</span></span> <mark>that this publication</mark> be as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fast</span></span> <mark>rapid</mark> and as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>synchronised</span></span> <mark>synchronized</mark> as possible between all categories of investors in all <mark>the</mark> Member States.",
            "Input.simple-5": "Not only does the protection of investors require timely public disclosure of inside information by <span class='tooltip' style='color:red'>^<span class='tooltiptext'>issuers, it</span></span> <mark>issuers. It</mark> also requires such disclosure to be as fast and as synchronised as possible between all categories of investors in all Member States.",
            "Answer.end_timestamp": 1619724397.094,
            "Answer.fluency-1": 93,
            "Answer.fluency-2": 84,
            "Answer.fluency-3": 93,
            "Answer.fluency-4": 86,
            "Answer.fluency-5": 97,
            "Answer.start_timestamp": 1619724386.498,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-19",
            "Input.complex": "Since there is no change in pharmacokinetics in patients with impaired renal function, and since there are no signs that doxazosin aggravates existing renal impairment, the usual dose can be used in these patients (see section 4. 4).",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>No alteration of pharmacokinetic characteristics</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>no change in pharmacokinetics</span></span> <mark>noted</mark> in patients with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impaired</span></span> renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>impairment</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>is</mark> no <span class='tooltip' style='color:red'>^<span class='tooltiptext'>signs</span></span> <mark>evidence</mark> that doxazosin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aggravates</span></span> <mark>may worsen</mark> existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can <mark>therefore</mark> be used in these patients (see section 4. 4).",
            "Input.simple-2": "Since there is no change in pharmacokinetics in patients with impaired renal function, and since there are no signs that doxazosin aggravates existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can be used in these patients (see section 4. 4).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>No alteration of pharmacokinetic characteristics</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>no change in pharmacokinetics</span></span> <mark>noted</mark> in patients with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impaired</span></span> renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>rats</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>P</mark> no <span class='tooltip' style='color:red'>^<span class='tooltiptext'>signs</span></span> <mark>evidence</mark> that doxazosin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aggravates</span></span> <mark>may worsen</mark> existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can <mark>therefore</mark> be used in these patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(see</span></span> <mark>quantities</mark> section 4. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>4).</span></span> <mark>cooperation</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>There</mark> is no change in pharmacokinetics in patients with impaired renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>function</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>is</mark> no signs that doxazosin aggravates existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment,</span></span> <mark>impairment. Therefore,</mark> the usual dose can be used in these patients (see section 4. 4).",
            "Input.simple-5": "Since there is no change in pharmacokinetics in patients with impaired renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function, and</span></span> <mark>function. And</mark> since there are no signs that doxazosin aggravates existing renal impairment, the usual dose can be used in these patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(see</span></span> <mark>-LRB- see</mark> section 4. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>4).</span></span>",
            "Answer.end_timestamp": 1619724231.659,
            "Answer.fluency-1": 45,
            "Answer.fluency-2": 60,
            "Answer.fluency-3": 70,
            "Answer.fluency-4": 58,
            "Answer.fluency-5": 45,
            "Answer.start_timestamp": 1619724221.633,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-19",
            "Input.complex": "Since there is no change in pharmacokinetics in patients with impaired renal function, and since there are no signs that doxazosin aggravates existing renal impairment, the usual dose can be used in these patients (see section 4. 4).",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>No alteration of pharmacokinetic characteristics</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>no change in pharmacokinetics</span></span> <mark>noted</mark> in patients with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impaired</span></span> renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>impairment</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>is</mark> no <span class='tooltip' style='color:red'>^<span class='tooltiptext'>signs</span></span> <mark>evidence</mark> that doxazosin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aggravates</span></span> <mark>may worsen</mark> existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can <mark>therefore</mark> be used in these patients (see section 4. 4).",
            "Input.simple-2": "Since there is no change in pharmacokinetics in patients with impaired renal function, and since there are no signs that doxazosin aggravates existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can be used in these patients (see section 4. 4).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>No alteration of pharmacokinetic characteristics</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>no change in pharmacokinetics</span></span> <mark>noted</mark> in patients with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impaired</span></span> renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>rats</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>P</mark> no <span class='tooltip' style='color:red'>^<span class='tooltiptext'>signs</span></span> <mark>evidence</mark> that doxazosin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aggravates</span></span> <mark>may worsen</mark> existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can <mark>therefore</mark> be used in these patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(see</span></span> <mark>quantities</mark> section 4. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>4).</span></span> <mark>cooperation</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>There</mark> is no change in pharmacokinetics in patients with impaired renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>function</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>is</mark> no signs that doxazosin aggravates existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment,</span></span> <mark>impairment. Therefore,</mark> the usual dose can be used in these patients (see section 4. 4).",
            "Input.simple-5": "Since there is no change in pharmacokinetics in patients with impaired renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function, and</span></span> <mark>function. And</mark> since there are no signs that doxazosin aggravates existing renal impairment, the usual dose can be used in these patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(see</span></span> <mark>-LRB- see</mark> section 4. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>4).</span></span>",
            "Answer.end_timestamp": 1619724487.884,
            "Answer.fluency-1": 59,
            "Answer.fluency-2": 78,
            "Answer.fluency-3": 54,
            "Answer.fluency-4": 77,
            "Answer.fluency-5": 63,
            "Answer.start_timestamp": 1619724484.293,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-19",
            "Input.complex": "Since there is no change in pharmacokinetics in patients with impaired renal function, and since there are no signs that doxazosin aggravates existing renal impairment, the usual dose can be used in these patients (see section 4. 4).",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>No alteration of pharmacokinetic characteristics</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>no change in pharmacokinetics</span></span> <mark>noted</mark> in patients with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impaired</span></span> renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>impairment</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>is</mark> no <span class='tooltip' style='color:red'>^<span class='tooltiptext'>signs</span></span> <mark>evidence</mark> that doxazosin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aggravates</span></span> <mark>may worsen</mark> existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can <mark>therefore</mark> be used in these patients (see section 4. 4).",
            "Input.simple-2": "Since there is no change in pharmacokinetics in patients with impaired renal function, and since there are no signs that doxazosin aggravates existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can be used in these patients (see section 4. 4).",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>No alteration of pharmacokinetic characteristics</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>no change in pharmacokinetics</span></span> <mark>noted</mark> in patients with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impaired</span></span> renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>rats</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>P</mark> no <span class='tooltip' style='color:red'>^<span class='tooltiptext'>signs</span></span> <mark>evidence</mark> that doxazosin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>aggravates</span></span> <mark>may worsen</mark> existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment, the</span></span> <mark>impairment. The</mark> usual dose can <mark>therefore</mark> be used in these patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(see</span></span> <mark>quantities</mark> section 4. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>4).</span></span> <mark>cooperation</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since there</span></span> <mark>There</mark> is no change in pharmacokinetics in patients with impaired renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function,</span></span> <mark>function</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> there <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are</span></span> <mark>is</mark> no signs that doxazosin aggravates existing renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>impairment,</span></span> <mark>impairment. Therefore,</mark> the usual dose can be used in these patients (see section 4. 4).",
            "Input.simple-5": "Since there is no change in pharmacokinetics in patients with impaired renal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function, and</span></span> <mark>function. And</mark> since there are no signs that doxazosin aggravates existing renal impairment, the usual dose can be used in these patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(see</span></span> <mark>-LRB- see</mark> section 4. <span class='tooltip' style='color:red'>^<span class='tooltiptext'>4).</span></span>",
            "Answer.end_timestamp": 1619730178.0,
            "Answer.fluency-1": 67,
            "Answer.fluency-2": 82,
            "Answer.fluency-3": 74,
            "Answer.fluency-4": 87,
            "Answer.fluency-5": 58,
            "Answer.start_timestamp": 1619730156.253,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-20",
            "Input.complex": "As more data are needed before drawing final conclusions, it is appropriate to extend for maize.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are needed</span></span> <mark>will need to be available</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drawing final conclusions,</span></span> <mark>definitive conclusions can be drawn. Therefore,</mark> it is appropriate to extend <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for maize.</span></span> <mark>by two years.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more data are needed</span></span> <mark>More series BE need to be available</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drawing final conclusions,</span></span> <mark>definitive conclusions provision be drawn. Therefore,</mark> it is appropriate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>promote</mark> extend <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for maize.</span></span> <mark>by two years.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is <mark>therefore</mark> appropriate to extend for maize.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is <mark>therefore</mark> appropriate to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>extend</span></span> <mark>apply</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>maize.</span></span> <mark>corn.</mark>",
            "Input.simple-5": "As more data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is appropriate to extend for maize.",
            "Answer.end_timestamp": 1619724371.589,
            "Answer.fluency-1": 32,
            "Answer.fluency-2": 47,
            "Answer.fluency-3": 30,
            "Answer.fluency-4": 56,
            "Answer.fluency-5": 45,
            "Answer.start_timestamp": 1619724366.32,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-20",
            "Input.complex": "As more data are needed before drawing final conclusions, it is appropriate to extend for maize.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are needed</span></span> <mark>will need to be available</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drawing final conclusions,</span></span> <mark>definitive conclusions can be drawn. Therefore,</mark> it is appropriate to extend <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for maize.</span></span> <mark>by two years.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more data are needed</span></span> <mark>More series BE need to be available</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drawing final conclusions,</span></span> <mark>definitive conclusions provision be drawn. Therefore,</mark> it is appropriate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>promote</mark> extend <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for maize.</span></span> <mark>by two years.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is <mark>therefore</mark> appropriate to extend for maize.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is <mark>therefore</mark> appropriate to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>extend</span></span> <mark>apply</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>maize.</span></span> <mark>corn.</mark>",
            "Input.simple-5": "As more data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is appropriate to extend for maize.",
            "Answer.end_timestamp": 1619724859.767,
            "Answer.fluency-1": 80,
            "Answer.fluency-2": 94,
            "Answer.fluency-3": 85,
            "Answer.fluency-4": 90,
            "Answer.fluency-5": 85,
            "Answer.start_timestamp": 1619724842.957,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-20",
            "Input.complex": "As more data are needed before drawing final conclusions, it is appropriate to extend for maize.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data <span class='tooltip' style='color:red'>^<span class='tooltiptext'>are needed</span></span> <mark>will need to be available</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drawing final conclusions,</span></span> <mark>definitive conclusions can be drawn. Therefore,</mark> it is appropriate to extend <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for maize.</span></span> <mark>by two years.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more data are needed</span></span> <mark>More series BE need to be available</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>drawing final conclusions,</span></span> <mark>definitive conclusions provision be drawn. Therefore,</mark> it is appropriate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>promote</mark> extend <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for maize.</span></span> <mark>by two years.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is <mark>therefore</mark> appropriate to extend for maize.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As more</span></span> <mark>More</mark> data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is <mark>therefore</mark> appropriate to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>extend</span></span> <mark>apply</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>maize.</span></span> <mark>corn.</mark>",
            "Input.simple-5": "As more data are needed before drawing final <span class='tooltip' style='color:red'>^<span class='tooltiptext'>conclusions, it</span></span> <mark>conclusions. It</mark> is appropriate to extend for maize.",
            "Answer.end_timestamp": 1619724505.055,
            "Answer.fluency-1": 95,
            "Answer.fluency-2": 87,
            "Answer.fluency-3": 93,
            "Answer.fluency-4": 90,
            "Answer.fluency-5": 97,
            "Answer.start_timestamp": 1619724488.371,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-21",
            "Input.complex": "Since lamivudine and the virus pass into breast milk it is recommended that mothers taking Zeffix do not breast-feed their infants.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <mark>therefore</mark> recommended that mothers taking Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breastfeeding</mark> their infants.",
            "Input.simple-2": "Since lamivudine and the virus <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pass</span></span> <mark>are passed</mark> into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk</span></span> <mark>milk,</mark> it is recommended that mothers <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking</span></span> <mark>who take</mark> Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breastfeeding</mark> their <span class='tooltip' style='color:red'>^<span class='tooltiptext'>infants.</span></span> <mark>babies. In this case, the mother should not breastplate the virus.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the <mark>hepatitis B</mark> virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <mark>therefore</mark> recommended that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mothers</span></span> <mark>women</mark> taking Zeffix <span class='tooltip' style='color:red'>^<span class='tooltiptext'>do</span></span> not <mark>to</mark> breast-feed their infants.",
            "Input.simple-4": "Since lamivudine and the virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is recommended that mothers taking Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breast - feed</mark> their infants.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the <mark>hepatitis B</mark> virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>recommended</span></span> <mark>therefore mutual</mark> that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mothers</span></span> <mark>determine</mark> taking Zeffix <span class='tooltip' style='color:red'>^<span class='tooltiptext'>do</span></span> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>Factory effective</mark> their infants.",
            "Answer.end_timestamp": 1619724160.994,
            "Answer.fluency-1": 95,
            "Answer.fluency-2": 46,
            "Answer.fluency-3": 78,
            "Answer.fluency-4": 100,
            "Answer.fluency-5": 40,
            "Answer.start_timestamp": 1619724138.19,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-21",
            "Input.complex": "Since lamivudine and the virus pass into breast milk it is recommended that mothers taking Zeffix do not breast-feed their infants.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <mark>therefore</mark> recommended that mothers taking Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breastfeeding</mark> their infants.",
            "Input.simple-2": "Since lamivudine and the virus <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pass</span></span> <mark>are passed</mark> into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk</span></span> <mark>milk,</mark> it is recommended that mothers <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking</span></span> <mark>who take</mark> Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breastfeeding</mark> their <span class='tooltip' style='color:red'>^<span class='tooltiptext'>infants.</span></span> <mark>babies. In this case, the mother should not breastplate the virus.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the <mark>hepatitis B</mark> virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <mark>therefore</mark> recommended that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mothers</span></span> <mark>women</mark> taking Zeffix <span class='tooltip' style='color:red'>^<span class='tooltiptext'>do</span></span> not <mark>to</mark> breast-feed their infants.",
            "Input.simple-4": "Since lamivudine and the virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is recommended that mothers taking Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breast - feed</mark> their infants.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the <mark>hepatitis B</mark> virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>recommended</span></span> <mark>therefore mutual</mark> that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mothers</span></span> <mark>determine</mark> taking Zeffix <span class='tooltip' style='color:red'>^<span class='tooltiptext'>do</span></span> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>Factory effective</mark> their infants.",
            "Answer.end_timestamp": 1619726910.227,
            "Answer.fluency-1": 59,
            "Answer.fluency-2": 46,
            "Answer.fluency-3": 67,
            "Answer.fluency-4": 59,
            "Answer.fluency-5": 43,
            "Answer.start_timestamp": 1619726881.546,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-21",
            "Input.complex": "Since lamivudine and the virus pass into breast milk it is recommended that mothers taking Zeffix do not breast-feed their infants.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <mark>therefore</mark> recommended that mothers taking Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breastfeeding</mark> their infants.",
            "Input.simple-2": "Since lamivudine and the virus <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pass</span></span> <mark>are passed</mark> into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk</span></span> <mark>milk,</mark> it is recommended that mothers <span class='tooltip' style='color:red'>^<span class='tooltiptext'>taking</span></span> <mark>who take</mark> Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breastfeeding</mark> their <span class='tooltip' style='color:red'>^<span class='tooltiptext'>infants.</span></span> <mark>babies. In this case, the mother should not breastplate the virus.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the <mark>hepatitis B</mark> virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <mark>therefore</mark> recommended that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mothers</span></span> <mark>women</mark> taking Zeffix <span class='tooltip' style='color:red'>^<span class='tooltiptext'>do</span></span> not <mark>to</mark> breast-feed their infants.",
            "Input.simple-4": "Since lamivudine and the virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is recommended that mothers taking Zeffix do not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>breast - feed</mark> their infants.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since lamivudine</span></span> <mark>Lamivudine</mark> and the <mark>hepatitis B</mark> virus pass into breast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>milk it</span></span> <mark>milk. It</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>recommended</span></span> <mark>therefore mutual</mark> that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>mothers</span></span> <mark>determine</mark> taking Zeffix <span class='tooltip' style='color:red'>^<span class='tooltiptext'>do</span></span> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>breast-feed</span></span> <mark>Factory effective</mark> their infants.",
            "Answer.end_timestamp": 1619726601.269,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 41,
            "Answer.fluency-3": 56,
            "Answer.fluency-4": 51,
            "Answer.fluency-5": 39,
            "Answer.start_timestamp": 1619726566.578,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-22",
            "Input.complex": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a <mark>substrate, inhibitor or inducer of</mark> cytochrome P <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(CYP)</span></span> 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzyme substrate and does not inhibit or induce CYP 450 enzymes,</span></span> <mark>(CYP450) enzymes. therefore,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not likely</span></span> <mark>unlikely</mark> to interact with active substances <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>which</mark> are substrates, inhibitors or inducers of these enzymes.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzymes, it</span></span> <mark>enzymes. It</mark> is <mark>therefore</mark> not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Input.simple-3": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes. <mark>It is therefore unlikely that it interact with these substances.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a <mark>concerned inhibitor or inducer avoid</mark> cytochrome P <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(CYP)</span></span> 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzyme substrate and does not inhibit or induce CYP 450 enzymes,</span></span> <mark>(CYP450) enzymes. therefore,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not likely to</span></span> <mark>unlikely existing</mark> interact with active substances <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>which</mark> are substrates, inhibitors <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or</span></span> <mark>children</mark> inducers of these enzymes.",
            "Input.simple-5": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme <span class='tooltip' style='color:red'>^<span class='tooltiptext'>substrate and</span></span> <mark>substrate. It</mark> does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Answer.end_timestamp": 1619724723.581,
            "Answer.fluency-1": 9,
            "Answer.fluency-2": 42,
            "Answer.fluency-3": 48,
            "Answer.fluency-4": 59,
            "Answer.fluency-5": 100,
            "Answer.start_timestamp": 1619724706.535,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-22",
            "Input.complex": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a <mark>substrate, inhibitor or inducer of</mark> cytochrome P <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(CYP)</span></span> 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzyme substrate and does not inhibit or induce CYP 450 enzymes,</span></span> <mark>(CYP450) enzymes. therefore,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not likely</span></span> <mark>unlikely</mark> to interact with active substances <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>which</mark> are substrates, inhibitors or inducers of these enzymes.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzymes, it</span></span> <mark>enzymes. It</mark> is <mark>therefore</mark> not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Input.simple-3": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes. <mark>It is therefore unlikely that it interact with these substances.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a <mark>concerned inhibitor or inducer avoid</mark> cytochrome P <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(CYP)</span></span> 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzyme substrate and does not inhibit or induce CYP 450 enzymes,</span></span> <mark>(CYP450) enzymes. therefore,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not likely to</span></span> <mark>unlikely existing</mark> interact with active substances <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>which</mark> are substrates, inhibitors <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or</span></span> <mark>children</mark> inducers of these enzymes.",
            "Input.simple-5": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme <span class='tooltip' style='color:red'>^<span class='tooltiptext'>substrate and</span></span> <mark>substrate. It</mark> does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Answer.end_timestamp": 1619724283.939,
            "Answer.fluency-1": 90,
            "Answer.fluency-2": 85,
            "Answer.fluency-3": 96,
            "Answer.fluency-4": 77,
            "Answer.fluency-5": 95,
            "Answer.start_timestamp": 1619724253.143,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-22",
            "Input.complex": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a <mark>substrate, inhibitor or inducer of</mark> cytochrome P <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(CYP)</span></span> 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzyme substrate and does not inhibit or induce CYP 450 enzymes,</span></span> <mark>(CYP450) enzymes. therefore,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not likely</span></span> <mark>unlikely</mark> to interact with active substances <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>which</mark> are substrates, inhibitors or inducers of these enzymes.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzymes, it</span></span> <mark>enzymes. It</mark> is <mark>therefore</mark> not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Input.simple-3": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes. <mark>It is therefore unlikely that it interact with these substances.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since vildagliptin</span></span> <mark>Vildagliptin</mark> is not a <mark>concerned inhibitor or inducer avoid</mark> cytochrome P <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(CYP)</span></span> 450 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enzyme substrate and does not inhibit or induce CYP 450 enzymes,</span></span> <mark>(CYP450) enzymes. therefore,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>not likely to</span></span> <mark>unlikely existing</mark> interact with active substances <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>which</mark> are substrates, inhibitors <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or</span></span> <mark>children</mark> inducers of these enzymes.",
            "Input.simple-5": "Since vildagliptin is not a cytochrome P (CYP) 450 enzyme <span class='tooltip' style='color:red'>^<span class='tooltiptext'>substrate and</span></span> <mark>substrate. It</mark> does not inhibit or induce CYP 450 enzymes, it is not likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes.",
            "Answer.end_timestamp": 1619727988.01,
            "Answer.fluency-1": 47,
            "Answer.fluency-2": 82,
            "Answer.fluency-3": 66,
            "Answer.fluency-4": 48,
            "Answer.fluency-5": 73,
            "Answer.start_timestamp": 1619727959.129,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-23",
            "Input.complex": "Although France 2s viability was restored from 1992 onwards, after several years of losses, the meagre profits it registered were possible only thanks to the additional capital injections granted by the French State in 1993 and 1994.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "Although France 2s viability was restored from 1992 onwards, after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses, the</span></span> <mark>losses. The</mark> meagre profits it registered were possible only thanks to the additional capital injections granted by the French State in 1993 and 1994.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s</span></span> <mark>2's</mark> viability was restored from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1992 onwards, after</span></span> <mark>1992. After</mark> several years of losses, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre</span></span> <mark>meager</mark> profits <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> registered were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>possible</span></span> only <mark>possible</mark> thanks to the additional capital injections granted by the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>state</mark> in 1993 and 1994.",
            "Input.simple-3": "Although France 2s viability was restored from 1992 onwards, after several years of losses, the meagre profits it registered were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>possible only thanks to the</span></span> <mark>possible. The</mark> additional capital injections granted by the French State in 1993 and 1994.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s viability</span></span> <mark>2</mark> was <span class='tooltip' style='color:red'>^<span class='tooltiptext'>restored from</span></span> <mark>able to become profitable again in</mark> 1992 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>onwards,</span></span> after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses,</span></span> <mark>losses. But</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre profits it registered were possible only thanks to</span></span> <mark>marginal country</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>additional capital injections granted by</span></span> <mark>station has made since then have only been possible because</mark> the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State in</span></span> <mark>state subject additional capital More</mark> 1993 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>include</mark> 1994.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s viability</span></span> <mark>2</mark> was <span class='tooltip' style='color:red'>^<span class='tooltiptext'>restored from</span></span> <mark>able to become profitable again in</mark> 1992 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>onwards,</span></span> after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses,</span></span> <mark>losses. But</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre profits it registered were possible only thanks to</span></span> <mark>marginal gains</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>additional capital injections granted by</span></span> <mark>station has made since then have only been possible because</mark> the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>state injected additional capital</mark> in 1993 and 1994.",
            "Answer.end_timestamp": 1619726946.927,
            "Answer.fluency-1": 79,
            "Answer.fluency-2": 78,
            "Answer.fluency-3": 62,
            "Answer.fluency-4": 47,
            "Answer.fluency-5": 68,
            "Answer.start_timestamp": 1619726911.486,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-23",
            "Input.complex": "Although France 2s viability was restored from 1992 onwards, after several years of losses, the meagre profits it registered were possible only thanks to the additional capital injections granted by the French State in 1993 and 1994.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "Although France 2s viability was restored from 1992 onwards, after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses, the</span></span> <mark>losses. The</mark> meagre profits it registered were possible only thanks to the additional capital injections granted by the French State in 1993 and 1994.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s</span></span> <mark>2's</mark> viability was restored from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1992 onwards, after</span></span> <mark>1992. After</mark> several years of losses, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre</span></span> <mark>meager</mark> profits <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> registered were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>possible</span></span> only <mark>possible</mark> thanks to the additional capital injections granted by the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>state</mark> in 1993 and 1994.",
            "Input.simple-3": "Although France 2s viability was restored from 1992 onwards, after several years of losses, the meagre profits it registered were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>possible only thanks to the</span></span> <mark>possible. The</mark> additional capital injections granted by the French State in 1993 and 1994.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s viability</span></span> <mark>2</mark> was <span class='tooltip' style='color:red'>^<span class='tooltiptext'>restored from</span></span> <mark>able to become profitable again in</mark> 1992 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>onwards,</span></span> after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses,</span></span> <mark>losses. But</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre profits it registered were possible only thanks to</span></span> <mark>marginal country</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>additional capital injections granted by</span></span> <mark>station has made since then have only been possible because</mark> the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State in</span></span> <mark>state subject additional capital More</mark> 1993 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>include</mark> 1994.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s viability</span></span> <mark>2</mark> was <span class='tooltip' style='color:red'>^<span class='tooltiptext'>restored from</span></span> <mark>able to become profitable again in</mark> 1992 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>onwards,</span></span> after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses,</span></span> <mark>losses. But</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre profits it registered were possible only thanks to</span></span> <mark>marginal gains</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>additional capital injections granted by</span></span> <mark>station has made since then have only been possible because</mark> the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>state injected additional capital</mark> in 1993 and 1994.",
            "Answer.end_timestamp": 1619724377.008,
            "Answer.fluency-1": 45,
            "Answer.fluency-2": 63,
            "Answer.fluency-3": 28,
            "Answer.fluency-4": 51,
            "Answer.fluency-5": 45,
            "Answer.start_timestamp": 1619724372.999,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-23",
            "Input.complex": "Although France 2s viability was restored from 1992 onwards, after several years of losses, the meagre profits it registered were possible only thanks to the additional capital injections granted by the French State in 1993 and 1994.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "Although France 2s viability was restored from 1992 onwards, after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses, the</span></span> <mark>losses. The</mark> meagre profits it registered were possible only thanks to the additional capital injections granted by the French State in 1993 and 1994.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s</span></span> <mark>2's</mark> viability was restored from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1992 onwards, after</span></span> <mark>1992. After</mark> several years of losses, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre</span></span> <mark>meager</mark> profits <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it</span></span> registered were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>possible</span></span> only <mark>possible</mark> thanks to the additional capital injections granted by the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>state</mark> in 1993 and 1994.",
            "Input.simple-3": "Although France 2s viability was restored from 1992 onwards, after several years of losses, the meagre profits it registered were <span class='tooltip' style='color:red'>^<span class='tooltiptext'>possible only thanks to the</span></span> <mark>possible. The</mark> additional capital injections granted by the French State in 1993 and 1994.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s viability</span></span> <mark>2</mark> was <span class='tooltip' style='color:red'>^<span class='tooltiptext'>restored from</span></span> <mark>able to become profitable again in</mark> 1992 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>onwards,</span></span> after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses,</span></span> <mark>losses. But</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre profits it registered were possible only thanks to</span></span> <mark>marginal country</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>additional capital injections granted by</span></span> <mark>station has made since then have only been possible because</mark> the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State in</span></span> <mark>state subject additional capital More</mark> 1993 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and</span></span> <mark>include</mark> 1994.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although</span></span> France <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2s viability</span></span> <mark>2</mark> was <span class='tooltip' style='color:red'>^<span class='tooltiptext'>restored from</span></span> <mark>able to become profitable again in</mark> 1992 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>onwards,</span></span> after several years of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>losses,</span></span> <mark>losses. But</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>meagre profits it registered were possible only thanks to</span></span> <mark>marginal gains</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>additional capital injections granted by</span></span> <mark>station has made since then have only been possible because</mark> the French <span class='tooltip' style='color:red'>^<span class='tooltiptext'>State</span></span> <mark>state injected additional capital</mark> in 1993 and 1994.",
            "Answer.end_timestamp": 1619724238.489,
            "Answer.fluency-1": 31,
            "Answer.fluency-2": 46,
            "Answer.fluency-3": 30,
            "Answer.fluency-4": 67,
            "Answer.fluency-5": 38,
            "Answer.start_timestamp": 1619724221.009,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-24",
            "Input.complex": "Having reviewed the provisional findings on the basis of the information gathered since then, it is concluded that the main findings as set out in the provisional Regulation are confirmed.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "Having reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it</span></span> <mark>then. It</mark> is concluded that the main findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> set out in the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>regulation</mark> are confirmed.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having reviewed the</span></span> <mark>The</mark> provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>findings on</span></span> <mark>tumors were re-examined into</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis</span></span> <mark>these</mark> of the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>gathered</span></span> <mark>collected</mark> since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded that</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>main findings as set out in</span></span> <mark>adoption of those who The conclusions at</mark> the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>stage</mark> are <mark>generally</mark> confirmed.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having</span></span> <mark>We have</mark> reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded</span></span> <mark>then. We conclude</mark> that the main findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> set out in the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>regulation</mark> are confirmed.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having reviewed the</span></span> <mark>The</mark> provisional findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>were re-examined in</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis</span></span> <mark>light</mark> of the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>gathered</span></span> <mark>collected</mark> since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded that</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>main findings as set out in</span></span> <mark>adoption of those conclusions. The conclusions at</mark> the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>stage</mark> are <mark>generally</mark> confirmed.",
            "Input.simple-5": "Having reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it</span></span> <mark>then. It</mark> is concluded that the main findings as set out in the provisional Regulation are confirmed.",
            "Answer.end_timestamp": 1619724261.721,
            "Answer.fluency-1": 82,
            "Answer.fluency-2": 54,
            "Answer.fluency-3": 68,
            "Answer.fluency-4": 84,
            "Answer.fluency-5": 71,
            "Answer.start_timestamp": 1619724233.086,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-24",
            "Input.complex": "Having reviewed the provisional findings on the basis of the information gathered since then, it is concluded that the main findings as set out in the provisional Regulation are confirmed.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "Having reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it</span></span> <mark>then. It</mark> is concluded that the main findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> set out in the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>regulation</mark> are confirmed.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having reviewed the</span></span> <mark>The</mark> provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>findings on</span></span> <mark>tumors were re-examined into</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis</span></span> <mark>these</mark> of the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>gathered</span></span> <mark>collected</mark> since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded that</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>main findings as set out in</span></span> <mark>adoption of those who The conclusions at</mark> the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>stage</mark> are <mark>generally</mark> confirmed.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having</span></span> <mark>We have</mark> reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded</span></span> <mark>then. We conclude</mark> that the main findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> set out in the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>regulation</mark> are confirmed.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having reviewed the</span></span> <mark>The</mark> provisional findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>were re-examined in</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis</span></span> <mark>light</mark> of the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>gathered</span></span> <mark>collected</mark> since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded that</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>main findings as set out in</span></span> <mark>adoption of those conclusions. The conclusions at</mark> the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>stage</mark> are <mark>generally</mark> confirmed.",
            "Input.simple-5": "Having reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it</span></span> <mark>then. It</mark> is concluded that the main findings as set out in the provisional Regulation are confirmed.",
            "Answer.end_timestamp": 1619724351.505,
            "Answer.fluency-1": 44,
            "Answer.fluency-2": 66,
            "Answer.fluency-3": 29,
            "Answer.fluency-4": 57,
            "Answer.fluency-5": 45,
            "Answer.start_timestamp": 1619724347.396,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-24",
            "Input.complex": "Having reviewed the provisional findings on the basis of the information gathered since then, it is concluded that the main findings as set out in the provisional Regulation are confirmed.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "Having reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it</span></span> <mark>then. It</mark> is concluded that the main findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> set out in the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>regulation</mark> are confirmed.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having reviewed the</span></span> <mark>The</mark> provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>findings on</span></span> <mark>tumors were re-examined into</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis</span></span> <mark>these</mark> of the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>gathered</span></span> <mark>collected</mark> since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded that</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>main findings as set out in</span></span> <mark>adoption of those who The conclusions at</mark> the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>stage</mark> are <mark>generally</mark> confirmed.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having</span></span> <mark>We have</mark> reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded</span></span> <mark>then. We conclude</mark> that the main findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> set out in the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>regulation</mark> are confirmed.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having reviewed the</span></span> <mark>The</mark> provisional findings <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>were re-examined in</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis</span></span> <mark>light</mark> of the information <span class='tooltip' style='color:red'>^<span class='tooltiptext'>gathered</span></span> <mark>collected</mark> since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it is concluded that</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>main findings as set out in</span></span> <mark>adoption of those conclusions. The conclusions at</mark> the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation</span></span> <mark>stage</mark> are <mark>generally</mark> confirmed.",
            "Input.simple-5": "Having reviewed the provisional findings on the basis of the information gathered since <span class='tooltip' style='color:red'>^<span class='tooltiptext'>then, it</span></span> <mark>then. It</mark> is concluded that the main findings as set out in the provisional Regulation are confirmed.",
            "Answer.end_timestamp": 1619724346.974,
            "Answer.fluency-1": 95,
            "Answer.fluency-2": 95,
            "Answer.fluency-3": 89,
            "Answer.fluency-4": 96,
            "Answer.fluency-5": 94,
            "Answer.start_timestamp": 1619724285.974,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-25",
            "Input.complex": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of trade, these derogations should be extended for a limited period in the light of the progress of the negotiations.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with these two countries will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be concluded</mark> before the end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>these derogations should</span></span> <mark>the exception provisions are to</mark> be extended for a limited period in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with these <span class='tooltip' style='color:red'>^<span class='tooltiptext'>two</span></span> <mark>incomplete</mark> countries will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be concluded</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>taxable</mark> end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>these derogations should</span></span> <mark>the exception provisions are to</mark> be extended for a limited period in <mark>accordance pamoate</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light</span></span> <mark>status</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>progress of the negotiations.</span></span> <mark>government</mark>",
            "Input.simple-3": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, these</span></span> <mark>trade. These</mark> derogations should be extended for a limited period in the light of the progress of the negotiations.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade,</span></span> <mark>trade. Therefore,</mark> these derogations should be extended for a limited period in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-5": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, these</span></span> <mark>trade. These</mark> derogations should <mark>therefore</mark> be extended for a limited period in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Answer.end_timestamp": 1619724365.231,
            "Answer.fluency-1": 40,
            "Answer.fluency-2": 70,
            "Answer.fluency-3": 55,
            "Answer.fluency-4": 80,
            "Answer.fluency-5": 65,
            "Answer.start_timestamp": 1619724360.418,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-25",
            "Input.complex": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of trade, these derogations should be extended for a limited period in the light of the progress of the negotiations.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with these two countries will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be concluded</mark> before the end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>these derogations should</span></span> <mark>the exception provisions are to</mark> be extended for a limited period in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with these <span class='tooltip' style='color:red'>^<span class='tooltiptext'>two</span></span> <mark>incomplete</mark> countries will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be concluded</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>taxable</mark> end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>these derogations should</span></span> <mark>the exception provisions are to</mark> be extended for a limited period in <mark>accordance pamoate</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light</span></span> <mark>status</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>progress of the negotiations.</span></span> <mark>government</mark>",
            "Input.simple-3": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, these</span></span> <mark>trade. These</mark> derogations should be extended for a limited period in the light of the progress of the negotiations.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade,</span></span> <mark>trade. Therefore,</mark> these derogations should be extended for a limited period in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-5": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, these</span></span> <mark>trade. These</mark> derogations should <mark>therefore</mark> be extended for a limited period in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Answer.end_timestamp": 1619730300.57,
            "Answer.fluency-1": 88,
            "Answer.fluency-2": 98,
            "Answer.fluency-3": 90,
            "Answer.fluency-4": 98,
            "Answer.fluency-5": 92,
            "Answer.start_timestamp": 1619730289.124,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-25",
            "Input.complex": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of trade, these derogations should be extended for a limited period in the light of the progress of the negotiations.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with these two countries will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be concluded</mark> before the end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>these derogations should</span></span> <mark>the exception provisions are to</mark> be extended for a limited period in <mark>accordance with</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light of the progress</span></span> <mark>status</mark> of the negotiations.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The ongoing</mark> bilateral negotiations <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in progress</span></span> with these <span class='tooltip' style='color:red'>^<span class='tooltiptext'>two</span></span> <mark>incomplete</mark> countries will not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>end</span></span> <mark>be concluded</mark> before <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>taxable</mark> end of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>year, in</span></span> <mark>year. In</mark> order to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>prevent any disruption of</span></span> <mark>avoid disruptions in</mark> trade, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>these derogations should</span></span> <mark>the exception provisions are to</mark> be extended for a limited period in <mark>accordance pamoate</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>light</span></span> <mark>status</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>progress of the negotiations.</span></span> <mark>government</mark>",
            "Input.simple-3": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, these</span></span> <mark>trade. These</mark> derogations should be extended for a limited period in the light of the progress of the negotiations.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade,</span></span> <mark>trade. Therefore,</mark> these derogations should be extended for a limited period in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Input.simple-5": "Since the bilateral negotiations in progress with these two countries will not end before the end of the year, in order to prevent any disruption of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>trade, these</span></span> <mark>trade. These</mark> derogations should <mark>therefore</mark> be extended for a limited period in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of the progress of the negotiations.",
            "Answer.end_timestamp": 1619724418.583,
            "Answer.fluency-1": 54,
            "Answer.fluency-2": 64,
            "Answer.fluency-3": 79,
            "Answer.fluency-4": 69,
            "Answer.fluency-5": 79,
            "Answer.start_timestamp": 1619724406.948,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-26",
            "Input.complex": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other jurisdictions, the fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn revenue which, in the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is not competent</span></span> <mark>has no jurisdiction</mark> to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>in relation</mark> to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions,</span></span> <mark>jurisdictions. However, this does not alter</mark> the fact that Qualifying Companies negotiate their tax rate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>demonstrates</span></span> clearly <mark>showing</mark> that they <span class='tooltip' style='color:red'>^<span class='tooltiptext'>earn revenue which,</span></span> <mark>generate income that,</mark> in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company taxation</span></span> <mark>corporate tax</mark> at the standard rate.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is not competent</span></span> <mark>has this jurisdiction</mark> to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>in relation</mark> to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions, the</span></span> <mark>jurisdictions. However, this does not alter units</mark> fact that Qualifying Companies negotiate their tax rate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>demonstrates</span></span> clearly <mark>showing</mark> that they <span class='tooltip' style='color:red'>^<span class='tooltiptext'>earn revenue which,</span></span> <mark>generate income that,</mark> in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company taxation at</span></span> <mark>corporate tax animals</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>standard</span></span> <mark>Companies</mark> rate.",
            "Input.simple-3": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other jurisdictions, the fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn <span class='tooltip' style='color:red'>^<span class='tooltiptext'>revenue which, in</span></span> <mark>revenue. In</mark> the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar is not competent to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating to</span></span> <mark>in</mark> other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions,</span></span> <mark>jurisdictions. However,</mark> the fact that Qualifying Companies negotiate their tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rate, demonstrates</span></span> <mark>rate</mark> clearly <mark>demonstrates</mark> that they earn <span class='tooltip' style='color:red'>^<span class='tooltiptext'>revenue</span></span> <mark>revenues</mark> which, in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to company taxation at the standard rate.",
            "Input.simple-5": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions, the</span></span> <mark>jurisdictions. The</mark> fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn revenue which, in the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Answer.end_timestamp": 1619727167.769,
            "Answer.fluency-1": 60,
            "Answer.fluency-2": 82,
            "Answer.fluency-3": 66,
            "Answer.fluency-4": 48,
            "Answer.fluency-5": 68,
            "Answer.start_timestamp": 1619726948.291,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-26",
            "Input.complex": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other jurisdictions, the fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn revenue which, in the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is not competent</span></span> <mark>has no jurisdiction</mark> to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>in relation</mark> to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions,</span></span> <mark>jurisdictions. However, this does not alter</mark> the fact that Qualifying Companies negotiate their tax rate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>demonstrates</span></span> clearly <mark>showing</mark> that they <span class='tooltip' style='color:red'>^<span class='tooltiptext'>earn revenue which,</span></span> <mark>generate income that,</mark> in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company taxation</span></span> <mark>corporate tax</mark> at the standard rate.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is not competent</span></span> <mark>has this jurisdiction</mark> to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>in relation</mark> to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions, the</span></span> <mark>jurisdictions. However, this does not alter units</mark> fact that Qualifying Companies negotiate their tax rate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>demonstrates</span></span> clearly <mark>showing</mark> that they <span class='tooltip' style='color:red'>^<span class='tooltiptext'>earn revenue which,</span></span> <mark>generate income that,</mark> in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company taxation at</span></span> <mark>corporate tax animals</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>standard</span></span> <mark>Companies</mark> rate.",
            "Input.simple-3": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other jurisdictions, the fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn <span class='tooltip' style='color:red'>^<span class='tooltiptext'>revenue which, in</span></span> <mark>revenue. In</mark> the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar is not competent to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating to</span></span> <mark>in</mark> other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions,</span></span> <mark>jurisdictions. However,</mark> the fact that Qualifying Companies negotiate their tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rate, demonstrates</span></span> <mark>rate</mark> clearly <mark>demonstrates</mark> that they earn <span class='tooltip' style='color:red'>^<span class='tooltiptext'>revenue</span></span> <mark>revenues</mark> which, in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to company taxation at the standard rate.",
            "Input.simple-5": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions, the</span></span> <mark>jurisdictions. The</mark> fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn revenue which, in the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Answer.end_timestamp": 1619724374.706,
            "Answer.fluency-1": 99,
            "Answer.fluency-2": 74,
            "Answer.fluency-3": 50,
            "Answer.fluency-4": 99,
            "Answer.fluency-5": 99,
            "Answer.start_timestamp": 1619724288.035,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-26",
            "Input.complex": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other jurisdictions, the fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn revenue which, in the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is not competent</span></span> <mark>has no jurisdiction</mark> to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>in relation</mark> to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions,</span></span> <mark>jurisdictions. However, this does not alter</mark> the fact that Qualifying Companies negotiate their tax rate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>demonstrates</span></span> clearly <mark>showing</mark> that they <span class='tooltip' style='color:red'>^<span class='tooltiptext'>earn revenue which,</span></span> <mark>generate income that,</mark> in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company taxation</span></span> <mark>corporate tax</mark> at the standard rate.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is not competent</span></span> <mark>has this jurisdiction</mark> to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>in relation</mark> to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions, the</span></span> <mark>jurisdictions. However, this does not alter units</mark> fact that Qualifying Companies negotiate their tax rate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>demonstrates</span></span> clearly <mark>showing</mark> that they <span class='tooltip' style='color:red'>^<span class='tooltiptext'>earn revenue which,</span></span> <mark>generate income that,</mark> in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company taxation at</span></span> <mark>corporate tax animals</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>standard</span></span> <mark>Companies</mark> rate.",
            "Input.simple-3": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other jurisdictions, the fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn <span class='tooltip' style='color:red'>^<span class='tooltiptext'>revenue which, in</span></span> <mark>revenue. In</mark> the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Although the</span></span> <mark>The</mark> Commission accepts the argument that Gibraltar is not competent to grant tax advantages <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating to</span></span> <mark>in</mark> other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions,</span></span> <mark>jurisdictions. However,</mark> the fact that Qualifying Companies negotiate their tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rate, demonstrates</span></span> <mark>rate</mark> clearly <mark>demonstrates</mark> that they earn <span class='tooltip' style='color:red'>^<span class='tooltiptext'>revenue</span></span> <mark>revenues</mark> which, in the absence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>their</span></span> special treatment, would be subject to company taxation at the standard rate.",
            "Input.simple-5": "Although the Commission accepts the argument that Gibraltar is not competent to grant tax advantages relating to other <span class='tooltip' style='color:red'>^<span class='tooltiptext'>jurisdictions, the</span></span> <mark>jurisdictions. The</mark> fact that Qualifying Companies negotiate their tax rate, demonstrates clearly that they earn revenue which, in the absence of their special treatment, would be subject to company taxation at the standard rate.",
            "Answer.end_timestamp": 1619724325.979,
            "Answer.fluency-1": 42,
            "Answer.fluency-2": 73,
            "Answer.fluency-3": 52,
            "Answer.fluency-4": 27,
            "Answer.fluency-5": 58,
            "Answer.start_timestamp": 1619724322.367,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-27",
            "Input.complex": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in 1997, they were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports of RBMs from</mark> Indonesia decreased <span class='tooltip' style='color:red'>^<span class='tooltiptext'>between 1998 and 2000</span></span> <mark>in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>investigation period. However, imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of collection of RBMs from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased between 1998 and 2000</span></span> <mark>provisional in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>investigation period. However, imports of Actions product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>million pieces</span></span> <mark>reactions units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-4": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>Although the</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased</span></span> <mark>declined</mark> between 1998 and 2000 and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again</span></span> between 2000 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the IP,</span></span> <mark>2000,</mark> it should be noted that while imports from the country concerned only started in 1997, they were already significant in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1998 and were at</span></span> <mark>1998. They reached</mark> a level of 32 million pieces in the IP.",
            "Answer.end_timestamp": 1619724465.544,
            "Answer.fluency-1": 46,
            "Answer.fluency-2": 69,
            "Answer.fluency-3": 37,
            "Answer.fluency-4": 65,
            "Answer.fluency-5": 51,
            "Answer.start_timestamp": 1619724460.06,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-27",
            "Input.complex": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in 1997, they were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports of RBMs from</mark> Indonesia decreased <span class='tooltip' style='color:red'>^<span class='tooltiptext'>between 1998 and 2000</span></span> <mark>in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>investigation period. However, imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of collection of RBMs from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased between 1998 and 2000</span></span> <mark>provisional in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>investigation period. However, imports of Actions product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>million pieces</span></span> <mark>reactions units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-4": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>Although the</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased</span></span> <mark>declined</mark> between 1998 and 2000 and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again</span></span> between 2000 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the IP,</span></span> <mark>2000,</mark> it should be noted that while imports from the country concerned only started in 1997, they were already significant in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1998 and were at</span></span> <mark>1998. They reached</mark> a level of 32 million pieces in the IP.",
            "Answer.end_timestamp": 1619730368.249,
            "Answer.fluency-1": 93,
            "Answer.fluency-2": 98,
            "Answer.fluency-3": 93,
            "Answer.fluency-4": 98,
            "Answer.fluency-5": 81,
            "Answer.start_timestamp": 1619730355.859,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-27",
            "Input.complex": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in 1997, they were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports of RBMs from</mark> Indonesia decreased <span class='tooltip' style='color:red'>^<span class='tooltiptext'>between 1998 and 2000</span></span> <mark>in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>investigation period. However, imports of this product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 million <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pieces</span></span> <mark>units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>The</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of collection of RBMs from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased between 1998 and 2000</span></span> <mark>provisional in the period 1998-2000</mark> and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again between 2000 and the IP, it should be noted that while imports</span></span> from <mark>2000 to</mark> the <mark>investigation period. However, imports of Actions product from this</mark> country <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned</span></span> only started in 1997, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>they</span></span> were already significant in 1998 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were at a level of</span></span> <mark>amounted to</mark> 32 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>million pieces</span></span> <mark>reactions units</mark> in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>IP.</span></span> <mark>investigation period.</mark>",
            "Input.simple-4": "Even if imports volume originating in Indonesia decreased between 1998 and 2000 and then slightly rose again between 2000 and the IP, it should be noted that while imports from the country concerned only started in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1997, they</span></span> <mark>1997. They</mark> were already significant in 1998 and were at a level of 32 million pieces in the IP.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even if imports</span></span> <mark>Although the</mark> volume <span class='tooltip' style='color:red'>^<span class='tooltiptext'>originating in</span></span> <mark>of imports from</mark> Indonesia <span class='tooltip' style='color:red'>^<span class='tooltiptext'>decreased</span></span> <mark>declined</mark> between 1998 and 2000 and then <mark>increased</mark> slightly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rose again</span></span> between 2000 and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the IP,</span></span> <mark>2000,</mark> it should be noted that while imports from the country concerned only started in 1997, they were already significant in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1998 and were at</span></span> <mark>1998. They reached</mark> a level of 32 million pieces in the IP.",
            "Answer.end_timestamp": 1619727900.45,
            "Answer.fluency-1": 48,
            "Answer.fluency-2": 81,
            "Answer.fluency-3": 64,
            "Answer.fluency-4": 46,
            "Answer.fluency-5": 67,
            "Answer.start_timestamp": 1619727886.343,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-28",
            "Input.complex": "Since those types of Cospas-Sarsat locator beacons are expected to be used in large numbers as distress beacons, it is necessary to provide that they, as far as they are covered by Directive 1999/5/EC, should be so designed as to function correctly according to accepted operational requirements.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Since those types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat</span></span> <mark>Cospas - Sarsat</mark> locator beacons are expected to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is necessary to provide that they, as far as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999 / 5 / EC,</mark> should be so designed as to function correctly according to accepted operational requirements.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those types of Cospas-Sarsat locator beacons are</span></span> <mark>It is</mark> expected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>that many of these Cospas-Sarsat beacons with position indication will</mark> be used <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in large numbers</span></span> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>distress beacons, it is necessary to provide that they,</span></span> <mark>losses studies Therefore, insofar</mark> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>far as they</span></span> <mark>section</mark> are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999/5 / EC, it</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so designed as</span></span> <mark>provided that they must be determine</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function</span></span> <mark>operate</mark> correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to accepted</span></span> <mark>in accordance with recognized</mark> operational requirements.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those</span></span> <mark>These</mark> types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat locator</span></span> beacons <mark>of Cospas-Sarsat</mark> are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>expected</span></span> <mark>intended</mark> to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is <mark>therefore</mark> necessary to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provide</span></span> <mark>ensure</mark> that they, as far as they are covered by Directive 1999/5/EC, should be so designed as to function correctly according to accepted operational requirements.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those types of Cospas-Sarsat locator beacons are</span></span> <mark>It is</mark> expected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>that many of these Cospas-Sarsat beacons with position indication will</mark> be used <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in large numbers</span></span> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>distress beacons, it is necessary to provide that they, as far</span></span> <mark>emergency beacons. Therefore, insofar</mark> as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999/5 / EC, it</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so</span></span> <mark>provided that they must be</mark> designed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function</span></span> <mark>operate</mark> correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to accepted</span></span> <mark>in accordance with recognized</mark> operational requirements.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those</span></span> <mark>These</mark> types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat</span></span> <mark>Cospas - Sarsat</mark> locator beacons are expected to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is <mark>therefore</mark> necessary to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provide</span></span> <mark>ensure</mark> that they, as far as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999 / 5 / EC,</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so</span></span> designed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> to function correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to</span></span> <mark>in accordance with</mark> accepted operational requirements.",
            "Answer.end_timestamp": 1619726287.666,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 87,
            "Answer.fluency-3": 75,
            "Answer.fluency-4": 99,
            "Answer.fluency-5": 88,
            "Answer.start_timestamp": 1619726219.68,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-28",
            "Input.complex": "Since those types of Cospas-Sarsat locator beacons are expected to be used in large numbers as distress beacons, it is necessary to provide that they, as far as they are covered by Directive 1999/5/EC, should be so designed as to function correctly according to accepted operational requirements.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Since those types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat</span></span> <mark>Cospas - Sarsat</mark> locator beacons are expected to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is necessary to provide that they, as far as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999 / 5 / EC,</mark> should be so designed as to function correctly according to accepted operational requirements.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those types of Cospas-Sarsat locator beacons are</span></span> <mark>It is</mark> expected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>that many of these Cospas-Sarsat beacons with position indication will</mark> be used <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in large numbers</span></span> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>distress beacons, it is necessary to provide that they,</span></span> <mark>losses studies Therefore, insofar</mark> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>far as they</span></span> <mark>section</mark> are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999/5 / EC, it</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so designed as</span></span> <mark>provided that they must be determine</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function</span></span> <mark>operate</mark> correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to accepted</span></span> <mark>in accordance with recognized</mark> operational requirements.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those</span></span> <mark>These</mark> types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat locator</span></span> beacons <mark>of Cospas-Sarsat</mark> are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>expected</span></span> <mark>intended</mark> to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is <mark>therefore</mark> necessary to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provide</span></span> <mark>ensure</mark> that they, as far as they are covered by Directive 1999/5/EC, should be so designed as to function correctly according to accepted operational requirements.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those types of Cospas-Sarsat locator beacons are</span></span> <mark>It is</mark> expected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>that many of these Cospas-Sarsat beacons with position indication will</mark> be used <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in large numbers</span></span> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>distress beacons, it is necessary to provide that they, as far</span></span> <mark>emergency beacons. Therefore, insofar</mark> as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999/5 / EC, it</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so</span></span> <mark>provided that they must be</mark> designed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function</span></span> <mark>operate</mark> correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to accepted</span></span> <mark>in accordance with recognized</mark> operational requirements.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those</span></span> <mark>These</mark> types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat</span></span> <mark>Cospas - Sarsat</mark> locator beacons are expected to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is <mark>therefore</mark> necessary to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provide</span></span> <mark>ensure</mark> that they, as far as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999 / 5 / EC,</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so</span></span> designed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> to function correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to</span></span> <mark>in accordance with</mark> accepted operational requirements.",
            "Answer.end_timestamp": 1619724425.84,
            "Answer.fluency-1": 78,
            "Answer.fluency-2": 92,
            "Answer.fluency-3": 92,
            "Answer.fluency-4": 88,
            "Answer.fluency-5": 85,
            "Answer.start_timestamp": 1619724401.776,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-28",
            "Input.complex": "Since those types of Cospas-Sarsat locator beacons are expected to be used in large numbers as distress beacons, it is necessary to provide that they, as far as they are covered by Directive 1999/5/EC, should be so designed as to function correctly according to accepted operational requirements.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Since those types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat</span></span> <mark>Cospas - Sarsat</mark> locator beacons are expected to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is necessary to provide that they, as far as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999 / 5 / EC,</mark> should be so designed as to function correctly according to accepted operational requirements.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those types of Cospas-Sarsat locator beacons are</span></span> <mark>It is</mark> expected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>that many of these Cospas-Sarsat beacons with position indication will</mark> be used <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in large numbers</span></span> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>distress beacons, it is necessary to provide that they,</span></span> <mark>losses studies Therefore, insofar</mark> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>far as they</span></span> <mark>section</mark> are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999/5 / EC, it</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so designed as</span></span> <mark>provided that they must be determine</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function</span></span> <mark>operate</mark> correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to accepted</span></span> <mark>in accordance with recognized</mark> operational requirements.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those</span></span> <mark>These</mark> types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat locator</span></span> beacons <mark>of Cospas-Sarsat</mark> are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>expected</span></span> <mark>intended</mark> to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is <mark>therefore</mark> necessary to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provide</span></span> <mark>ensure</mark> that they, as far as they are covered by Directive 1999/5/EC, should be so designed as to function correctly according to accepted operational requirements.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those types of Cospas-Sarsat locator beacons are</span></span> <mark>It is</mark> expected <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>that many of these Cospas-Sarsat beacons with position indication will</mark> be used <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in large numbers</span></span> as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>distress beacons, it is necessary to provide that they, as far</span></span> <mark>emergency beacons. Therefore, insofar</mark> as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999/5 / EC, it</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so</span></span> <mark>provided that they must be</mark> designed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>function</span></span> <mark>operate</mark> correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to accepted</span></span> <mark>in accordance with recognized</mark> operational requirements.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since those</span></span> <mark>These</mark> types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Cospas-Sarsat</span></span> <mark>Cospas - Sarsat</mark> locator beacons are expected to be used in large numbers as distress <span class='tooltip' style='color:red'>^<span class='tooltiptext'>beacons, it</span></span> <mark>beacons. It</mark> is <mark>therefore</mark> necessary to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provide</span></span> <mark>ensure</mark> that they, as far as they are covered by Directive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>1999/5/EC,</span></span> <mark>1999 / 5 / EC,</mark> should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>so</span></span> designed <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as</span></span> to function correctly <span class='tooltip' style='color:red'>^<span class='tooltiptext'>according to</span></span> <mark>in accordance with</mark> accepted operational requirements.",
            "Answer.end_timestamp": 1619724163.007,
            "Answer.fluency-1": 36,
            "Answer.fluency-2": 59,
            "Answer.fluency-3": 77,
            "Answer.fluency-4": 43,
            "Answer.fluency-5": 65,
            "Answer.start_timestamp": 1619724156.201,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-29",
            "Input.complex": "Recognising the importance of protecting the radio navigation spectrum from disruption and interference, the Parties shall identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The Parties additional</mark> the importance of protecting <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> radio navigation spectrum <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from</span></span> <mark>been</mark> disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. To this end, they</mark> identify sources of interference <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and seek mutually</span></span> <mark>shares pursue renal</mark> acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> interference.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The Parties recognize</mark> the importance of protecting <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. To this end, they</mark> identify sources of interference and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seek</span></span> <mark>pursue</mark> mutually acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> interference.",
            "Input.simple-3": "Recognising the importance of protecting the radio navigation spectrum from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>disruption and interference, the</span></span> <mark>disruption. The</mark> Parties shall identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The parties recognize</mark> the importance of protecting the radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. They must</mark> identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The parties recognize</mark> the importance of protecting the radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. The parties will</mark> identify sources of interference and seek mutually acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such interference.</span></span> <mark>this type of violation.</mark>",
            "Answer.end_timestamp": 1619726409.611,
            "Answer.fluency-1": 64,
            "Answer.fluency-2": 75,
            "Answer.fluency-3": 68,
            "Answer.fluency-4": 86,
            "Answer.fluency-5": 51,
            "Answer.start_timestamp": 1619726383.243,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-29",
            "Input.complex": "Recognising the importance of protecting the radio navigation spectrum from disruption and interference, the Parties shall identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The Parties additional</mark> the importance of protecting <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> radio navigation spectrum <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from</span></span> <mark>been</mark> disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. To this end, they</mark> identify sources of interference <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and seek mutually</span></span> <mark>shares pursue renal</mark> acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> interference.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The Parties recognize</mark> the importance of protecting <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. To this end, they</mark> identify sources of interference and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seek</span></span> <mark>pursue</mark> mutually acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> interference.",
            "Input.simple-3": "Recognising the importance of protecting the radio navigation spectrum from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>disruption and interference, the</span></span> <mark>disruption. The</mark> Parties shall identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The parties recognize</mark> the importance of protecting the radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. They must</mark> identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The parties recognize</mark> the importance of protecting the radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. The parties will</mark> identify sources of interference and seek mutually acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such interference.</span></span> <mark>this type of violation.</mark>",
            "Answer.end_timestamp": 1619724253.722,
            "Answer.fluency-1": 2,
            "Answer.fluency-2": 100,
            "Answer.fluency-3": 25,
            "Answer.fluency-4": 99,
            "Answer.fluency-5": 98,
            "Answer.start_timestamp": 1619724149.717,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-29",
            "Input.complex": "Recognising the importance of protecting the radio navigation spectrum from disruption and interference, the Parties shall identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The Parties additional</mark> the importance of protecting <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> radio navigation spectrum <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from</span></span> <mark>been</mark> disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. To this end, they</mark> identify sources of interference <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and seek mutually</span></span> <mark>shares pursue renal</mark> acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> interference.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The Parties recognize</mark> the importance of protecting <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. To this end, they</mark> identify sources of interference and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seek</span></span> <mark>pursue</mark> mutually acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> interference.",
            "Input.simple-3": "Recognising the importance of protecting the radio navigation spectrum from <span class='tooltip' style='color:red'>^<span class='tooltiptext'>disruption and interference, the</span></span> <mark>disruption. The</mark> Parties shall identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The parties recognize</mark> the importance of protecting the radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. They must</mark> identify sources of interference and seek mutually acceptable solutions to combat such interference.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Recognising</span></span> <mark>The parties recognize</mark> the importance of protecting the radio navigation spectrum from disruption and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interference, the Parties shall</span></span> <mark>interference. The parties will</mark> identify sources of interference and seek mutually acceptable solutions to combat <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such interference.</span></span> <mark>this type of violation.</mark>",
            "Answer.end_timestamp": 1619724874.664,
            "Answer.fluency-1": 84,
            "Answer.fluency-2": 94,
            "Answer.fluency-3": 87,
            "Answer.fluency-4": 94,
            "Answer.fluency-5": 100,
            "Answer.start_timestamp": 1619724861.165,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-30",
            "Input.complex": "Because animal studies (see also section 5. 3) have shown a high risk of vaginal bleeding presumably from the placenta and of pregnancy loss, the benefit of treatment has to be evaluated against the potential risks.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal studies (see also section 5. 3)</span></span> <mark>Studies in animals</mark> have shown a high risk of vaginal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bleeding</span></span> <mark>bleeding,</mark> presumably <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from the placenta</span></span> <mark>placental,</mark> and of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss, the benefit of treatment has to be evaluated against the</span></span> <mark>abortions (see section 5. 3). The expected benefits and</mark> potential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>risks.</span></span> <mark>risks must be taken into consideration.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal</span></span> <mark>Animal</mark> studies (see also section 5. 3) have shown a high risk of vaginal bleeding <span class='tooltip' style='color:red'>^<span class='tooltiptext'>presumably</span></span> <mark>probably</mark> from the placenta and <mark>loss</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss,</span></span> <mark>pregnancy. Therefore,</mark> the benefit of treatment <span class='tooltip' style='color:red'>^<span class='tooltiptext'>has to</span></span> <mark>must</mark> be evaluated against <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> potential risks.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal studies (see also section 5. 3)</span></span> <mark>Studies in animals</mark> have shown a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>high</span></span> <mark>once</mark> risk of vaginal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bleeding</span></span> <mark>bleeding,</mark> presumably <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from the placenta</span></span> <mark>placental,</mark> and of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss, the benefit of treatment has to be evaluated against the</span></span> <mark>abortions (see section 5. 3). The expected definitive and</mark> potential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>risks.</span></span> <mark>that must be taken injection consideration.</mark>",
            "Input.simple-4": "Because animal studies (see also section 5. 3) have shown a high risk of vaginal bleeding presumably from the placenta and of pregnancy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>loss, the</span></span> <mark>loss. The</mark> benefit of treatment has to be evaluated against the potential risks.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal</span></span> <mark>Animal</mark> studies (see also section 5. 3) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have shown</span></span> <mark>show</mark> a high risk of vaginal bleeding <span class='tooltip' style='color:red'>^<span class='tooltiptext'>presumably</span></span> <mark>likely</mark> from the placenta and <mark>the loss</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss,</span></span> <mark>pregnancy. Therefore,</mark> the benefit of treatment <span class='tooltip' style='color:red'>^<span class='tooltiptext'>has to</span></span> <mark>should</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated</span></span> <mark>assessed</mark> against the potential risks.",
            "Answer.end_timestamp": 1619730392.894,
            "Answer.fluency-1": 53,
            "Answer.fluency-2": 71,
            "Answer.fluency-3": 95,
            "Answer.fluency-4": 73,
            "Answer.fluency-5": 66,
            "Answer.start_timestamp": 1619730379.895,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-30",
            "Input.complex": "Because animal studies (see also section 5. 3) have shown a high risk of vaginal bleeding presumably from the placenta and of pregnancy loss, the benefit of treatment has to be evaluated against the potential risks.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal studies (see also section 5. 3)</span></span> <mark>Studies in animals</mark> have shown a high risk of vaginal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bleeding</span></span> <mark>bleeding,</mark> presumably <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from the placenta</span></span> <mark>placental,</mark> and of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss, the benefit of treatment has to be evaluated against the</span></span> <mark>abortions (see section 5. 3). The expected benefits and</mark> potential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>risks.</span></span> <mark>risks must be taken into consideration.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal</span></span> <mark>Animal</mark> studies (see also section 5. 3) have shown a high risk of vaginal bleeding <span class='tooltip' style='color:red'>^<span class='tooltiptext'>presumably</span></span> <mark>probably</mark> from the placenta and <mark>loss</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss,</span></span> <mark>pregnancy. Therefore,</mark> the benefit of treatment <span class='tooltip' style='color:red'>^<span class='tooltiptext'>has to</span></span> <mark>must</mark> be evaluated against <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> potential risks.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal studies (see also section 5. 3)</span></span> <mark>Studies in animals</mark> have shown a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>high</span></span> <mark>once</mark> risk of vaginal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bleeding</span></span> <mark>bleeding,</mark> presumably <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from the placenta</span></span> <mark>placental,</mark> and of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss, the benefit of treatment has to be evaluated against the</span></span> <mark>abortions (see section 5. 3). The expected definitive and</mark> potential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>risks.</span></span> <mark>that must be taken injection consideration.</mark>",
            "Input.simple-4": "Because animal studies (see also section 5. 3) have shown a high risk of vaginal bleeding presumably from the placenta and of pregnancy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>loss, the</span></span> <mark>loss. The</mark> benefit of treatment has to be evaluated against the potential risks.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal</span></span> <mark>Animal</mark> studies (see also section 5. 3) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have shown</span></span> <mark>show</mark> a high risk of vaginal bleeding <span class='tooltip' style='color:red'>^<span class='tooltiptext'>presumably</span></span> <mark>likely</mark> from the placenta and <mark>the loss</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss,</span></span> <mark>pregnancy. Therefore,</mark> the benefit of treatment <span class='tooltip' style='color:red'>^<span class='tooltiptext'>has to</span></span> <mark>should</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated</span></span> <mark>assessed</mark> against the potential risks.",
            "Answer.end_timestamp": 1619724286.64,
            "Answer.fluency-1": 44,
            "Answer.fluency-2": 67,
            "Answer.fluency-3": 38,
            "Answer.fluency-4": 71,
            "Answer.fluency-5": 55,
            "Answer.start_timestamp": 1619724276.237,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-30",
            "Input.complex": "Because animal studies (see also section 5. 3) have shown a high risk of vaginal bleeding presumably from the placenta and of pregnancy loss, the benefit of treatment has to be evaluated against the potential risks.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal studies (see also section 5. 3)</span></span> <mark>Studies in animals</mark> have shown a high risk of vaginal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bleeding</span></span> <mark>bleeding,</mark> presumably <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from the placenta</span></span> <mark>placental,</mark> and of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss, the benefit of treatment has to be evaluated against the</span></span> <mark>abortions (see section 5. 3). The expected benefits and</mark> potential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>risks.</span></span> <mark>risks must be taken into consideration.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal</span></span> <mark>Animal</mark> studies (see also section 5. 3) have shown a high risk of vaginal bleeding <span class='tooltip' style='color:red'>^<span class='tooltiptext'>presumably</span></span> <mark>probably</mark> from the placenta and <mark>loss</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss,</span></span> <mark>pregnancy. Therefore,</mark> the benefit of treatment <span class='tooltip' style='color:red'>^<span class='tooltiptext'>has to</span></span> <mark>must</mark> be evaluated against <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> potential risks.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal studies (see also section 5. 3)</span></span> <mark>Studies in animals</mark> have shown a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>high</span></span> <mark>once</mark> risk of vaginal <span class='tooltip' style='color:red'>^<span class='tooltiptext'>bleeding</span></span> <mark>bleeding,</mark> presumably <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from the placenta</span></span> <mark>placental,</mark> and of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss, the benefit of treatment has to be evaluated against the</span></span> <mark>abortions (see section 5. 3). The expected definitive and</mark> potential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>risks.</span></span> <mark>that must be taken injection consideration.</mark>",
            "Input.simple-4": "Because animal studies (see also section 5. 3) have shown a high risk of vaginal bleeding presumably from the placenta and of pregnancy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>loss, the</span></span> <mark>loss. The</mark> benefit of treatment has to be evaluated against the potential risks.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Because animal</span></span> <mark>Animal</mark> studies (see also section 5. 3) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have shown</span></span> <mark>show</mark> a high risk of vaginal bleeding <span class='tooltip' style='color:red'>^<span class='tooltiptext'>presumably</span></span> <mark>likely</mark> from the placenta and <mark>the loss</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pregnancy loss,</span></span> <mark>pregnancy. Therefore,</mark> the benefit of treatment <span class='tooltip' style='color:red'>^<span class='tooltiptext'>has to</span></span> <mark>should</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated</span></span> <mark>assessed</mark> against the potential risks.",
            "Answer.end_timestamp": 1619726626.542,
            "Answer.fluency-1": 60,
            "Answer.fluency-2": 27,
            "Answer.fluency-3": 39,
            "Answer.fluency-4": 54,
            "Answer.fluency-5": 44,
            "Answer.start_timestamp": 1619726606.463,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-31",
            "Input.complex": "As the criteria (1), (5) and (7) of Annex III cannot be amended through comitology, amendments in respect of periods after 2012 should only be made through codecision.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the criteria</span></span> <mark>The put</mark> (1), (5) and (7) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>time out in</mark> Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>should not</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>the comitology procedure. Amendments covering</mark> periods after 2012 should only be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>made through codecision.</span></span> <mark>adopted reactions accordance with the co-decision required</mark>",
            "Input.simple-2": "As the criteria (1), (5) and (7) of Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>can not</mark> be amended through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments</span></span> <mark>comitology. Amendments</mark> in respect of periods after 2012 should only be made through codecision.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As</span></span> <mark>Since</mark> the criteria (1), (5) and (7) of Annex III cannot be amended <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through comitology, amendments in respect of</span></span> <mark>by comitology. Amendments relating to</mark> periods after 2012 should only be made through codecision.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> criteria (1), (5) and (7) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>set out in</mark> Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>should not</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>the comitology procedure. Amendments covering</mark> periods after 2012 should only be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>made through codecision.</span></span> <mark>adopted in accordance with the co-decision procedure.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> criteria (1), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(5)</span></span> <mark>5)</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(7)</span></span> <mark>7)</mark> of Annex III cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>comitology. Therefore, changes to</mark> periods after 2012 should only be made <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>by</mark> codecision.",
            "Answer.end_timestamp": 1619727567.609,
            "Answer.fluency-1": 43,
            "Answer.fluency-2": 65,
            "Answer.fluency-3": 81,
            "Answer.fluency-4": 72,
            "Answer.fluency-5": 54,
            "Answer.start_timestamp": 1619727480.182,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-31",
            "Input.complex": "As the criteria (1), (5) and (7) of Annex III cannot be amended through comitology, amendments in respect of periods after 2012 should only be made through codecision.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the criteria</span></span> <mark>The put</mark> (1), (5) and (7) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>time out in</mark> Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>should not</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>the comitology procedure. Amendments covering</mark> periods after 2012 should only be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>made through codecision.</span></span> <mark>adopted reactions accordance with the co-decision required</mark>",
            "Input.simple-2": "As the criteria (1), (5) and (7) of Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>can not</mark> be amended through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments</span></span> <mark>comitology. Amendments</mark> in respect of periods after 2012 should only be made through codecision.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As</span></span> <mark>Since</mark> the criteria (1), (5) and (7) of Annex III cannot be amended <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through comitology, amendments in respect of</span></span> <mark>by comitology. Amendments relating to</mark> periods after 2012 should only be made through codecision.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> criteria (1), (5) and (7) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>set out in</mark> Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>should not</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>the comitology procedure. Amendments covering</mark> periods after 2012 should only be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>made through codecision.</span></span> <mark>adopted in accordance with the co-decision procedure.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> criteria (1), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(5)</span></span> <mark>5)</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(7)</span></span> <mark>7)</mark> of Annex III cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>comitology. Therefore, changes to</mark> periods after 2012 should only be made <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>by</mark> codecision.",
            "Answer.end_timestamp": 1619724705.379,
            "Answer.fluency-1": 26,
            "Answer.fluency-2": 60,
            "Answer.fluency-3": 99,
            "Answer.fluency-4": 22,
            "Answer.fluency-5": 64,
            "Answer.start_timestamp": 1619724690.932,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-31",
            "Input.complex": "As the criteria (1), (5) and (7) of Annex III cannot be amended through comitology, amendments in respect of periods after 2012 should only be made through codecision.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the criteria</span></span> <mark>The put</mark> (1), (5) and (7) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>time out in</mark> Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>should not</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>the comitology procedure. Amendments covering</mark> periods after 2012 should only be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>made through codecision.</span></span> <mark>adopted reactions accordance with the co-decision required</mark>",
            "Input.simple-2": "As the criteria (1), (5) and (7) of Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>can not</mark> be amended through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments</span></span> <mark>comitology. Amendments</mark> in respect of periods after 2012 should only be made through codecision.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As</span></span> <mark>Since</mark> the criteria (1), (5) and (7) of Annex III cannot be amended <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through comitology, amendments in respect of</span></span> <mark>by comitology. Amendments relating to</mark> periods after 2012 should only be made through codecision.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> criteria (1), (5) and (7) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>set out in</mark> Annex III <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>should not</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>the comitology procedure. Amendments covering</mark> periods after 2012 should only be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>made through codecision.</span></span> <mark>adopted in accordance with the co-decision procedure.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>As the</span></span> <mark>The</mark> criteria (1), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(5)</span></span> <mark>5)</mark> and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>(7)</span></span> <mark>7)</mark> of Annex III cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amended</span></span> <mark>changed</mark> through <span class='tooltip' style='color:red'>^<span class='tooltiptext'>comitology, amendments in respect of</span></span> <mark>comitology. Therefore, changes to</mark> periods after 2012 should only be made <span class='tooltip' style='color:red'>^<span class='tooltiptext'>through</span></span> <mark>by</mark> codecision.",
            "Answer.end_timestamp": 1619730404.97,
            "Answer.fluency-1": 99,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 98,
            "Answer.fluency-4": 98,
            "Answer.fluency-5": 100,
            "Answer.start_timestamp": 1619730392.864,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-32",
            "Input.complex": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of olanzapine that is complete approximately six to eight months after the last injection, supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine</span></span> <mark>olanizapine</mark> that is complete approximately six to eight months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection,</span></span> <mark>injection. The</mark> supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.simple-2": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine</span></span> <mark>olanizapine</mark> that is complete approximately six to eight months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision by a clinician,</span></span> <mark>injection. A clinician supervision,</mark> especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Due to the</span></span> <mark>The</mark> slow dissolution of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>aims</mark> olanzapine pamoate salt <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which provides</span></span> <mark>allows</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>slow</span></span> continuous <mark>slow</mark> release of olanzapine <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that is complete approximately six</span></span> <mark>which ends promote 6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision</span></span> <mark>injection. Monitoring</mark> by a clinician, especially during the first <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2 months</span></span> <mark>two negotiations</mark> after <span class='tooltip' style='color:red'>^<span class='tooltiptext'>discontinuation of ZYPADHERA,</span></span> <mark>stopping ZYPADHERA</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>necessary</mark> when switching to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another</span></span> <mark>other</mark> antipsychotic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product.</span></span> <mark>Present</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Due to the</span></span> <mark>The</mark> slow dissolution of the olanzapine pamoate salt <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which provides</span></span> <mark>allows</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>slow</span></span> continuous <mark>slow</mark> release of olanzapine <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that is complete</span></span> <mark>which ends</mark> approximately <span class='tooltip' style='color:red'>^<span class='tooltiptext'>six</span></span> <mark>6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision</span></span> <mark>injection. Monitoring</mark> by a clinician, especially during the first <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2</span></span> <mark>two</mark> months after <span class='tooltip' style='color:red'>^<span class='tooltiptext'>discontinuation of ZYPADHERA,</span></span> <mark>stopping ZYPADHERA</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>necessary</mark> when switching to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another</span></span> <mark>other</mark> antipsychotic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product.</span></span> <mark>therapy.</mark>",
            "Input.simple-5": "Due to the slow dissolution of the olanzapine pamoate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>salt</span></span> <mark>salt,</mark> which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine that is complete approximately six</span></span> <mark>ca. 6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last injection, supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>required</mark> when switching to another antipsychotic product.",
            "Answer.end_timestamp": 1619724299.442,
            "Answer.fluency-1": 62,
            "Answer.fluency-2": 79,
            "Answer.fluency-3": 48,
            "Answer.fluency-4": 71,
            "Answer.fluency-5": 59,
            "Answer.start_timestamp": 1619724294.077,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-32",
            "Input.complex": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of olanzapine that is complete approximately six to eight months after the last injection, supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine</span></span> <mark>olanizapine</mark> that is complete approximately six to eight months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection,</span></span> <mark>injection. The</mark> supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.simple-2": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine</span></span> <mark>olanizapine</mark> that is complete approximately six to eight months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision by a clinician,</span></span> <mark>injection. A clinician supervision,</mark> especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Due to the</span></span> <mark>The</mark> slow dissolution of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>aims</mark> olanzapine pamoate salt <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which provides</span></span> <mark>allows</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>slow</span></span> continuous <mark>slow</mark> release of olanzapine <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that is complete approximately six</span></span> <mark>which ends promote 6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision</span></span> <mark>injection. Monitoring</mark> by a clinician, especially during the first <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2 months</span></span> <mark>two negotiations</mark> after <span class='tooltip' style='color:red'>^<span class='tooltiptext'>discontinuation of ZYPADHERA,</span></span> <mark>stopping ZYPADHERA</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>necessary</mark> when switching to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another</span></span> <mark>other</mark> antipsychotic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product.</span></span> <mark>Present</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Due to the</span></span> <mark>The</mark> slow dissolution of the olanzapine pamoate salt <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which provides</span></span> <mark>allows</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>slow</span></span> continuous <mark>slow</mark> release of olanzapine <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that is complete</span></span> <mark>which ends</mark> approximately <span class='tooltip' style='color:red'>^<span class='tooltiptext'>six</span></span> <mark>6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision</span></span> <mark>injection. Monitoring</mark> by a clinician, especially during the first <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2</span></span> <mark>two</mark> months after <span class='tooltip' style='color:red'>^<span class='tooltiptext'>discontinuation of ZYPADHERA,</span></span> <mark>stopping ZYPADHERA</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>necessary</mark> when switching to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another</span></span> <mark>other</mark> antipsychotic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product.</span></span> <mark>therapy.</mark>",
            "Input.simple-5": "Due to the slow dissolution of the olanzapine pamoate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>salt</span></span> <mark>salt,</mark> which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine that is complete approximately six</span></span> <mark>ca. 6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last injection, supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>required</mark> when switching to another antipsychotic product.",
            "Answer.end_timestamp": 1619724496.07,
            "Answer.fluency-1": 82,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 89,
            "Answer.fluency-4": 86,
            "Answer.fluency-5": 90,
            "Answer.start_timestamp": 1619724475.539,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-32",
            "Input.complex": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of olanzapine that is complete approximately six to eight months after the last injection, supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine</span></span> <mark>olanizapine</mark> that is complete approximately six to eight months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection,</span></span> <mark>injection. The</mark> supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.simple-2": "Due to the slow dissolution of the olanzapine pamoate salt which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine</span></span> <mark>olanizapine</mark> that is complete approximately six to eight months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision by a clinician,</span></span> <mark>injection. A clinician supervision,</mark> especially during the first 2 months after discontinuation of ZYPADHERA, is needed when switching to another antipsychotic product.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Due to the</span></span> <mark>The</mark> slow dissolution of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> <mark>aims</mark> olanzapine pamoate salt <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which provides</span></span> <mark>allows</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>slow</span></span> continuous <mark>slow</mark> release of olanzapine <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that is complete approximately six</span></span> <mark>which ends promote 6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision</span></span> <mark>injection. Monitoring</mark> by a clinician, especially during the first <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2 months</span></span> <mark>two negotiations</mark> after <span class='tooltip' style='color:red'>^<span class='tooltiptext'>discontinuation of ZYPADHERA,</span></span> <mark>stopping ZYPADHERA</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>necessary</mark> when switching to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another</span></span> <mark>other</mark> antipsychotic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product.</span></span> <mark>Present</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Due to the</span></span> <mark>The</mark> slow dissolution of the olanzapine pamoate salt <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which provides</span></span> <mark>allows</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>slow</span></span> continuous <mark>slow</mark> release of olanzapine <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that is complete</span></span> <mark>which ends</mark> approximately <span class='tooltip' style='color:red'>^<span class='tooltiptext'>six</span></span> <mark>6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last <span class='tooltip' style='color:red'>^<span class='tooltiptext'>injection, supervision</span></span> <mark>injection. Monitoring</mark> by a clinician, especially during the first <span class='tooltip' style='color:red'>^<span class='tooltiptext'>2</span></span> <mark>two</mark> months after <span class='tooltip' style='color:red'>^<span class='tooltiptext'>discontinuation of ZYPADHERA,</span></span> <mark>stopping ZYPADHERA</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>necessary</mark> when switching to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another</span></span> <mark>other</mark> antipsychotic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>product.</span></span> <mark>therapy.</mark>",
            "Input.simple-5": "Due to the slow dissolution of the olanzapine pamoate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>salt</span></span> <mark>salt,</mark> which provides a slow continuous release of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>olanzapine that is complete approximately six</span></span> <mark>ca. 6</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>eight</span></span> <mark>8</mark> months after the last injection, supervision by a clinician, especially during the first 2 months after discontinuation of ZYPADHERA, is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>needed</span></span> <mark>required</mark> when switching to another antipsychotic product.",
            "Answer.end_timestamp": 1619725459.97,
            "Answer.fluency-1": 97,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 99,
            "Answer.fluency-4": 58,
            "Answer.fluency-5": 96,
            "Answer.start_timestamp": 1619725445.392,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-33",
            "Input.complex": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer levels and the inevitable time-scale of financing the decommissioning liabilities, the Commission concludes that part of Measure A relating to those liabilities cannot be qualified as on-going subsidy to BE since they are defined and relate to costs already incurred.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking into account the particular</span></span> <mark>The special</mark> nature of the nuclear industry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allow the handling of</span></span> <mark>make it possible to handle</mark> radioactive material before its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>radiation rate</span></span> <mark>radioactivity</mark> has <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reached</span></span> <mark>decreased to a</mark> safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels</span></span> <mark>level,</mark> and <mark>also means that</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inevitable time-scale</span></span> <mark>duration</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>financing</span></span> the <mark>financing of gains</mark> decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities,</span></span> <mark>obligations cannot be avoided. Taking these two prejudiced into account,</mark> the Commission concludes that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>part</span></span> <mark>the corporate</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Measure</span></span> <mark>measure</mark> A <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>that relates</mark> to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities</span></span> <mark>obligations</mark> cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>qualified as on-going subsidy</span></span> <mark>considered a continuous grant</mark> to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since they</span></span> <mark>as these obligations</mark> are defined and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relate to</span></span> <mark>concern</mark> costs <span class='tooltip' style='color:red'>^<span class='tooltiptext'>already</span></span> <mark>shares</mark> incurred.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking</span></span> <mark>The Commission takes</mark> into account the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particular</span></span> <mark>specific</mark> nature of the nuclear industry that does not allow the handling of radioactive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material</span></span> <mark>materials</mark> before its radiation rate has reached safer levels and the inevitable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>time-scale</span></span> <mark>time - scale</mark> of financing <mark>of</mark> the decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the</span></span> <mark>liabilities. The</mark> Commission concludes that part of Measure A relating to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those liabilities</span></span> <mark>these obligations</mark> cannot be qualified as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on-going</span></span> <mark>an ongoing</mark> subsidy to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> <mark>because</mark> they are defined and relate to costs already incurred.",
            "Input.simple-3": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels and the inevitable time-scale of financing the decommissioning liabilities, the</span></span> <mark>levels. The</mark> Commission concludes that part of Measure A relating to those liabilities <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>can not</mark> be qualified as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on-going</span></span> <mark>on - going</mark> subsidy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to BE</span></span> <mark>costs incurred</mark> since they are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>defined and relate to costs</span></span> already <span class='tooltip' style='color:red'>^<span class='tooltiptext'>incurred.</span></span> <mark>defined to BE costs.</mark>",
            "Input.simple-4": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels and</span></span> <mark>levels. And</mark> the inevitable time-scale of financing the decommissioning liabilities, the Commission concludes that part of Measure A relating to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities cannot</span></span> <mark>Liabilities can not</mark> be qualified as on-going subsidy to BE since they are defined and relate to costs already incurred.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking into account the particular</span></span> <mark>The special</mark> nature of the nuclear industry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allow the handling of</span></span> <mark>make it possible to handle</mark> radioactive material before its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>radiation rate</span></span> <mark>radioactivity</mark> has <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reached</span></span> <mark>decreased to a</mark> safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels</span></span> <mark>level,</mark> and <mark>also means that</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inevitable time-scale</span></span> <mark>duration</mark> of <mark>the</mark> financing <mark>of</mark> the decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities,</span></span> <mark>obligations cannot be avoided. Taking these two elements into account,</mark> the Commission concludes that <mark>the</mark> part of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Measure</span></span> <mark>measure</mark> A <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>that relates</mark> to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities</span></span> <mark>obligations</mark> cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>qualified as on-going subsidy</span></span> <mark>considered a continuous grant</mark> to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since they</span></span> <mark>as these obligations</mark> are defined and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relate to</span></span> <mark>concern</mark> costs already incurred.",
            "Answer.end_timestamp": 1619732044.7,
            "Answer.fluency-1": 62,
            "Answer.fluency-2": 53,
            "Answer.fluency-3": 65,
            "Answer.fluency-4": 54,
            "Answer.fluency-5": -1,
            "Answer.start_timestamp": 1619732030.456,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-33",
            "Input.complex": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer levels and the inevitable time-scale of financing the decommissioning liabilities, the Commission concludes that part of Measure A relating to those liabilities cannot be qualified as on-going subsidy to BE since they are defined and relate to costs already incurred.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking into account the particular</span></span> <mark>The special</mark> nature of the nuclear industry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allow the handling of</span></span> <mark>make it possible to handle</mark> radioactive material before its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>radiation rate</span></span> <mark>radioactivity</mark> has <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reached</span></span> <mark>decreased to a</mark> safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels</span></span> <mark>level,</mark> and <mark>also means that</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inevitable time-scale</span></span> <mark>duration</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>financing</span></span> the <mark>financing of gains</mark> decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities,</span></span> <mark>obligations cannot be avoided. Taking these two prejudiced into account,</mark> the Commission concludes that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>part</span></span> <mark>the corporate</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Measure</span></span> <mark>measure</mark> A <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>that relates</mark> to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities</span></span> <mark>obligations</mark> cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>qualified as on-going subsidy</span></span> <mark>considered a continuous grant</mark> to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since they</span></span> <mark>as these obligations</mark> are defined and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relate to</span></span> <mark>concern</mark> costs <span class='tooltip' style='color:red'>^<span class='tooltiptext'>already</span></span> <mark>shares</mark> incurred.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking</span></span> <mark>The Commission takes</mark> into account the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particular</span></span> <mark>specific</mark> nature of the nuclear industry that does not allow the handling of radioactive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material</span></span> <mark>materials</mark> before its radiation rate has reached safer levels and the inevitable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>time-scale</span></span> <mark>time - scale</mark> of financing <mark>of</mark> the decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the</span></span> <mark>liabilities. The</mark> Commission concludes that part of Measure A relating to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those liabilities</span></span> <mark>these obligations</mark> cannot be qualified as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on-going</span></span> <mark>an ongoing</mark> subsidy to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> <mark>because</mark> they are defined and relate to costs already incurred.",
            "Input.simple-3": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels and the inevitable time-scale of financing the decommissioning liabilities, the</span></span> <mark>levels. The</mark> Commission concludes that part of Measure A relating to those liabilities <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>can not</mark> be qualified as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on-going</span></span> <mark>on - going</mark> subsidy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to BE</span></span> <mark>costs incurred</mark> since they are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>defined and relate to costs</span></span> already <span class='tooltip' style='color:red'>^<span class='tooltiptext'>incurred.</span></span> <mark>defined to BE costs.</mark>",
            "Input.simple-4": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels and</span></span> <mark>levels. And</mark> the inevitable time-scale of financing the decommissioning liabilities, the Commission concludes that part of Measure A relating to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities cannot</span></span> <mark>Liabilities can not</mark> be qualified as on-going subsidy to BE since they are defined and relate to costs already incurred.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking into account the particular</span></span> <mark>The special</mark> nature of the nuclear industry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allow the handling of</span></span> <mark>make it possible to handle</mark> radioactive material before its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>radiation rate</span></span> <mark>radioactivity</mark> has <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reached</span></span> <mark>decreased to a</mark> safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels</span></span> <mark>level,</mark> and <mark>also means that</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inevitable time-scale</span></span> <mark>duration</mark> of <mark>the</mark> financing <mark>of</mark> the decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities,</span></span> <mark>obligations cannot be avoided. Taking these two elements into account,</mark> the Commission concludes that <mark>the</mark> part of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Measure</span></span> <mark>measure</mark> A <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>that relates</mark> to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities</span></span> <mark>obligations</mark> cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>qualified as on-going subsidy</span></span> <mark>considered a continuous grant</mark> to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since they</span></span> <mark>as these obligations</mark> are defined and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relate to</span></span> <mark>concern</mark> costs already incurred.",
            "Answer.end_timestamp": 1619724424.912,
            "Answer.fluency-1": 95,
            "Answer.fluency-2": 85,
            "Answer.fluency-3": 94,
            "Answer.fluency-4": 80,
            "Answer.fluency-5": 94,
            "Answer.start_timestamp": 1619724411.068,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-33",
            "Input.complex": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer levels and the inevitable time-scale of financing the decommissioning liabilities, the Commission concludes that part of Measure A relating to those liabilities cannot be qualified as on-going subsidy to BE since they are defined and relate to costs already incurred.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking into account the particular</span></span> <mark>The special</mark> nature of the nuclear industry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allow the handling of</span></span> <mark>make it possible to handle</mark> radioactive material before its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>radiation rate</span></span> <mark>radioactivity</mark> has <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reached</span></span> <mark>decreased to a</mark> safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels</span></span> <mark>level,</mark> and <mark>also means that</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inevitable time-scale</span></span> <mark>duration</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>financing</span></span> the <mark>financing of gains</mark> decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities,</span></span> <mark>obligations cannot be avoided. Taking these two prejudiced into account,</mark> the Commission concludes that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>part</span></span> <mark>the corporate</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Measure</span></span> <mark>measure</mark> A <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>that relates</mark> to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities</span></span> <mark>obligations</mark> cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>qualified as on-going subsidy</span></span> <mark>considered a continuous grant</mark> to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since they</span></span> <mark>as these obligations</mark> are defined and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relate to</span></span> <mark>concern</mark> costs <span class='tooltip' style='color:red'>^<span class='tooltiptext'>already</span></span> <mark>shares</mark> incurred.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking</span></span> <mark>The Commission takes</mark> into account the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particular</span></span> <mark>specific</mark> nature of the nuclear industry that does not allow the handling of radioactive <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material</span></span> <mark>materials</mark> before its radiation rate has reached safer levels and the inevitable <span class='tooltip' style='color:red'>^<span class='tooltiptext'>time-scale</span></span> <mark>time - scale</mark> of financing <mark>of</mark> the decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the</span></span> <mark>liabilities. The</mark> Commission concludes that part of Measure A relating to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those liabilities</span></span> <mark>these obligations</mark> cannot be qualified as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on-going</span></span> <mark>an ongoing</mark> subsidy to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since</span></span> <mark>because</mark> they are defined and relate to costs already incurred.",
            "Input.simple-3": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels and the inevitable time-scale of financing the decommissioning liabilities, the</span></span> <mark>levels. The</mark> Commission concludes that part of Measure A relating to those liabilities <span class='tooltip' style='color:red'>^<span class='tooltiptext'>cannot</span></span> <mark>can not</mark> be qualified as <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on-going</span></span> <mark>on - going</mark> subsidy <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to BE</span></span> <mark>costs incurred</mark> since they are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>defined and relate to costs</span></span> already <span class='tooltip' style='color:red'>^<span class='tooltiptext'>incurred.</span></span> <mark>defined to BE costs.</mark>",
            "Input.simple-4": "Taking into account the particular nature of the nuclear industry that does not allow the handling of radioactive material before its radiation rate has reached safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels and</span></span> <mark>levels. And</mark> the inevitable time-scale of financing the decommissioning liabilities, the Commission concludes that part of Measure A relating to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities cannot</span></span> <mark>Liabilities can not</mark> be qualified as on-going subsidy to BE since they are defined and relate to costs already incurred.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Taking into account the particular</span></span> <mark>The special</mark> nature of the nuclear industry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>allow the handling of</span></span> <mark>make it possible to handle</mark> radioactive material before its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>radiation rate</span></span> <mark>radioactivity</mark> has <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reached</span></span> <mark>decreased to a</mark> safer <span class='tooltip' style='color:red'>^<span class='tooltiptext'>levels</span></span> <mark>level,</mark> and <mark>also means that</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inevitable time-scale</span></span> <mark>duration</mark> of <mark>the</mark> financing <mark>of</mark> the decommissioning <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities,</span></span> <mark>obligations cannot be avoided. Taking these two elements into account,</mark> the Commission concludes that <mark>the</mark> part of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Measure</span></span> <mark>measure</mark> A <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relating</span></span> <mark>that relates</mark> to those <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities</span></span> <mark>obligations</mark> cannot be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>qualified as on-going subsidy</span></span> <mark>considered a continuous grant</mark> to BE <span class='tooltip' style='color:red'>^<span class='tooltiptext'>since they</span></span> <mark>as these obligations</mark> are defined and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>relate to</span></span> <mark>concern</mark> costs already incurred.",
            "Answer.end_timestamp": 1619727912.916,
            "Answer.fluency-1": 78,
            "Answer.fluency-2": 37,
            "Answer.fluency-3": 49,
            "Answer.fluency-4": 69,
            "Answer.fluency-5": 57,
            "Answer.start_timestamp": 1619727901.47,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-34",
            "Input.complex": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential character; whereas in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the articles in question;",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the above criterion</span></span> <mark>this feature</mark> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable sufficient</span></span> <mark>take fully satisfactory</mark> account <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be taken</span></span> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material which gives</span></span> <mark>characterizing substance of</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>goods</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question their essential character; whereas</span></span> <mark>question. For this reason, and also</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the light</span></span> <mark>view</mark> of new <mark>knowledge resulting from the</mark> technical <span class='tooltip' style='color:red'>^<span class='tooltiptext'>developments in</span></span> <mark>development of</mark> the manufacture of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those products, other classification criteria should be sought that correspond more closely</span></span> <mark>these goods, it is advisable</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>economic facts and</span></span> <mark>look for other characteristics for the classification that better correspond</mark> to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specific function of</span></span> <mark>economic circumstances and</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles in question;</span></span> <mark>intended use of these goods.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the above criterion</span></span> <mark>this feature</mark> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable sufficient</span></span> <mark>take fully satisfactory</mark> account <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be taken</span></span> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material which gives the articles in question their essential character; whereas in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function</span></span> <mark>characterizing substance</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>goods</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question;</span></span> <mark>question. For this reason, and also in view of new knowledge resulting from the technical development indicate the manufacture pass these goods, it is advisable to look for other characteristics for the shares that better correspond to the economic circumstances and mechanism intended use of these goods.</mark>",
            "Input.simple-3": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. On the other hand,</mark> in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>items</mark> in question;",
            "Input.simple-4": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. Whereas</mark> in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>article</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question;</span></span> <mark>question;.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that the above criterion does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable</span></span> <mark>allow</mark> sufficient <span class='tooltip' style='color:red'>^<span class='tooltiptext'>account to be taken</span></span> <mark>consideration</mark> of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. However,</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of new technical developments in the manufacture of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those</span></span> <mark>these</mark> products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the articles <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in question;</span></span> <mark>concerned.</mark>",
            "Answer.end_timestamp": 1619724633.866,
            "Answer.fluency-1": 74,
            "Answer.fluency-2": 50,
            "Answer.fluency-3": 75,
            "Answer.fluency-4": 75,
            "Answer.fluency-5": 74,
            "Answer.start_timestamp": 1619724456.137,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-34",
            "Input.complex": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential character; whereas in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the articles in question;",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the above criterion</span></span> <mark>this feature</mark> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable sufficient</span></span> <mark>take fully satisfactory</mark> account <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be taken</span></span> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material which gives</span></span> <mark>characterizing substance of</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>goods</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question their essential character; whereas</span></span> <mark>question. For this reason, and also</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the light</span></span> <mark>view</mark> of new <mark>knowledge resulting from the</mark> technical <span class='tooltip' style='color:red'>^<span class='tooltiptext'>developments in</span></span> <mark>development of</mark> the manufacture of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those products, other classification criteria should be sought that correspond more closely</span></span> <mark>these goods, it is advisable</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>economic facts and</span></span> <mark>look for other characteristics for the classification that better correspond</mark> to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specific function of</span></span> <mark>economic circumstances and</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles in question;</span></span> <mark>intended use of these goods.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the above criterion</span></span> <mark>this feature</mark> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable sufficient</span></span> <mark>take fully satisfactory</mark> account <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be taken</span></span> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material which gives the articles in question their essential character; whereas in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function</span></span> <mark>characterizing substance</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>goods</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question;</span></span> <mark>question. For this reason, and also in view of new knowledge resulting from the technical development indicate the manufacture pass these goods, it is advisable to look for other characteristics for the shares that better correspond to the economic circumstances and mechanism intended use of these goods.</mark>",
            "Input.simple-3": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. On the other hand,</mark> in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>items</mark> in question;",
            "Input.simple-4": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. Whereas</mark> in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>article</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question;</span></span> <mark>question;.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that the above criterion does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable</span></span> <mark>allow</mark> sufficient <span class='tooltip' style='color:red'>^<span class='tooltiptext'>account to be taken</span></span> <mark>consideration</mark> of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. However,</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of new technical developments in the manufacture of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those</span></span> <mark>these</mark> products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the articles <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in question;</span></span> <mark>concerned.</mark>",
            "Answer.end_timestamp": 1619725738.621,
            "Answer.fluency-1": 82,
            "Answer.fluency-2": 77,
            "Answer.fluency-3": 88,
            "Answer.fluency-4": 82,
            "Answer.fluency-5": 84,
            "Answer.start_timestamp": 1619725442.372,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-34",
            "Input.complex": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential character; whereas in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the articles in question;",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the above criterion</span></span> <mark>this feature</mark> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable sufficient</span></span> <mark>take fully satisfactory</mark> account <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be taken</span></span> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material which gives</span></span> <mark>characterizing substance of</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>goods</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question their essential character; whereas</span></span> <mark>question. For this reason, and also</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the light</span></span> <mark>view</mark> of new <mark>knowledge resulting from the</mark> technical <span class='tooltip' style='color:red'>^<span class='tooltiptext'>developments in</span></span> <mark>development of</mark> the manufacture of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those products, other classification criteria should be sought that correspond more closely</span></span> <mark>these goods, it is advisable</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>economic facts and</span></span> <mark>look for other characteristics for the classification that better correspond</mark> to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specific function of</span></span> <mark>economic circumstances and</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles in question;</span></span> <mark>intended use of these goods.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the above criterion</span></span> <mark>this feature</mark> does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable sufficient</span></span> <mark>take fully satisfactory</mark> account <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be taken</span></span> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>material which gives the articles in question their essential character; whereas in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function</span></span> <mark>characterizing substance</mark> of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>goods</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question;</span></span> <mark>question. For this reason, and also in view of new knowledge resulting from the technical development indicate the manufacture pass these goods, it is advisable to look for other characteristics for the shares that better correspond to the economic circumstances and mechanism intended use of these goods.</mark>",
            "Input.simple-3": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. On the other hand,</mark> in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>items</mark> in question;",
            "Input.simple-4": "Whereas experience has shown that the above criterion does not enable sufficient account to be taken of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. Whereas</mark> in the light of new technical developments in the manufacture of those products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>articles</span></span> <mark>article</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>question;</span></span> <mark>question;.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whereas experience</span></span> <mark>Experience</mark> has shown that the above criterion does not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>enable</span></span> <mark>allow</mark> sufficient <span class='tooltip' style='color:red'>^<span class='tooltiptext'>account to be taken</span></span> <mark>consideration</mark> of the material which gives the articles in question their essential <span class='tooltip' style='color:red'>^<span class='tooltiptext'>character; whereas</span></span> <mark>character. However,</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> light of new technical developments in the manufacture of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>those</span></span> <mark>these</mark> products, other classification criteria should be sought that correspond more closely to economic facts and to the specific function of the articles <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in question;</span></span> <mark>concerned.</mark>",
            "Answer.end_timestamp": 1619733504.497,
            "Answer.fluency-1": 56,
            "Answer.fluency-2": 77,
            "Answer.fluency-3": 54,
            "Answer.fluency-4": 81,
            "Answer.fluency-5": 64,
            "Answer.start_timestamp": 1619733360.827,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-35",
            "Input.complex": "Even though it is neither the object nor the effect of this Regulation to amend national legislation on access to documents, it is nevertheless clear that, by virtue of the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this Regulation.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Even though it is neither the object nor the effect of this Regulation to amend national legislation on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents, it</span></span> <mark>documents. It</mark> is nevertheless clear that, by virtue of the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it is neither the object nor the effect of this</span></span> <mark>This</mark> Regulation <mark>does not aim</mark> to amend national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>legislation</span></span> <mark>rules</mark> on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. However,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that,</span></span> <mark>that</mark> by virtue of the principle of loyal cooperation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which governs</span></span> <mark>in</mark> relations between the institutions and the Member States, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States should take care not to hamper</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proper</span></span> <mark>latter will have to ensure that the correct</mark> application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation is not prejudiced.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it</span></span> <mark>It</mark> is neither the object nor the effect of this Regulation to amend national legislation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>relating to</mark> access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. However,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear that, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by virtue of</span></span> <mark>given</mark> the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though</span></span> <mark>Although</mark> it is neither the object nor the effect of this Regulation to amend national legislation on access to documents, it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> <mark>nonetheless</mark> clear that, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by virtue of</span></span> <mark>thanks to</mark> the principle of loyal cooperation which governs relations between the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>institutions and</span></span> <mark>institutions. And</mark> the Member States, Member States should take care not to hamper the proper application of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this</span></span> <mark>the</mark> Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it is neither the object nor the effect of this</span></span> <mark>This</mark> Regulation <mark>DEA not aim</mark> to amend national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>legislation</span></span> <mark>rules</mark> on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. measures</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that,</span></span> <mark>that</mark> by virtue <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>This</mark> the principle of loyal cooperation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which governs</span></span> <mark>in</mark> relations between the institutions and the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member</span></span> <mark>manufacture</mark> States, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States should take care not to hamper</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proper</span></span> <mark>latter will have to ensure that the correct</mark> application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation is not prejudiced.</mark>",
            "Answer.end_timestamp": 1619724381.824,
            "Answer.fluency-1": 35,
            "Answer.fluency-2": 52,
            "Answer.fluency-3": 25,
            "Answer.fluency-4": 58,
            "Answer.fluency-5": 50,
            "Answer.start_timestamp": 1619724378.165,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-35",
            "Input.complex": "Even though it is neither the object nor the effect of this Regulation to amend national legislation on access to documents, it is nevertheless clear that, by virtue of the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this Regulation.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Even though it is neither the object nor the effect of this Regulation to amend national legislation on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents, it</span></span> <mark>documents. It</mark> is nevertheless clear that, by virtue of the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it is neither the object nor the effect of this</span></span> <mark>This</mark> Regulation <mark>does not aim</mark> to amend national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>legislation</span></span> <mark>rules</mark> on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. However,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that,</span></span> <mark>that</mark> by virtue of the principle of loyal cooperation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which governs</span></span> <mark>in</mark> relations between the institutions and the Member States, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States should take care not to hamper</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proper</span></span> <mark>latter will have to ensure that the correct</mark> application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation is not prejudiced.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it</span></span> <mark>It</mark> is neither the object nor the effect of this Regulation to amend national legislation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>relating to</mark> access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. However,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear that, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by virtue of</span></span> <mark>given</mark> the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though</span></span> <mark>Although</mark> it is neither the object nor the effect of this Regulation to amend national legislation on access to documents, it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> <mark>nonetheless</mark> clear that, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by virtue of</span></span> <mark>thanks to</mark> the principle of loyal cooperation which governs relations between the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>institutions and</span></span> <mark>institutions. And</mark> the Member States, Member States should take care not to hamper the proper application of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this</span></span> <mark>the</mark> Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it is neither the object nor the effect of this</span></span> <mark>This</mark> Regulation <mark>DEA not aim</mark> to amend national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>legislation</span></span> <mark>rules</mark> on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. measures</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that,</span></span> <mark>that</mark> by virtue <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>This</mark> the principle of loyal cooperation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which governs</span></span> <mark>in</mark> relations between the institutions and the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member</span></span> <mark>manufacture</mark> States, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States should take care not to hamper</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proper</span></span> <mark>latter will have to ensure that the correct</mark> application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation is not prejudiced.</mark>",
            "Answer.end_timestamp": 1619726642.847,
            "Answer.fluency-1": 65,
            "Answer.fluency-2": 38,
            "Answer.fluency-3": 51,
            "Answer.fluency-4": 61,
            "Answer.fluency-5": 41,
            "Answer.start_timestamp": 1619726630.247,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-35",
            "Input.complex": "Even though it is neither the object nor the effect of this Regulation to amend national legislation on access to documents, it is nevertheless clear that, by virtue of the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this Regulation.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "Even though it is neither the object nor the effect of this Regulation to amend national legislation on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents, it</span></span> <mark>documents. It</mark> is nevertheless clear that, by virtue of the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it is neither the object nor the effect of this</span></span> <mark>This</mark> Regulation <mark>does not aim</mark> to amend national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>legislation</span></span> <mark>rules</mark> on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. However,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that,</span></span> <mark>that</mark> by virtue of the principle of loyal cooperation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which governs</span></span> <mark>in</mark> relations between the institutions and the Member States, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States should take care not to hamper</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proper</span></span> <mark>latter will have to ensure that the correct</mark> application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation is not prejudiced.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it</span></span> <mark>It</mark> is neither the object nor the effect of this Regulation to amend national legislation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>relating to</mark> access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. However,</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear that, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by virtue of</span></span> <mark>given</mark> the principle of loyal cooperation which governs relations between the institutions and the Member States, Member States should take care not to hamper the proper application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though</span></span> <mark>Although</mark> it is neither the object nor the effect of this Regulation to amend national legislation on access to documents, it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> <mark>nonetheless</mark> clear that, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by virtue of</span></span> <mark>thanks to</mark> the principle of loyal cooperation which governs relations between the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>institutions and</span></span> <mark>institutions. And</mark> the Member States, Member States should take care not to hamper the proper application of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this</span></span> <mark>the</mark> Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Even though it is neither the object nor the effect of this</span></span> <mark>This</mark> Regulation <mark>DEA not aim</mark> to amend national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>legislation</span></span> <mark>rules</mark> on access to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>documents,</span></span> <mark>documents. measures</mark> it is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>nevertheless</span></span> clear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that,</span></span> <mark>that</mark> by virtue <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>This</mark> the principle of loyal cooperation <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which governs</span></span> <mark>in</mark> relations between the institutions and the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member</span></span> <mark>manufacture</mark> States, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States should take care not to hamper</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>proper</span></span> <mark>latter will have to ensure that the correct</mark> application of this <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation is not prejudiced.</mark>",
            "Answer.end_timestamp": 1619724435.217,
            "Answer.fluency-1": 31,
            "Answer.fluency-2": 41,
            "Answer.fluency-3": 65,
            "Answer.fluency-4": 55,
            "Answer.fluency-5": 40,
            "Answer.start_timestamp": 1619724420.192,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-36",
            "Input.complex": "Because of the combined production process (see above), when DEA is produced, the other types of ethanolamine (MEA and TEA) are produced as well and in larger quantities.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Because <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of the</span></span> <mark>it is a</mark> combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced, the</span></span> <mark>United</mark> other types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ethanolamine</span></span> <mark>ethanolamines</mark> (MEA and TEA) are <mark>also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> <mark>stopping the production of DEA. The benefits products are renal produced</mark> in larger quantities.",
            "Input.simple-2": "Because <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of the</span></span> <mark>it is a</mark> combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced,</span></span> the other types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ethanolamine</span></span> <mark>ethanolamines</mark> (MEA and TEA) are <mark>also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> <mark>in the production of DEA. The latter products are even produced</mark> in larger quantities.",
            "Input.simple-3": "Because of the combined production process (see above), when DEA is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>produced, the</span></span> <mark>produced. The</mark> other types of ethanolamine (MEA and TEA) are produced as well and in larger quantities.",
            "Input.simple-4": "Because of the combined production process (see above), when DEA is produced, the other types of ethanolamine (MEA and TEA) are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>produced as well and</span></span> <mark>produced. And</mark> in larger quantities.",
            "Input.simple-5": "Because of the combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced,</span></span> the other types of ethanolamine (MEA and TEA) are <mark>produced. They are also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> in larger quantities.",
            "Answer.end_timestamp": 1619730378.783,
            "Answer.fluency-1": 72,
            "Answer.fluency-2": 65,
            "Answer.fluency-3": 87,
            "Answer.fluency-4": 82,
            "Answer.fluency-5": 54,
            "Answer.start_timestamp": 1619730368.034,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-36",
            "Input.complex": "Because of the combined production process (see above), when DEA is produced, the other types of ethanolamine (MEA and TEA) are produced as well and in larger quantities.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Because <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of the</span></span> <mark>it is a</mark> combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced, the</span></span> <mark>United</mark> other types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ethanolamine</span></span> <mark>ethanolamines</mark> (MEA and TEA) are <mark>also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> <mark>stopping the production of DEA. The benefits products are renal produced</mark> in larger quantities.",
            "Input.simple-2": "Because <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of the</span></span> <mark>it is a</mark> combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced,</span></span> the other types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ethanolamine</span></span> <mark>ethanolamines</mark> (MEA and TEA) are <mark>also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> <mark>in the production of DEA. The latter products are even produced</mark> in larger quantities.",
            "Input.simple-3": "Because of the combined production process (see above), when DEA is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>produced, the</span></span> <mark>produced. The</mark> other types of ethanolamine (MEA and TEA) are produced as well and in larger quantities.",
            "Input.simple-4": "Because of the combined production process (see above), when DEA is produced, the other types of ethanolamine (MEA and TEA) are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>produced as well and</span></span> <mark>produced. And</mark> in larger quantities.",
            "Input.simple-5": "Because of the combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced,</span></span> the other types of ethanolamine (MEA and TEA) are <mark>produced. They are also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> in larger quantities.",
            "Answer.end_timestamp": 1619724714.585,
            "Answer.fluency-1": 83,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 89,
            "Answer.fluency-4": 95,
            "Answer.fluency-5": 86,
            "Answer.start_timestamp": 1619724694.146,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-36",
            "Input.complex": "Because of the combined production process (see above), when DEA is produced, the other types of ethanolamine (MEA and TEA) are produced as well and in larger quantities.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "Because <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of the</span></span> <mark>it is a</mark> combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced, the</span></span> <mark>United</mark> other types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ethanolamine</span></span> <mark>ethanolamines</mark> (MEA and TEA) are <mark>also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> <mark>stopping the production of DEA. The benefits products are renal produced</mark> in larger quantities.",
            "Input.simple-2": "Because <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of the</span></span> <mark>it is a</mark> combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced,</span></span> the other types of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>ethanolamine</span></span> <mark>ethanolamines</mark> (MEA and TEA) are <mark>also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> <mark>in the production of DEA. The latter products are even produced</mark> in larger quantities.",
            "Input.simple-3": "Because of the combined production process (see above), when DEA is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>produced, the</span></span> <mark>produced. The</mark> other types of ethanolamine (MEA and TEA) are produced as well and in larger quantities.",
            "Input.simple-4": "Because of the combined production process (see above), when DEA is produced, the other types of ethanolamine (MEA and TEA) are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>produced as well and</span></span> <mark>produced. And</mark> in larger quantities.",
            "Input.simple-5": "Because of the combined production process (see above), <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when DEA is produced,</span></span> the other types of ethanolamine (MEA and TEA) are <mark>produced. They are also</mark> produced <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as well and</span></span> in larger quantities.",
            "Answer.end_timestamp": 1619729928.091,
            "Answer.fluency-1": 57,
            "Answer.fluency-2": 41,
            "Answer.fluency-3": 74,
            "Answer.fluency-4": 65,
            "Answer.fluency-5": 55,
            "Answer.start_timestamp": 1619729908.886,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-37",
            "Input.complex": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the questionnaire sent by the Commission services, it is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Another Chinese exporter,</mark> Dong Guan Tian Bao Lighter Factory, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another Chinese exporter, who submitted a reply</span></span> <mark>replied</mark> to the questionnaire, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which was, in any case,</span></span> <mark>however</mark> incomplete, more <span class='tooltip' style='color:red'>^<span class='tooltiptext'>than</span></span> <mark>national</mark> six months after the deadline <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specified</span></span> <mark>indicated</mark> in the questionnaire sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services,</span></span> <mark>Commission. Therefore,</mark> it is considered that the dumping margin established <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>blood</mark> the People's Republic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>based</mark> China should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>apply.</span></span> <mark>apply to completed exporter.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Regarding</mark> Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire, which was, in</span></span> <mark>questionnaire. In</mark> any case, <mark>this questionnaire was</mark> incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire sent by the</span></span> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>services,</span></span> <mark>questionnaire,</mark> it is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.simple-3": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire</span></span> <mark>Commission services</mark> sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services, it</span></span> <mark>Commission. It</mark> is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Another Chinese exporter,</mark> Dong Guan Tian Bao Lighter Factory, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another Chinese exporter, who submitted a reply</span></span> <mark>replied</mark> to the questionnaire, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which was, in any case,</span></span> <mark>however</mark> incomplete, more than six months after the deadline <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specified</span></span> <mark>indicated</mark> in the questionnaire sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services,</span></span> <mark>Commission. Therefore,</mark> it is considered that the dumping margin established for the People's Republic of China should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>apply.</span></span> <mark>apply to this exporter.</mark>",
            "Input.simple-5": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire</span></span> <mark>Questionnaire</mark> sent by the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>services, it</span></span> <mark>services. It</mark> is considered that the dumping margin established for the People's Republic of China should apply.",
            "Answer.end_timestamp": 1619727281.796,
            "Answer.fluency-1": 56,
            "Answer.fluency-2": 36,
            "Answer.fluency-3": 63,
            "Answer.fluency-4": 87,
            "Answer.fluency-5": 71,
            "Answer.start_timestamp": 1619727271.764,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-37",
            "Input.complex": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the questionnaire sent by the Commission services, it is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Another Chinese exporter,</mark> Dong Guan Tian Bao Lighter Factory, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another Chinese exporter, who submitted a reply</span></span> <mark>replied</mark> to the questionnaire, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which was, in any case,</span></span> <mark>however</mark> incomplete, more <span class='tooltip' style='color:red'>^<span class='tooltiptext'>than</span></span> <mark>national</mark> six months after the deadline <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specified</span></span> <mark>indicated</mark> in the questionnaire sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services,</span></span> <mark>Commission. Therefore,</mark> it is considered that the dumping margin established <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>blood</mark> the People's Republic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>based</mark> China should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>apply.</span></span> <mark>apply to completed exporter.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Regarding</mark> Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire, which was, in</span></span> <mark>questionnaire. In</mark> any case, <mark>this questionnaire was</mark> incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire sent by the</span></span> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>services,</span></span> <mark>questionnaire,</mark> it is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.simple-3": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire</span></span> <mark>Commission services</mark> sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services, it</span></span> <mark>Commission. It</mark> is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Another Chinese exporter,</mark> Dong Guan Tian Bao Lighter Factory, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another Chinese exporter, who submitted a reply</span></span> <mark>replied</mark> to the questionnaire, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which was, in any case,</span></span> <mark>however</mark> incomplete, more than six months after the deadline <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specified</span></span> <mark>indicated</mark> in the questionnaire sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services,</span></span> <mark>Commission. Therefore,</mark> it is considered that the dumping margin established for the People's Republic of China should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>apply.</span></span> <mark>apply to this exporter.</mark>",
            "Input.simple-5": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire</span></span> <mark>Questionnaire</mark> sent by the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>services, it</span></span> <mark>services. It</mark> is considered that the dumping margin established for the People's Republic of China should apply.",
            "Answer.end_timestamp": 1619724292.894,
            "Answer.fluency-1": 41,
            "Answer.fluency-2": 70,
            "Answer.fluency-3": 40,
            "Answer.fluency-4": 66,
            "Answer.fluency-5": 52,
            "Answer.start_timestamp": 1619724288.034,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-37",
            "Input.complex": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the questionnaire sent by the Commission services, it is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Another Chinese exporter,</mark> Dong Guan Tian Bao Lighter Factory, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another Chinese exporter, who submitted a reply</span></span> <mark>replied</mark> to the questionnaire, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which was, in any case,</span></span> <mark>however</mark> incomplete, more <span class='tooltip' style='color:red'>^<span class='tooltiptext'>than</span></span> <mark>national</mark> six months after the deadline <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specified</span></span> <mark>indicated</mark> in the questionnaire sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services,</span></span> <mark>Commission. Therefore,</mark> it is considered that the dumping margin established <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>blood</mark> the People's Republic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of</span></span> <mark>based</mark> China should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>apply.</span></span> <mark>apply to completed exporter.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Regarding</mark> Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire, which was, in</span></span> <mark>questionnaire. In</mark> any case, <mark>this questionnaire was</mark> incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire sent by the</span></span> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>services,</span></span> <mark>questionnaire,</mark> it is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.simple-3": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire</span></span> <mark>Commission services</mark> sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services, it</span></span> <mark>Commission. It</mark> is considered that the dumping margin established for the People's Republic of China should apply.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>With regard to</span></span> <mark>Another Chinese exporter,</mark> Dong Guan Tian Bao Lighter Factory, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>another Chinese exporter, who submitted a reply</span></span> <mark>replied</mark> to the questionnaire, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>which was, in any case,</span></span> <mark>however</mark> incomplete, more than six months after the deadline <span class='tooltip' style='color:red'>^<span class='tooltiptext'>specified</span></span> <mark>indicated</mark> in the questionnaire sent by the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission services,</span></span> <mark>Commission. Therefore,</mark> it is considered that the dumping margin established for the People's Republic of China should <span class='tooltip' style='color:red'>^<span class='tooltiptext'>apply.</span></span> <mark>apply to this exporter.</mark>",
            "Input.simple-5": "With regard to Dong Guan Tian Bao Lighter Factory, another Chinese exporter, who submitted a reply to the questionnaire, which was, in any case, incomplete, more than six months after the deadline specified in the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>questionnaire</span></span> <mark>Questionnaire</mark> sent by the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>services, it</span></span> <mark>services. It</mark> is considered that the dumping margin established for the People's Republic of China should apply.",
            "Answer.end_timestamp": 1619725841.86,
            "Answer.fluency-1": 60,
            "Answer.fluency-2": 75,
            "Answer.fluency-3": 62,
            "Answer.fluency-4": 50,
            "Answer.fluency-5": 73,
            "Answer.start_timestamp": 1619724447.078,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-38",
            "Input.complex": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon redosing, the presence of antibodies should be evaluated and if these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since patients</span></span> <mark>Patients</mark> who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an initial short exposure to</span></span> TYSABRI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and then had an extended</span></span> <mark>for a short initial period followed by a prolonged</mark> period without treatment are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>more</span></span> at <mark>greater</mark> risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of developing</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon redosing,</span></span> <mark>reactions. These patients should be tested for</mark> the presence of antibodies <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be evaluated and if these remain positive</span></span> <mark>before resuming treatment;</mark> in <mark>the event of</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>confirmatory</span></span> <mark>positive result confirmed by a second</mark> test <span class='tooltip' style='color:red'>^<span class='tooltiptext'>after</span></span> <mark>carried out</mark> 6 weeks <mark>later, the</mark> treatment should not be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>resumed.</span></span> <mark>reintroduced.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since patients</span></span> <mark>Patients</mark> who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an initial short exposure to</span></span> TYSABRI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and then had an extended</span></span> <mark>for a short initial period followed by a prolonged</mark> period without treatment are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>more</span></span> at <mark>greater</mark> risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of developing</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon redosing,</span></span> <mark>reactions. These patients should be carried for</mark> the presence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antibodies should be evaluated and if these remain positive</span></span> <mark>specifying before resuming treatment;</mark> in <mark>the event of</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>confirmatory test after</span></span> <mark>positive result confirmed by a second interfere carried out</mark> 6 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>weeks</span></span> <mark>feed later, the</mark> treatment should not be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>resumed.</span></span> <mark>reintroduced.</mark>",
            "Input.simple-3": "Since patients who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received an initial short exposure to TYSABRI and then had <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an extended</span></span> <mark>a prolonged</mark> period without treatment are more at risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon</span></span> <mark>after</mark> redosing, the presence of antibodies should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated and if</span></span> <mark>evaluated. If</mark> these <mark>antibodies</mark> remain positive in a confirmatory test after 6 weeks <mark>of</mark> treatment should not be resumed.",
            "Input.simple-4": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon redosing, the presence of antibodies should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated and if</span></span> <mark>evaluated. If</mark> these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Input.simple-5": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon <span class='tooltip' style='color:red'>^<span class='tooltiptext'>redosing, the</span></span> <mark>redosing. The</mark> presence of antibodies should be evaluated and if these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Answer.end_timestamp": 1619724448.187,
            "Answer.fluency-1": 82,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 88,
            "Answer.fluency-4": 92,
            "Answer.fluency-5": 87,
            "Answer.start_timestamp": 1619724427.186,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-38",
            "Input.complex": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon redosing, the presence of antibodies should be evaluated and if these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since patients</span></span> <mark>Patients</mark> who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an initial short exposure to</span></span> TYSABRI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and then had an extended</span></span> <mark>for a short initial period followed by a prolonged</mark> period without treatment are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>more</span></span> at <mark>greater</mark> risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of developing</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon redosing,</span></span> <mark>reactions. These patients should be tested for</mark> the presence of antibodies <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be evaluated and if these remain positive</span></span> <mark>before resuming treatment;</mark> in <mark>the event of</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>confirmatory</span></span> <mark>positive result confirmed by a second</mark> test <span class='tooltip' style='color:red'>^<span class='tooltiptext'>after</span></span> <mark>carried out</mark> 6 weeks <mark>later, the</mark> treatment should not be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>resumed.</span></span> <mark>reintroduced.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since patients</span></span> <mark>Patients</mark> who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an initial short exposure to</span></span> TYSABRI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and then had an extended</span></span> <mark>for a short initial period followed by a prolonged</mark> period without treatment are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>more</span></span> at <mark>greater</mark> risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of developing</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon redosing,</span></span> <mark>reactions. These patients should be carried for</mark> the presence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antibodies should be evaluated and if these remain positive</span></span> <mark>specifying before resuming treatment;</mark> in <mark>the event of</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>confirmatory test after</span></span> <mark>positive result confirmed by a second interfere carried out</mark> 6 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>weeks</span></span> <mark>feed later, the</mark> treatment should not be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>resumed.</span></span> <mark>reintroduced.</mark>",
            "Input.simple-3": "Since patients who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received an initial short exposure to TYSABRI and then had <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an extended</span></span> <mark>a prolonged</mark> period without treatment are more at risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon</span></span> <mark>after</mark> redosing, the presence of antibodies should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated and if</span></span> <mark>evaluated. If</mark> these <mark>antibodies</mark> remain positive in a confirmatory test after 6 weeks <mark>of</mark> treatment should not be resumed.",
            "Input.simple-4": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon redosing, the presence of antibodies should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated and if</span></span> <mark>evaluated. If</mark> these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Input.simple-5": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon <span class='tooltip' style='color:red'>^<span class='tooltiptext'>redosing, the</span></span> <mark>redosing. The</mark> presence of antibodies should be evaluated and if these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Answer.end_timestamp": 1619724220.169,
            "Answer.fluency-1": 57,
            "Answer.fluency-2": 79,
            "Answer.fluency-3": 65,
            "Answer.fluency-4": 49,
            "Answer.fluency-5": 65,
            "Answer.start_timestamp": 1619724156.834,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-38",
            "Input.complex": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon redosing, the presence of antibodies should be evaluated and if these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since patients</span></span> <mark>Patients</mark> who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an initial short exposure to</span></span> TYSABRI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and then had an extended</span></span> <mark>for a short initial period followed by a prolonged</mark> period without treatment are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>more</span></span> at <mark>greater</mark> risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of developing</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon redosing,</span></span> <mark>reactions. These patients should be tested for</mark> the presence of antibodies <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be evaluated and if these remain positive</span></span> <mark>before resuming treatment;</mark> in <mark>the event of</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>confirmatory</span></span> <mark>positive result confirmed by a second</mark> test <span class='tooltip' style='color:red'>^<span class='tooltiptext'>after</span></span> <mark>carried out</mark> 6 weeks <mark>later, the</mark> treatment should not be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>resumed.</span></span> <mark>reintroduced.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since patients</span></span> <mark>Patients</mark> who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an initial short exposure to</span></span> TYSABRI <span class='tooltip' style='color:red'>^<span class='tooltiptext'>and then had an extended</span></span> <mark>for a short initial period followed by a prolonged</mark> period without treatment are <span class='tooltip' style='color:red'>^<span class='tooltiptext'>more</span></span> at <mark>greater</mark> risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of developing</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon redosing,</span></span> <mark>reactions. These patients should be carried for</mark> the presence of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antibodies should be evaluated and if these remain positive</span></span> <mark>specifying before resuming treatment;</mark> in <mark>the event of</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>confirmatory test after</span></span> <mark>positive result confirmed by a second interfere carried out</mark> 6 <span class='tooltip' style='color:red'>^<span class='tooltiptext'>weeks</span></span> <mark>feed later, the</mark> treatment should not be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>resumed.</span></span> <mark>reintroduced.</mark>",
            "Input.simple-3": "Since patients who <span class='tooltip' style='color:red'>^<span class='tooltiptext'>have</span></span> received an initial short exposure to TYSABRI and then had <span class='tooltip' style='color:red'>^<span class='tooltiptext'>an extended</span></span> <mark>a prolonged</mark> period without treatment are more at risk <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>of</mark> hypersensitivity <span class='tooltip' style='color:red'>^<span class='tooltiptext'>upon</span></span> <mark>after</mark> redosing, the presence of antibodies should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated and if</span></span> <mark>evaluated. If</mark> these <mark>antibodies</mark> remain positive in a confirmatory test after 6 weeks <mark>of</mark> treatment should not be resumed.",
            "Input.simple-4": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon redosing, the presence of antibodies should be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>evaluated and if</span></span> <mark>evaluated. If</mark> these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Input.simple-5": "Since patients who have received an initial short exposure to TYSABRI and then had an extended period without treatment are more at risk for hypersensitivity upon <span class='tooltip' style='color:red'>^<span class='tooltiptext'>redosing, the</span></span> <mark>redosing. The</mark> presence of antibodies should be evaluated and if these remain positive in a confirmatory test after 6 weeks treatment should not be resumed.",
            "Answer.end_timestamp": 1619730217.972,
            "Answer.fluency-1": 97,
            "Answer.fluency-2": 93,
            "Answer.fluency-3": 98,
            "Answer.fluency-4": 95,
            "Answer.fluency-5": 97,
            "Answer.start_timestamp": 1619730173.973,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-39",
            "Input.complex": "While BGB had a relatively strong position on the Berlin banking market in both personal and corporate banking, its market shares were not as high as Berliner Volksbank claimed.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "While BGB had a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking, its</span></span> <mark>banking. Its</mark> market shares were not as high as Berliner Volksbank claimed.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB had a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>banking. However,</mark> its market shares were not as high as Berliner Volksbank claimed.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>occupies</mark> a relatively strong position <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>in</mark> the Berlin banking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>market in</span></span> <mark>market,</mark> both <span class='tooltip' style='color:red'>^<span class='tooltiptext'>personal</span></span> <mark>for private</mark> and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>clients. However,</mark> its market shares <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were</span></span> <mark>do</mark> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as high as</span></span> <mark>reach the magnitude attributed to them by</mark> Berliner <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Volksbank claimed.</span></span> <mark>Volksbank.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>has</mark> a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>banking. However,</mark> its market shares were not as high as Berliner Volksbank <span class='tooltip' style='color:red'>^<span class='tooltiptext'>claimed.</span></span> <mark>said.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>occupies</mark> a relatively strong position <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>in</mark> the Berlin banking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>market in</span></span> <mark>magnitude</mark> both <span class='tooltip' style='color:red'>^<span class='tooltiptext'>personal</span></span> <mark>for private</mark> and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>clients. manufacture</mark> its market <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shares were</span></span> <mark>basic do</mark> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as high as</span></span> <mark>reach the magnitude attributed to them incomplete</mark> Berliner <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Volksbank claimed.</span></span> <mark>Volksbank.</mark>",
            "Answer.end_timestamp": 1619724635.184,
            "Answer.fluency-1": 25,
            "Answer.fluency-2": 99,
            "Answer.fluency-3": 99,
            "Answer.fluency-4": 99,
            "Answer.fluency-5": 23,
            "Answer.start_timestamp": 1619724573.934,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-39",
            "Input.complex": "While BGB had a relatively strong position on the Berlin banking market in both personal and corporate banking, its market shares were not as high as Berliner Volksbank claimed.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "While BGB had a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking, its</span></span> <mark>banking. Its</mark> market shares were not as high as Berliner Volksbank claimed.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB had a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>banking. However,</mark> its market shares were not as high as Berliner Volksbank claimed.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>occupies</mark> a relatively strong position <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>in</mark> the Berlin banking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>market in</span></span> <mark>market,</mark> both <span class='tooltip' style='color:red'>^<span class='tooltiptext'>personal</span></span> <mark>for private</mark> and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>clients. However,</mark> its market shares <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were</span></span> <mark>do</mark> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as high as</span></span> <mark>reach the magnitude attributed to them by</mark> Berliner <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Volksbank claimed.</span></span> <mark>Volksbank.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>has</mark> a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>banking. However,</mark> its market shares were not as high as Berliner Volksbank <span class='tooltip' style='color:red'>^<span class='tooltiptext'>claimed.</span></span> <mark>said.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>occupies</mark> a relatively strong position <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>in</mark> the Berlin banking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>market in</span></span> <mark>magnitude</mark> both <span class='tooltip' style='color:red'>^<span class='tooltiptext'>personal</span></span> <mark>for private</mark> and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>clients. manufacture</mark> its market <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shares were</span></span> <mark>basic do</mark> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as high as</span></span> <mark>reach the magnitude attributed to them incomplete</mark> Berliner <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Volksbank claimed.</span></span> <mark>Volksbank.</mark>",
            "Answer.end_timestamp": 1619724673.429,
            "Answer.fluency-1": 25,
            "Answer.fluency-2": 42,
            "Answer.fluency-3": 51,
            "Answer.fluency-4": 14,
            "Answer.fluency-5": 72,
            "Answer.start_timestamp": 1619724660.249,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-39",
            "Input.complex": "While BGB had a relatively strong position on the Berlin banking market in both personal and corporate banking, its market shares were not as high as Berliner Volksbank claimed.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-ref-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "While BGB had a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking, its</span></span> <mark>banking. Its</mark> market shares were not as high as Berliner Volksbank claimed.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB had a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>banking. However,</mark> its market shares were not as high as Berliner Volksbank claimed.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>occupies</mark> a relatively strong position <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>in</mark> the Berlin banking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>market in</span></span> <mark>market,</mark> both <span class='tooltip' style='color:red'>^<span class='tooltiptext'>personal</span></span> <mark>for private</mark> and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>clients. However,</mark> its market shares <span class='tooltip' style='color:red'>^<span class='tooltiptext'>were</span></span> <mark>do</mark> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as high as</span></span> <mark>reach the magnitude attributed to them by</mark> Berliner <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Volksbank claimed.</span></span> <mark>Volksbank.</mark>",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>has</mark> a relatively strong position on the Berlin banking market in both personal and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>banking. However,</mark> its market shares were not as high as Berliner Volksbank <span class='tooltip' style='color:red'>^<span class='tooltiptext'>claimed.</span></span> <mark>said.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>While</span></span> BGB <span class='tooltip' style='color:red'>^<span class='tooltiptext'>had</span></span> <mark>occupies</mark> a relatively strong position <span class='tooltip' style='color:red'>^<span class='tooltiptext'>on</span></span> <mark>in</mark> the Berlin banking <span class='tooltip' style='color:red'>^<span class='tooltiptext'>market in</span></span> <mark>magnitude</mark> both <span class='tooltip' style='color:red'>^<span class='tooltiptext'>personal</span></span> <mark>for private</mark> and corporate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>banking,</span></span> <mark>clients. manufacture</mark> its market <span class='tooltip' style='color:red'>^<span class='tooltiptext'>shares were</span></span> <mark>basic do</mark> not <span class='tooltip' style='color:red'>^<span class='tooltiptext'>as high as</span></span> <mark>reach the magnitude attributed to them incomplete</mark> Berliner <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Volksbank claimed.</span></span> <mark>Volksbank.</mark>",
            "Answer.end_timestamp": 1619724384.802,
            "Answer.fluency-1": 88,
            "Answer.fluency-2": 94,
            "Answer.fluency-3": 84,
            "Answer.fluency-4": 96,
            "Answer.fluency-5": 85,
            "Answer.start_timestamp": 1619724371.963,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-40",
            "Input.complex": "In addition to the verification visits that were already carried out by the Commission at the provisional stage, the company Unifi Textured yarns Ltd, a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition to the verification visits that were</span></span> <mark>The Commission had</mark> already carried out <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by the Commission</span></span> <mark>on-the-spot checks</mark> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stage,</span></span> <mark>stage. In addition, following</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company</span></span> <mark>imposition of provisional measures, a verification was carried out at</mark> Unifi Textured yarns Ltd, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>an Irish-based</mark> Community producer of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>PTY located in Ireland, was also visited after the imposition of the provisional measures.</span></span> <mark>PTY.</mark>",
            "Input.simple-2": "In addition to the verification visits <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that were</span></span> already carried out by the Commission at the provisional stage, the company Unifi Textured yarns <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Ltd,</span></span> <mark>Ltd.,</mark> a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.simple-3": "In addition to the verification visits that were already carried out by the Commission at the provisional stage, the company Unifi Textured yarns <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Ltd, a</span></span> <mark>Ltd.</mark> Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition to the verification visits that were</span></span> <mark>The Commission had</mark> already <mark>station out on-the-spot checks at provisional stage. In addition, shareholder the frame of provisional measures, a verification was</mark> carried out <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by the Commission</span></span> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the provisional stage, the company</span></span> Unifi Textured yarns Ltd, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>an Irish-based</mark> Community <span class='tooltip' style='color:red'>^<span class='tooltiptext'>producer</span></span> <mark>is</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>PTY located in Ireland, was also visited after the imposition of the provisional measures.</span></span> <mark>PTY.</mark>",
            "Input.simple-5": "In addition to the verification visits that were already carried out by the Commission at the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stage, the</span></span> <mark>stage. The</mark> company Unifi Textured yarns Ltd, a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Answer.end_timestamp": 1619727890.46,
            "Answer.fluency-1": 52,
            "Answer.fluency-2": 68,
            "Answer.fluency-3": 88,
            "Answer.fluency-4": 77,
            "Answer.fluency-5": 56,
            "Answer.start_timestamp": 1619727797.689,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-40",
            "Input.complex": "In addition to the verification visits that were already carried out by the Commission at the provisional stage, the company Unifi Textured yarns Ltd, a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition to the verification visits that were</span></span> <mark>The Commission had</mark> already carried out <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by the Commission</span></span> <mark>on-the-spot checks</mark> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stage,</span></span> <mark>stage. In addition, following</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company</span></span> <mark>imposition of provisional measures, a verification was carried out at</mark> Unifi Textured yarns Ltd, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>an Irish-based</mark> Community producer of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>PTY located in Ireland, was also visited after the imposition of the provisional measures.</span></span> <mark>PTY.</mark>",
            "Input.simple-2": "In addition to the verification visits <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that were</span></span> already carried out by the Commission at the provisional stage, the company Unifi Textured yarns <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Ltd,</span></span> <mark>Ltd.,</mark> a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.simple-3": "In addition to the verification visits that were already carried out by the Commission at the provisional stage, the company Unifi Textured yarns <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Ltd, a</span></span> <mark>Ltd.</mark> Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition to the verification visits that were</span></span> <mark>The Commission had</mark> already <mark>station out on-the-spot checks at provisional stage. In addition, shareholder the frame of provisional measures, a verification was</mark> carried out <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by the Commission</span></span> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the provisional stage, the company</span></span> Unifi Textured yarns Ltd, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>an Irish-based</mark> Community <span class='tooltip' style='color:red'>^<span class='tooltiptext'>producer</span></span> <mark>is</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>PTY located in Ireland, was also visited after the imposition of the provisional measures.</span></span> <mark>PTY.</mark>",
            "Input.simple-5": "In addition to the verification visits that were already carried out by the Commission at the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stage, the</span></span> <mark>stage. The</mark> company Unifi Textured yarns Ltd, a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Answer.end_timestamp": 1619724659.052,
            "Answer.fluency-1": 36,
            "Answer.fluency-2": 66,
            "Answer.fluency-3": 7,
            "Answer.fluency-4": 23,
            "Answer.fluency-5": 52,
            "Answer.start_timestamp": 1619724645.583,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-40",
            "Input.complex": "In addition to the verification visits that were already carried out by the Commission at the provisional stage, the company Unifi Textured yarns Ltd, a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-control",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition to the verification visits that were</span></span> <mark>The Commission had</mark> already carried out <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by the Commission</span></span> <mark>on-the-spot checks</mark> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stage,</span></span> <mark>stage. In addition, following</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>company</span></span> <mark>imposition of provisional measures, a verification was carried out at</mark> Unifi Textured yarns Ltd, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>an Irish-based</mark> Community producer of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>PTY located in Ireland, was also visited after the imposition of the provisional measures.</span></span> <mark>PTY.</mark>",
            "Input.simple-2": "In addition to the verification visits <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that were</span></span> already carried out by the Commission at the provisional stage, the company Unifi Textured yarns <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Ltd,</span></span> <mark>Ltd.,</mark> a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.simple-3": "In addition to the verification visits that were already carried out by the Commission at the provisional stage, the company Unifi Textured yarns <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Ltd, a</span></span> <mark>Ltd.</mark> Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In addition to the verification visits that were</span></span> <mark>The Commission had</mark> already <mark>station out on-the-spot checks at provisional stage. In addition, shareholder the frame of provisional measures, a verification was</mark> carried out <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by the Commission</span></span> at <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the provisional stage, the company</span></span> Unifi Textured yarns Ltd, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>a</span></span> <mark>an Irish-based</mark> Community <span class='tooltip' style='color:red'>^<span class='tooltiptext'>producer</span></span> <mark>is</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>PTY located in Ireland, was also visited after the imposition of the provisional measures.</span></span> <mark>PTY.</mark>",
            "Input.simple-5": "In addition to the verification visits that were already carried out by the Commission at the provisional <span class='tooltip' style='color:red'>^<span class='tooltiptext'>stage, the</span></span> <mark>stage. The</mark> company Unifi Textured yarns Ltd, a Community producer of PTY located in Ireland, was also visited after the imposition of the provisional measures.",
            "Answer.end_timestamp": 1619724780.579,
            "Answer.fluency-1": 80,
            "Answer.fluency-2": 92,
            "Answer.fluency-3": 87,
            "Answer.fluency-4": 94,
            "Answer.fluency-5": 86,
            "Answer.start_timestamp": 1619724717.631,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-41",
            "Input.complex": "Having determined, after consulting the Advisory Committee, that sufficient evidence existed for the initiation of an expiry review, the Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic Regulation.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after consulting</span></span> <mark>The Commission, in consultation with</mark> the Advisory <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Committee,</span></span> <mark>quantify has determined</mark> that <mark>there is</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed for the initiation of an</span></span> <mark>to complementary initiating a review following available</mark> expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review,</span></span> <mark>of</mark> the <mark>loyal measures. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pursuant to</span></span> <mark>under</mark> Article 11 (2) of the basic Regulation.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after</span></span> <mark>After</mark> consulting the Advisory Committee, <mark>the Commission has determined</mark> that <mark>there was</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed</span></span> for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) pursuant to Article 11 (2) of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basic</span></span> <mark>Basic</mark> Regulation.",
            "Input.simple-3": "Having determined, after consulting the Advisory Committee, that sufficient evidence existed for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic Regulation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after consulting</span></span> <mark>The Commission, in consultation with</mark> the Advisory Committee, <mark>has determined</mark> that <mark>there is</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed for</span></span> <mark>to justify initiating a review following</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>initiation of an</span></span> expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review,</span></span> <mark>of</mark> the <mark>existing measures. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pursuant to</span></span> <mark>under</mark> Article 11 (2) of the basic Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after</span></span> <mark>After</mark> consulting the Advisory Committee, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>there was</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed</span></span> for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Answer.end_timestamp": 1619724571.462,
            "Answer.fluency-1": 25,
            "Answer.fluency-2": 99,
            "Answer.fluency-3": 25,
            "Answer.fluency-4": 99,
            "Answer.fluency-5": 99,
            "Answer.start_timestamp": 1619724464.878,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-41",
            "Input.complex": "Having determined, after consulting the Advisory Committee, that sufficient evidence existed for the initiation of an expiry review, the Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic Regulation.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after consulting</span></span> <mark>The Commission, in consultation with</mark> the Advisory <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Committee,</span></span> <mark>quantify has determined</mark> that <mark>there is</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed for the initiation of an</span></span> <mark>to complementary initiating a review following available</mark> expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review,</span></span> <mark>of</mark> the <mark>loyal measures. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pursuant to</span></span> <mark>under</mark> Article 11 (2) of the basic Regulation.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after</span></span> <mark>After</mark> consulting the Advisory Committee, <mark>the Commission has determined</mark> that <mark>there was</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed</span></span> for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) pursuant to Article 11 (2) of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basic</span></span> <mark>Basic</mark> Regulation.",
            "Input.simple-3": "Having determined, after consulting the Advisory Committee, that sufficient evidence existed for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic Regulation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after consulting</span></span> <mark>The Commission, in consultation with</mark> the Advisory Committee, <mark>has determined</mark> that <mark>there is</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed for</span></span> <mark>to justify initiating a review following</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>initiation of an</span></span> expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review,</span></span> <mark>of</mark> the <mark>existing measures. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pursuant to</span></span> <mark>under</mark> Article 11 (2) of the basic Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after</span></span> <mark>After</mark> consulting the Advisory Committee, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>there was</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed</span></span> for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Answer.end_timestamp": 1619724309.66,
            "Answer.fluency-1": 50,
            "Answer.fluency-2": 73,
            "Answer.fluency-3": 33,
            "Answer.fluency-4": 59,
            "Answer.fluency-5": 47,
            "Answer.start_timestamp": 1619724306.087,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-41",
            "Input.complex": "Having determined, after consulting the Advisory Committee, that sufficient evidence existed for the initiation of an expiry review, the Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic Regulation.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-custom-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after consulting</span></span> <mark>The Commission, in consultation with</mark> the Advisory <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Committee,</span></span> <mark>quantify has determined</mark> that <mark>there is</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed for the initiation of an</span></span> <mark>to complementary initiating a review following available</mark> expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review,</span></span> <mark>of</mark> the <mark>loyal measures. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pursuant to</span></span> <mark>under</mark> Article 11 (2) of the basic Regulation.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after</span></span> <mark>After</mark> consulting the Advisory Committee, <mark>the Commission has determined</mark> that <mark>there was</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed</span></span> for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) pursuant to Article 11 (2) of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basic</span></span> <mark>Basic</mark> Regulation.",
            "Input.simple-3": "Having determined, after consulting the Advisory Committee, that sufficient evidence existed for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic Regulation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after consulting</span></span> <mark>The Commission, in consultation with</mark> the Advisory Committee, <mark>has determined</mark> that <mark>there is</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed for</span></span> <mark>to justify initiating a review following</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>initiation of an</span></span> expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review,</span></span> <mark>of</mark> the <mark>existing measures. The</mark> Commission <mark>has therefore</mark> initiated an investigation (6) <span class='tooltip' style='color:red'>^<span class='tooltiptext'>pursuant to</span></span> <mark>under</mark> Article 11 (2) of the basic Regulation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Having determined, after</span></span> <mark>After</mark> consulting the Advisory Committee, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>that</span></span> <mark>there was</mark> sufficient evidence <span class='tooltip' style='color:red'>^<span class='tooltiptext'>existed</span></span> for the initiation of an expiry <span class='tooltip' style='color:red'>^<span class='tooltiptext'>review, the</span></span> <mark>review. The</mark> Commission initiated an investigation (6) pursuant to Article 11 (2) of the basic <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Regulation.</span></span> <mark>regulation.</mark>",
            "Answer.end_timestamp": 1619730288.025,
            "Answer.fluency-1": 91,
            "Answer.fluency-2": 98,
            "Answer.fluency-3": 87,
            "Answer.fluency-4": 98,
            "Answer.fluency-5": 86,
            "Answer.start_timestamp": 1619730269.739,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-42",
            "Input.complex": "Considering that a new certification regime is hereby established, a period of time should be provided for its implementation.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regime</span></span> <mark>scheme</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hereby established, a period of time should</span></span> <mark>thus put in place. There must</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provided</span></span> <mark>a time limit</mark> for its implementation.",
            "Input.simple-2": "Considering that a new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering</span></span> <mark>Given</mark> that a new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regime</span></span> <mark>scheme</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hereby established, a period of time should</span></span> <mark>thus put in place. There must</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provided</span></span> <mark>hypersensitivity regard principles</mark> for its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>implementation.</span></span> <mark>concerned</mark>",
            "Answer.end_timestamp": 1619724380.673,
            "Answer.fluency-1": 60,
            "Answer.fluency-2": 74,
            "Answer.fluency-3": 42,
            "Answer.fluency-4": 50,
            "Answer.fluency-5": 57,
            "Answer.start_timestamp": 1619724229.573,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-42",
            "Input.complex": "Considering that a new certification regime is hereby established, a period of time should be provided for its implementation.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regime</span></span> <mark>scheme</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hereby established, a period of time should</span></span> <mark>thus put in place. There must</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provided</span></span> <mark>a time limit</mark> for its implementation.",
            "Input.simple-2": "Considering that a new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering</span></span> <mark>Given</mark> that a new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regime</span></span> <mark>scheme</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hereby established, a period of time should</span></span> <mark>thus put in place. There must</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provided</span></span> <mark>hypersensitivity regard principles</mark> for its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>implementation.</span></span> <mark>concerned</mark>",
            "Answer.end_timestamp": 1619724153.354,
            "Answer.fluency-1": 27,
            "Answer.fluency-2": 47,
            "Answer.fluency-3": 26,
            "Answer.fluency-4": 46,
            "Answer.fluency-5": 63,
            "Answer.start_timestamp": 1619724147.913,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-42",
            "Input.complex": "Considering that a new certification regime is hereby established, a period of time should be provided for its implementation.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-wiki",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regime</span></span> <mark>scheme</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hereby established, a period of time should</span></span> <mark>thus put in place. There must</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provided</span></span> <mark>a time limit</mark> for its implementation.",
            "Input.simple-2": "Considering that a new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering</span></span> <mark>Given</mark> that a new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification regime is hereby <span class='tooltip' style='color:red'>^<span class='tooltiptext'>established, a</span></span> <mark>established. A</mark> period of time should be provided for its implementation.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Considering that a</span></span> <mark>A</mark> new certification <span class='tooltip' style='color:red'>^<span class='tooltiptext'>regime</span></span> <mark>scheme</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hereby established, a period of time should</span></span> <mark>thus put in place. There must</mark> be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>provided</span></span> <mark>hypersensitivity regard principles</mark> for its <span class='tooltip' style='color:red'>^<span class='tooltiptext'>implementation.</span></span> <mark>concerned</mark>",
            "Answer.end_timestamp": 1619730135.025,
            "Answer.fluency-1": 28,
            "Answer.fluency-2": 46,
            "Answer.fluency-3": 61,
            "Answer.fluency-4": 18,
            "Answer.fluency-5": 78,
            "Answer.start_timestamp": 1619730121.483,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-43",
            "Input.complex": "For the purposes of the annual report to be submitted to the Commission by Member States, it is appropriate for the Commission to establish its specific requirements.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "For the purposes of the annual report to be submitted to the Commission by Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate for the Commission to establish its specific requirements.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For the purposes of the annual</span></span> <mark>Member States should submit a</mark> report <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be submitted</span></span> to the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by Member States, it is appropriate for the</span></span> <mark>once a year. The</mark> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to establish its specific requirements.</span></span> <mark>should determine what the report should provide information about.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For the purposes of the annual</span></span> <mark>Member States should light a</mark> report <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be submitted</span></span> to the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by Member States, it is appropriate for the</span></span> <mark>once slow year. The</mark> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to establish its specific requirements.</span></span> <mark>started determine product the report should provide information about.</mark>",
            "Input.simple-4": "For the purposes of the annual report to be submitted to the Commission by Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate for the Commission to establish its specific requirements.",
            "Input.simple-5": "For the purposes of the annual report to be submitted to the Commission by <mark>the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>that</mark> the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> establish its specific requirements.",
            "Answer.end_timestamp": 1619726863.139,
            "Answer.fluency-1": 43,
            "Answer.fluency-2": 63,
            "Answer.fluency-3": 50,
            "Answer.fluency-4": 36,
            "Answer.fluency-5": 73,
            "Answer.start_timestamp": 1619725848.908,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-43",
            "Input.complex": "For the purposes of the annual report to be submitted to the Commission by Member States, it is appropriate for the Commission to establish its specific requirements.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "For the purposes of the annual report to be submitted to the Commission by Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate for the Commission to establish its specific requirements.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For the purposes of the annual</span></span> <mark>Member States should submit a</mark> report <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be submitted</span></span> to the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by Member States, it is appropriate for the</span></span> <mark>once a year. The</mark> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to establish its specific requirements.</span></span> <mark>should determine what the report should provide information about.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For the purposes of the annual</span></span> <mark>Member States should light a</mark> report <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be submitted</span></span> to the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by Member States, it is appropriate for the</span></span> <mark>once slow year. The</mark> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to establish its specific requirements.</span></span> <mark>started determine product the report should provide information about.</mark>",
            "Input.simple-4": "For the purposes of the annual report to be submitted to the Commission by Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate for the Commission to establish its specific requirements.",
            "Input.simple-5": "For the purposes of the annual report to be submitted to the Commission by <mark>the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>that</mark> the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> establish its specific requirements.",
            "Answer.end_timestamp": 1619724334.886,
            "Answer.fluency-1": 57,
            "Answer.fluency-2": 33,
            "Answer.fluency-3": 60,
            "Answer.fluency-4": 31,
            "Answer.fluency-5": 69,
            "Answer.start_timestamp": 1619724327.047,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-43",
            "Input.complex": "For the purposes of the annual report to be submitted to the Commission by Member States, it is appropriate for the Commission to establish its specific requirements.",
            "Input.sid-1": "bisect-custom-bisect",
            "Input.sid-2": "bisect-ref-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-tf-bisect",
            "Input.simple-1": "For the purposes of the annual report to be submitted to the Commission by Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate for the Commission to establish its specific requirements.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For the purposes of the annual</span></span> <mark>Member States should submit a</mark> report <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be submitted</span></span> to the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by Member States, it is appropriate for the</span></span> <mark>once a year. The</mark> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to establish its specific requirements.</span></span> <mark>should determine what the report should provide information about.</mark>",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For the purposes of the annual</span></span> <mark>Member States should light a</mark> report <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to be submitted</span></span> to the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>by Member States, it is appropriate for the</span></span> <mark>once slow year. The</mark> Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to establish its specific requirements.</span></span> <mark>started determine product the report should provide information about.</mark>",
            "Input.simple-4": "For the purposes of the annual report to be submitted to the Commission by Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate for the Commission to establish its specific requirements.",
            "Input.simple-5": "For the purposes of the annual report to be submitted to the Commission by <mark>the</mark> Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, it</span></span> <mark>States. It</mark> is appropriate <span class='tooltip' style='color:red'>^<span class='tooltiptext'>for</span></span> <mark>that</mark> the Commission <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> establish its specific requirements.",
            "Answer.end_timestamp": 1619724471.295,
            "Answer.fluency-1": 96,
            "Answer.fluency-2": 88,
            "Answer.fluency-3": 97,
            "Answer.fluency-4": 89,
            "Answer.fluency-5": 99,
            "Answer.start_timestamp": 1619724459.062,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-44",
            "Input.complex": "Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of the renin-angiotensin-aldosterone system, lisinopril is antihypertensive even in patients with low renin hypertension.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of</span></span> <mark>Action on</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system,</span></span> <mark>system is considered to be the type mechanism responsible for lowering blood pressure. However, the antihypertensive initiating of</mark> lisinopril is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antihypertensive even</span></span> <mark>also existing</mark> in <mark>hypertensive</mark> patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>with</span></span> <mark>Berlin</mark> low renin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hypertension.</span></span> <mark>concentrations.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the</span></span> <mark>The</mark> mechanism through which lisinopril lowers blood pressure is believed to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>primarily suppression of</span></span> <mark>mainly suppressing</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system, lisinopril</span></span> <mark>system. However, lisinosterone</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the</span></span> <mark>The</mark> mechanism through which lisinopril lowers blood pressure is believed to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>primarily</span></span> <mark>mainly the</mark> suppression of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>renin-angiotensin-aldosterone system, lisinopril</span></span> <mark>renin - angiotensin - aldosterone system. However, it</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-4": "Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>renin-angiotensin-aldosterone system, lisinopril</span></span> <mark>renin - angiotensin - aldosterone system. Lipril</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of</span></span> <mark>Action on</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system,</span></span> <mark>system is considered to be the main mechanism responsible for lowering blood pressure. However, the antihypertensive activity of</mark> lisinopril is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antihypertensive even</span></span> <mark>also manifested</mark> in <mark>hypertensive</mark> patients with low renin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hypertension.</span></span> <mark>concentrations.</mark>",
            "Answer.end_timestamp": 1619726152.795,
            "Answer.fluency-1": 75,
            "Answer.fluency-2": 85,
            "Answer.fluency-3": 75,
            "Answer.fluency-4": 100,
            "Answer.fluency-5": 75,
            "Answer.start_timestamp": 1619726121.747,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-44",
            "Input.complex": "Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of the renin-angiotensin-aldosterone system, lisinopril is antihypertensive even in patients with low renin hypertension.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of</span></span> <mark>Action on</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system,</span></span> <mark>system is considered to be the type mechanism responsible for lowering blood pressure. However, the antihypertensive initiating of</mark> lisinopril is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antihypertensive even</span></span> <mark>also existing</mark> in <mark>hypertensive</mark> patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>with</span></span> <mark>Berlin</mark> low renin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hypertension.</span></span> <mark>concentrations.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the</span></span> <mark>The</mark> mechanism through which lisinopril lowers blood pressure is believed to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>primarily suppression of</span></span> <mark>mainly suppressing</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system, lisinopril</span></span> <mark>system. However, lisinosterone</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the</span></span> <mark>The</mark> mechanism through which lisinopril lowers blood pressure is believed to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>primarily</span></span> <mark>mainly the</mark> suppression of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>renin-angiotensin-aldosterone system, lisinopril</span></span> <mark>renin - angiotensin - aldosterone system. However, it</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-4": "Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>renin-angiotensin-aldosterone system, lisinopril</span></span> <mark>renin - angiotensin - aldosterone system. Lipril</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of</span></span> <mark>Action on</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system,</span></span> <mark>system is considered to be the main mechanism responsible for lowering blood pressure. However, the antihypertensive activity of</mark> lisinopril is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antihypertensive even</span></span> <mark>also manifested</mark> in <mark>hypertensive</mark> patients with low renin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hypertension.</span></span> <mark>concentrations.</mark>",
            "Answer.end_timestamp": 1619724346.322,
            "Answer.fluency-1": 65,
            "Answer.fluency-2": 78,
            "Answer.fluency-3": 35,
            "Answer.fluency-4": 59,
            "Answer.fluency-5": 53,
            "Answer.start_timestamp": 1619724341.763,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-44",
            "Input.complex": "Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of the renin-angiotensin-aldosterone system, lisinopril is antihypertensive even in patients with low renin hypertension.",
            "Input.sid-1": "bisect-control",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-tf-wiki",
            "Input.sid-5": "bisect-ref-bisect",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of</span></span> <mark>Action on</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system,</span></span> <mark>system is considered to be the type mechanism responsible for lowering blood pressure. However, the antihypertensive initiating of</mark> lisinopril is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antihypertensive even</span></span> <mark>also existing</mark> in <mark>hypertensive</mark> patients <span class='tooltip' style='color:red'>^<span class='tooltiptext'>with</span></span> <mark>Berlin</mark> low renin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hypertension.</span></span> <mark>concentrations.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the</span></span> <mark>The</mark> mechanism through which lisinopril lowers blood pressure is believed to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>primarily suppression of</span></span> <mark>mainly suppressing</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system, lisinopril</span></span> <mark>system. However, lisinosterone</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the</span></span> <mark>The</mark> mechanism through which lisinopril lowers blood pressure is believed to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>primarily</span></span> <mark>mainly the</mark> suppression of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>renin-angiotensin-aldosterone system, lisinopril</span></span> <mark>renin - angiotensin - aldosterone system. However, it</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-4": "Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>renin-angiotensin-aldosterone system, lisinopril</span></span> <mark>renin - angiotensin - aldosterone system. Lipril</mark> is antihypertensive even in patients with low renin hypertension.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Whilst the mechanism through which lisinopril lowers blood pressure is believed to be primarily suppression of</span></span> <mark>Action on</mark> the renin-angiotensin-aldosterone <span class='tooltip' style='color:red'>^<span class='tooltiptext'>system,</span></span> <mark>system is considered to be the main mechanism responsible for lowering blood pressure. However, the antihypertensive activity of</mark> lisinopril is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>antihypertensive even</span></span> <mark>also manifested</mark> in <mark>hypertensive</mark> patients with low renin <span class='tooltip' style='color:red'>^<span class='tooltiptext'>hypertension.</span></span> <mark>concentrations.</mark>",
            "Answer.end_timestamp": 1619724827.293,
            "Answer.fluency-1": 84,
            "Answer.fluency-2": 94,
            "Answer.fluency-3": 88,
            "Answer.fluency-4": 95,
            "Answer.fluency-5": 84,
            "Answer.start_timestamp": 1619724811.354,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-45",
            "Input.complex": "After having recalled why it is not possible to quantify precisely the costs of the nuclear liabilities, the UK authorities submitted that it is not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled</span></span> <mark>The United Kingdom authorities first of all recall</mark> why it is not possible to quantify precisely the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>costs</span></span> <mark>cost</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted</span></span> <mark>liabilities. They then argue</mark> that <mark>in this case</mark> it is not necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in this case</span></span> to know the precise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>quantum</span></span> <mark>amount</mark> of aid or to determine which measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amount to</span></span> <mark>constitute</mark> aid <mark>in order</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach</span></span> <mark>arrive at</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>view on</span></span> <mark>position as to</mark> whether the package is the minimum necessary.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having</span></span> <mark>The UK authorities have</mark> recalled why it is not possible to quantify precisely the costs of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted</span></span> <mark>liabilities. They argued</mark> that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it is not necessary</span></span> in this case <mark>it was not necessary</mark> to know the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>precise quantum</span></span> <mark>exact amount</mark> of aid or to determine which measures amount to aid <mark>should be taken</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach a view on</span></span> <mark>determine</mark> whether the package is the minimum necessary.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled</span></span> <mark>The United Kingdom showing first of all recall</mark> why it is not possible to quantify precisely the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>costs</span></span> <mark>cost</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted that</span></span> <mark>liabilities. They then list Patients in this case</mark> it is not necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in this case</span></span> to know the precise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>quantum</span></span> <mark>amount</mark> of aid or to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determine</span></span> <mark>basis</mark> which measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amount to</span></span> <mark>constitute</mark> aid <mark>in order</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach</span></span> <mark>arrive at</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>view on</span></span> <mark>position as to</mark> whether the package is the minimum necessary.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled why</span></span> <mark>The UK authorities have indicated that</mark> it is not possible to quantify precisely the costs of the nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted that it</span></span> <mark>liabilities. It</mark> is <mark>therefore</mark> not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Input.simple-5": "After having recalled why it is not possible to quantify precisely the costs of the nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the</span></span> <mark>liabilities. The</mark> UK authorities submitted that it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Answer.end_timestamp": 1619730366.728,
            "Answer.fluency-1": 62,
            "Answer.fluency-2": 83,
            "Answer.fluency-3": 71,
            "Answer.fluency-4": 59,
            "Answer.fluency-5": 49,
            "Answer.start_timestamp": 1619730352.953,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-45",
            "Input.complex": "After having recalled why it is not possible to quantify precisely the costs of the nuclear liabilities, the UK authorities submitted that it is not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled</span></span> <mark>The United Kingdom authorities first of all recall</mark> why it is not possible to quantify precisely the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>costs</span></span> <mark>cost</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted</span></span> <mark>liabilities. They then argue</mark> that <mark>in this case</mark> it is not necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in this case</span></span> to know the precise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>quantum</span></span> <mark>amount</mark> of aid or to determine which measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amount to</span></span> <mark>constitute</mark> aid <mark>in order</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach</span></span> <mark>arrive at</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>view on</span></span> <mark>position as to</mark> whether the package is the minimum necessary.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having</span></span> <mark>The UK authorities have</mark> recalled why it is not possible to quantify precisely the costs of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted</span></span> <mark>liabilities. They argued</mark> that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it is not necessary</span></span> in this case <mark>it was not necessary</mark> to know the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>precise quantum</span></span> <mark>exact amount</mark> of aid or to determine which measures amount to aid <mark>should be taken</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach a view on</span></span> <mark>determine</mark> whether the package is the minimum necessary.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled</span></span> <mark>The United Kingdom showing first of all recall</mark> why it is not possible to quantify precisely the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>costs</span></span> <mark>cost</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted that</span></span> <mark>liabilities. They then list Patients in this case</mark> it is not necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in this case</span></span> to know the precise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>quantum</span></span> <mark>amount</mark> of aid or to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determine</span></span> <mark>basis</mark> which measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amount to</span></span> <mark>constitute</mark> aid <mark>in order</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach</span></span> <mark>arrive at</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>view on</span></span> <mark>position as to</mark> whether the package is the minimum necessary.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled why</span></span> <mark>The UK authorities have indicated that</mark> it is not possible to quantify precisely the costs of the nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted that it</span></span> <mark>liabilities. It</mark> is <mark>therefore</mark> not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Input.simple-5": "After having recalled why it is not possible to quantify precisely the costs of the nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the</span></span> <mark>liabilities. The</mark> UK authorities submitted that it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Answer.end_timestamp": 1619724474.913,
            "Answer.fluency-1": 57,
            "Answer.fluency-2": 76,
            "Answer.fluency-3": 41,
            "Answer.fluency-4": 70,
            "Answer.fluency-5": 57,
            "Answer.start_timestamp": 1619724466.812,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-45",
            "Input.complex": "After having recalled why it is not possible to quantify precisely the costs of the nuclear liabilities, the UK authorities submitted that it is not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-control",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled</span></span> <mark>The United Kingdom authorities first of all recall</mark> why it is not possible to quantify precisely the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>costs</span></span> <mark>cost</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted</span></span> <mark>liabilities. They then argue</mark> that <mark>in this case</mark> it is not necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in this case</span></span> to know the precise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>quantum</span></span> <mark>amount</mark> of aid or to determine which measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amount to</span></span> <mark>constitute</mark> aid <mark>in order</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach</span></span> <mark>arrive at</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>view on</span></span> <mark>position as to</mark> whether the package is the minimum necessary.",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having</span></span> <mark>The UK authorities have</mark> recalled why it is not possible to quantify precisely the costs of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted</span></span> <mark>liabilities. They argued</mark> that <span class='tooltip' style='color:red'>^<span class='tooltiptext'>it is not necessary</span></span> in this case <mark>it was not necessary</mark> to know the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>precise quantum</span></span> <mark>exact amount</mark> of aid or to determine which measures amount to aid <mark>should be taken</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach a view on</span></span> <mark>determine</mark> whether the package is the minimum necessary.",
            "Input.simple-3": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled</span></span> <mark>The United Kingdom showing first of all recall</mark> why it is not possible to quantify precisely the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>costs</span></span> <mark>cost</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>the</span></span> nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted that</span></span> <mark>liabilities. They then list Patients in this case</mark> it is not necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>in this case</span></span> to know the precise <span class='tooltip' style='color:red'>^<span class='tooltiptext'>quantum</span></span> <mark>amount</mark> of aid or to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>determine</span></span> <mark>basis</mark> which measures <span class='tooltip' style='color:red'>^<span class='tooltiptext'>amount to</span></span> <mark>constitute</mark> aid <mark>in order</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>reach</span></span> <mark>arrive at</mark> a <span class='tooltip' style='color:red'>^<span class='tooltiptext'>view on</span></span> <mark>position as to</mark> whether the package is the minimum necessary.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>After having recalled why</span></span> <mark>The UK authorities have indicated that</mark> it is not possible to quantify precisely the costs of the nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the UK authorities submitted that it</span></span> <mark>liabilities. It</mark> is <mark>therefore</mark> not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Input.simple-5": "After having recalled why it is not possible to quantify precisely the costs of the nuclear <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liabilities, the</span></span> <mark>liabilities. The</mark> UK authorities submitted that it <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is</span></span> <mark>was</mark> not necessary in this case to know the precise quantum of aid or to determine which measures amount to aid to reach a view on whether the package is the minimum necessary.",
            "Answer.end_timestamp": 1619725478.805,
            "Answer.fluency-1": 96,
            "Answer.fluency-2": 90,
            "Answer.fluency-3": 99,
            "Answer.fluency-4": 90,
            "Answer.fluency-5": 98,
            "Answer.start_timestamp": 1619725461.903,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-46",
            "Input.complex": "For each seat to be filled which is appositioned to the Member States, the Commission, after consulting the Member States concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For</span></span> <mark>It selects this for</mark> each <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seat to be filled which is appositioned</span></span> <mark>of the seats assigned</mark> to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, the Commission, after consulting the Member</span></span> States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned, shall appoint the members</span></span> from among <span class='tooltip' style='color:red'>^<span class='tooltiptext'>top level national experts who are competent in</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fields</span></span> <mark>high government experts responsible for the areas</mark> referred to in Article 2. <mark>The Commission appoints them after consulting the Member States concerned.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For</span></span> <mark>It selects this for</mark> each <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seat to be filled which is appositioned</span></span> <mark>of the seats assigned</mark> to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States,</span></span> <mark>States from</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission,</span></span> <mark>the high government experts responsible for the areas referred to safer Article severe The Commission appoints consent</mark> after consulting the Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.</span></span> <mark>concerned.</mark>",
            "Input.simple-3": "For each seat to be filled which is appositioned to the Member States, the Commission, after consulting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States</span></span> <mark>member states</mark> concerned, shall appoint the members from among top level national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>experts who</span></span> <mark>experts. They</mark> are competent in the fields referred to in Article 2.",
            "Input.simple-4": "For each seat to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>filled</span></span> <mark>filled,</mark> which is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appositioned</span></span> <mark>delegated</mark> to the Member States, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission, after consulting the Member States concerned,</span></span> <mark>Commission</mark> shall appoint the members <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from among</span></span> <mark>of the</mark> top <mark>-</mark> level national experts who are competent in the fields referred to in Article 2. <mark>After consulting the relevant Member States.</mark>",
            "Input.simple-5": "For each seat to be filled which is appositioned to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, the</span></span> <mark>States. The</mark> Commission, after consulting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member</span></span> <mark>member</mark> States concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.",
            "Answer.end_timestamp": 1619726880.308,
            "Answer.fluency-1": 67,
            "Answer.fluency-2": 56,
            "Answer.fluency-3": 34,
            "Answer.fluency-4": 65,
            "Answer.fluency-5": 91,
            "Answer.start_timestamp": 1619726864.607,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-46",
            "Input.complex": "For each seat to be filled which is appositioned to the Member States, the Commission, after consulting the Member States concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For</span></span> <mark>It selects this for</mark> each <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seat to be filled which is appositioned</span></span> <mark>of the seats assigned</mark> to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, the Commission, after consulting the Member</span></span> States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned, shall appoint the members</span></span> from among <span class='tooltip' style='color:red'>^<span class='tooltiptext'>top level national experts who are competent in</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fields</span></span> <mark>high government experts responsible for the areas</mark> referred to in Article 2. <mark>The Commission appoints them after consulting the Member States concerned.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For</span></span> <mark>It selects this for</mark> each <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seat to be filled which is appositioned</span></span> <mark>of the seats assigned</mark> to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States,</span></span> <mark>States from</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission,</span></span> <mark>the high government experts responsible for the areas referred to safer Article severe The Commission appoints consent</mark> after consulting the Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.</span></span> <mark>concerned.</mark>",
            "Input.simple-3": "For each seat to be filled which is appositioned to the Member States, the Commission, after consulting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States</span></span> <mark>member states</mark> concerned, shall appoint the members from among top level national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>experts who</span></span> <mark>experts. They</mark> are competent in the fields referred to in Article 2.",
            "Input.simple-4": "For each seat to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>filled</span></span> <mark>filled,</mark> which is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appositioned</span></span> <mark>delegated</mark> to the Member States, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission, after consulting the Member States concerned,</span></span> <mark>Commission</mark> shall appoint the members <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from among</span></span> <mark>of the</mark> top <mark>-</mark> level national experts who are competent in the fields referred to in Article 2. <mark>After consulting the relevant Member States.</mark>",
            "Input.simple-5": "For each seat to be filled which is appositioned to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, the</span></span> <mark>States. The</mark> Commission, after consulting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member</span></span> <mark>member</mark> States concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.",
            "Answer.end_timestamp": 1619724671.786,
            "Answer.fluency-1": 90,
            "Answer.fluency-2": 80,
            "Answer.fluency-3": 90,
            "Answer.fluency-4": 81,
            "Answer.fluency-5": 79,
            "Answer.start_timestamp": 1619724653.649,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-46",
            "Input.complex": "For each seat to be filled which is appositioned to the Member States, the Commission, after consulting the Member States concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-tf-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For</span></span> <mark>It selects this for</mark> each <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seat to be filled which is appositioned</span></span> <mark>of the seats assigned</mark> to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, the Commission, after consulting the Member</span></span> States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned, shall appoint the members</span></span> from among <span class='tooltip' style='color:red'>^<span class='tooltiptext'>top level national experts who are competent in</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>fields</span></span> <mark>high government experts responsible for the areas</mark> referred to in Article 2. <mark>The Commission appoints them after consulting the Member States concerned.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>For</span></span> <mark>It selects this for</mark> each <span class='tooltip' style='color:red'>^<span class='tooltiptext'>seat to be filled which is appositioned</span></span> <mark>of the seats assigned</mark> to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States,</span></span> <mark>States from</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission,</span></span> <mark>the high government experts responsible for the areas referred to safer Article severe The Commission appoints consent</mark> after consulting the Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.</span></span> <mark>concerned.</mark>",
            "Input.simple-3": "For each seat to be filled which is appositioned to the Member States, the Commission, after consulting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member States</span></span> <mark>member states</mark> concerned, shall appoint the members from among top level national <span class='tooltip' style='color:red'>^<span class='tooltiptext'>experts who</span></span> <mark>experts. They</mark> are competent in the fields referred to in Article 2.",
            "Input.simple-4": "For each seat to be <span class='tooltip' style='color:red'>^<span class='tooltiptext'>filled</span></span> <mark>filled,</mark> which is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appositioned</span></span> <mark>delegated</mark> to the Member States, the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Commission, after consulting the Member States concerned,</span></span> <mark>Commission</mark> shall appoint the members <span class='tooltip' style='color:red'>^<span class='tooltiptext'>from among</span></span> <mark>of the</mark> top <mark>-</mark> level national experts who are competent in the fields referred to in Article 2. <mark>After consulting the relevant Member States.</mark>",
            "Input.simple-5": "For each seat to be filled which is appositioned to the Member <span class='tooltip' style='color:red'>^<span class='tooltiptext'>States, the</span></span> <mark>States. The</mark> Commission, after consulting the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>Member</span></span> <mark>member</mark> States concerned, shall appoint the members from among top level national experts who are competent in the fields referred to in Article 2.",
            "Answer.end_timestamp": 1619725022.26,
            "Answer.fluency-1": 76,
            "Answer.fluency-2": 64,
            "Answer.fluency-3": 44,
            "Answer.fluency-4": 66,
            "Answer.fluency-5": 53,
            "Answer.start_timestamp": 1619724974.106,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-47",
            "Input.complex": "Since montelukast is metabolised by CYP 3A4, caution should be exercised, particularly in children, when montelukast is coadministered with inducers of CYP 3A4, such as phenytoin, phenobarbital and rifampicin.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since montelukast</span></span> <mark>Montelukast</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4. Therefore,</mark> caution <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be exercised, particularly</span></span> <mark>is required, especially</mark> in children, when <mark>co-administering</mark> montelukast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is coadministered</span></span> with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inducers of</span></span> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4 inducing drugs</mark> such as phenytoin, phenobarbital and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rifampicin.</span></span> <mark>rifampin.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since montelukast</span></span> <mark>Montelukast</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised by</span></span> <mark>metabolized offer</mark> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4. Therefore,</mark> caution <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be exercised, particularly</span></span> <mark>is argue IP</mark> in children, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when</span></span> <mark>continuous co-administering</mark> montelukast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is coadministered</span></span> with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inducers of</span></span> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4 inducing drugs</mark> such as phenytoin, phenobarbital and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rifampicin.</span></span> <mark>rifampin.</mark>",
            "Input.simple-3": "Since montelukast is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP 3A4, caution should be exercised, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particularly</span></span> <mark>especially</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children, when montelukast</span></span> <mark>children. When montelukestukastuka</mark> is coadministered with inducers of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>CYP 3A4,</span></span> <mark>CYP3A4</mark> such as phenytoin, phenobarbital and rifampicin.",
            "Input.simple-4": "Since montelukast is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP 3A4, caution should be exercised, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particularly</span></span> <mark>especially</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children,</span></span> <mark>children. This is</mark> when <span class='tooltip' style='color:red'>^<span class='tooltiptext'>montelukast</span></span> <mark>montelokast</mark> is coadministered with inducers <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of CYP 3A4,</span></span> such as phenytoin, phenobarbital and rifampicin.",
            "Input.simple-5": "Since montelukast is metabolised by CYP 3A4, caution should be exercised, particularly in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children, when montelukast is</span></span> <mark>children. Montelukasts are</mark> coadministered with inducers of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>CYP 3A4,</span></span> <mark>CYP3A4</mark> such as phenytoin, phenobarbital and rifampicin.",
            "Answer.end_timestamp": 1619727604.059,
            "Answer.fluency-1": 52,
            "Answer.fluency-2": 77,
            "Answer.fluency-3": 65,
            "Answer.fluency-4": 52,
            "Answer.fluency-5": 61,
            "Answer.start_timestamp": 1619727568.822,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-47",
            "Input.complex": "Since montelukast is metabolised by CYP 3A4, caution should be exercised, particularly in children, when montelukast is coadministered with inducers of CYP 3A4, such as phenytoin, phenobarbital and rifampicin.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since montelukast</span></span> <mark>Montelukast</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4. Therefore,</mark> caution <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be exercised, particularly</span></span> <mark>is required, especially</mark> in children, when <mark>co-administering</mark> montelukast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is coadministered</span></span> with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inducers of</span></span> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4 inducing drugs</mark> such as phenytoin, phenobarbital and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rifampicin.</span></span> <mark>rifampin.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since montelukast</span></span> <mark>Montelukast</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised by</span></span> <mark>metabolized offer</mark> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4. Therefore,</mark> caution <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be exercised, particularly</span></span> <mark>is argue IP</mark> in children, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when</span></span> <mark>continuous co-administering</mark> montelukast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is coadministered</span></span> with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inducers of</span></span> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4 inducing drugs</mark> such as phenytoin, phenobarbital and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rifampicin.</span></span> <mark>rifampin.</mark>",
            "Input.simple-3": "Since montelukast is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP 3A4, caution should be exercised, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particularly</span></span> <mark>especially</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children, when montelukast</span></span> <mark>children. When montelukestukastuka</mark> is coadministered with inducers of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>CYP 3A4,</span></span> <mark>CYP3A4</mark> such as phenytoin, phenobarbital and rifampicin.",
            "Input.simple-4": "Since montelukast is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP 3A4, caution should be exercised, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particularly</span></span> <mark>especially</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children,</span></span> <mark>children. This is</mark> when <span class='tooltip' style='color:red'>^<span class='tooltiptext'>montelukast</span></span> <mark>montelokast</mark> is coadministered with inducers <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of CYP 3A4,</span></span> such as phenytoin, phenobarbital and rifampicin.",
            "Input.simple-5": "Since montelukast is metabolised by CYP 3A4, caution should be exercised, particularly in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children, when montelukast is</span></span> <mark>children. Montelukasts are</mark> coadministered with inducers of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>CYP 3A4,</span></span> <mark>CYP3A4</mark> such as phenytoin, phenobarbital and rifampicin.",
            "Answer.end_timestamp": 1619724315.409,
            "Answer.fluency-1": 47,
            "Answer.fluency-2": 79,
            "Answer.fluency-3": 48,
            "Answer.fluency-4": 19,
            "Answer.fluency-5": 62,
            "Answer.start_timestamp": 1619724310.929,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-47",
            "Input.complex": "Since montelukast is metabolised by CYP 3A4, caution should be exercised, particularly in children, when montelukast is coadministered with inducers of CYP 3A4, such as phenytoin, phenobarbital and rifampicin.",
            "Input.sid-1": "bisect-ref-bisect",
            "Input.sid-2": "bisect-control",
            "Input.sid-3": "bisect-tf-bisect",
            "Input.sid-4": "bisect-custom-bisect",
            "Input.sid-5": "bisect-tf-wiki",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since montelukast</span></span> <mark>Montelukast</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4. Therefore,</mark> caution <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be exercised, particularly</span></span> <mark>is required, especially</mark> in children, when <mark>co-administering</mark> montelukast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is coadministered</span></span> with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inducers of</span></span> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4 inducing drugs</mark> such as phenytoin, phenobarbital and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rifampicin.</span></span> <mark>rifampin.</mark>",
            "Input.simple-2": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since montelukast</span></span> <mark>Montelukast</mark> is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised by</span></span> <mark>metabolized offer</mark> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4. Therefore,</mark> caution <span class='tooltip' style='color:red'>^<span class='tooltiptext'>should be exercised, particularly</span></span> <mark>is argue IP</mark> in children, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>when</span></span> <mark>continuous co-administering</mark> montelukast <span class='tooltip' style='color:red'>^<span class='tooltiptext'>is coadministered</span></span> with <span class='tooltip' style='color:red'>^<span class='tooltiptext'>inducers of</span></span> CYP <span class='tooltip' style='color:red'>^<span class='tooltiptext'>3A4,</span></span> <mark>3A4 inducing drugs</mark> such as phenytoin, phenobarbital and <span class='tooltip' style='color:red'>^<span class='tooltiptext'>rifampicin.</span></span> <mark>rifampin.</mark>",
            "Input.simple-3": "Since montelukast is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP 3A4, caution should be exercised, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particularly</span></span> <mark>especially</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children, when montelukast</span></span> <mark>children. When montelukestukastuka</mark> is coadministered with inducers of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>CYP 3A4,</span></span> <mark>CYP3A4</mark> such as phenytoin, phenobarbital and rifampicin.",
            "Input.simple-4": "Since montelukast is <span class='tooltip' style='color:red'>^<span class='tooltiptext'>metabolised</span></span> <mark>metabolized</mark> by CYP 3A4, caution should be exercised, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>particularly</span></span> <mark>especially</mark> in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children,</span></span> <mark>children. This is</mark> when <span class='tooltip' style='color:red'>^<span class='tooltiptext'>montelukast</span></span> <mark>montelokast</mark> is coadministered with inducers <span class='tooltip' style='color:red'>^<span class='tooltiptext'>of CYP 3A4,</span></span> such as phenytoin, phenobarbital and rifampicin.",
            "Input.simple-5": "Since montelukast is metabolised by CYP 3A4, caution should be exercised, particularly in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>children, when montelukast is</span></span> <mark>children. Montelukasts are</mark> coadministered with inducers of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>CYP 3A4,</span></span> <mark>CYP3A4</mark> such as phenytoin, phenobarbital and rifampicin.",
            "Answer.end_timestamp": 1619724445.748,
            "Answer.fluency-1": 55,
            "Answer.fluency-2": 69,
            "Answer.fluency-3": 83,
            "Answer.fluency-4": 70,
            "Answer.fluency-5": 59,
            "Answer.start_timestamp": 1619724436.379,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-48",
            "Input.complex": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with</span></span> <mark>out. With</mark> a view, where appropriate, to making necessary adjustments.",
            "Input.simple-2": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with a view, where</span></span> <mark>out. Where</mark> appropriate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to making</span></span> <mark>the</mark> necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>adjustments.</span></span> <mark>adjustments should be made.</mark>",
            "Input.simple-3": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with a view, where</span></span> <mark>out. Where</mark> appropriate, <mark>it should be necessary</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>making</span></span> <mark>make</mark> necessary adjustments.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In order</span></span> <mark>Actions are continuously monitored and periodically evaluated</mark> to increase the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>value</span></span> <mark>usefulness</mark> and impact of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this framework, continuous monitoring and regular evaluation of</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.</span></span> <mark>framework. If necessary, the frame is adjusted.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In order</span></span> <mark>Actions are continuously monitored no pamoate attributed</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>increase</span></span> <mark>identify</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>value</span></span> <mark>usefulness</mark> and impact of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this framework, continuous monitoring and regular evaluation of</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.</span></span> <mark>framework. If necessary, the frame is adjusted.</mark>",
            "Answer.end_timestamp": 1619726611.309,
            "Answer.fluency-1": 78,
            "Answer.fluency-2": 90,
            "Answer.fluency-3": 84,
            "Answer.fluency-4": 91,
            "Answer.fluency-5": 85,
            "Answer.start_timestamp": 1619726590.426,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-48",
            "Input.complex": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with</span></span> <mark>out. With</mark> a view, where appropriate, to making necessary adjustments.",
            "Input.simple-2": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with a view, where</span></span> <mark>out. Where</mark> appropriate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to making</span></span> <mark>the</mark> necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>adjustments.</span></span> <mark>adjustments should be made.</mark>",
            "Input.simple-3": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with a view, where</span></span> <mark>out. Where</mark> appropriate, <mark>it should be necessary</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>making</span></span> <mark>make</mark> necessary adjustments.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In order</span></span> <mark>Actions are continuously monitored and periodically evaluated</mark> to increase the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>value</span></span> <mark>usefulness</mark> and impact of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this framework, continuous monitoring and regular evaluation of</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.</span></span> <mark>framework. If necessary, the frame is adjusted.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In order</span></span> <mark>Actions are continuously monitored no pamoate attributed</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>increase</span></span> <mark>identify</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>value</span></span> <mark>usefulness</mark> and impact of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this framework, continuous monitoring and regular evaluation of</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.</span></span> <mark>framework. If necessary, the frame is adjusted.</mark>",
            "Answer.end_timestamp": 1619724304.933,
            "Answer.fluency-1": 64,
            "Answer.fluency-2": 36,
            "Answer.fluency-3": 69,
            "Answer.fluency-4": 91,
            "Answer.fluency-5": 69,
            "Answer.start_timestamp": 1619724300.71,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-48",
            "Input.complex": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.",
            "Input.sid-1": "bisect-tf-wiki",
            "Input.sid-2": "bisect-tf-bisect",
            "Input.sid-3": "bisect-custom-bisect",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with</span></span> <mark>out. With</mark> a view, where appropriate, to making necessary adjustments.",
            "Input.simple-2": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with a view, where</span></span> <mark>out. Where</mark> appropriate, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to making</span></span> <mark>the</mark> necessary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>adjustments.</span></span> <mark>adjustments should be made.</mark>",
            "Input.simple-3": "In order to increase the value and impact of this framework, continuous monitoring and regular evaluation of the actions undertaken should be carried <span class='tooltip' style='color:red'>^<span class='tooltiptext'>out, with a view, where</span></span> <mark>out. Where</mark> appropriate, <mark>it should be necessary</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>making</span></span> <mark>make</mark> necessary adjustments.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In order</span></span> <mark>Actions are continuously monitored and periodically evaluated</mark> to increase the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>value</span></span> <mark>usefulness</mark> and impact of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this framework, continuous monitoring and regular evaluation of</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.</span></span> <mark>framework. If necessary, the frame is adjusted.</mark>",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>In order</span></span> <mark>Actions are continuously monitored no pamoate attributed</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>increase</span></span> <mark>identify</mark> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>value</span></span> <mark>usefulness</mark> and impact of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>this framework, continuous monitoring and regular evaluation of</span></span> the <span class='tooltip' style='color:red'>^<span class='tooltiptext'>actions undertaken should be carried out, with a view, where appropriate, to making necessary adjustments.</span></span> <mark>framework. If necessary, the frame is adjusted.</mark>",
            "Answer.end_timestamp": 1619730391.821,
            "Answer.fluency-1": 93,
            "Answer.fluency-2": 95,
            "Answer.fluency-3": 88,
            "Answer.fluency-4": 99,
            "Answer.fluency-5": 95,
            "Answer.start_timestamp": 1619730369.538,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-49",
            "Input.complex": "Since the tax situation of one or more persons liable to tax established in several Member States often is of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual agreement and on a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax situation of one or more persons liable to tax established in several Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of common or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible for</span></span> <mark>interest. Therefore,</mark> simultaneous controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>should</mark> be carried out to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>these</mark> persons by two or more Member States, by mutual agreement and on a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-2": "Since the tax situation of one or more persons liable to tax established in several Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual agreement and on a voluntary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis, whenever</span></span> <mark>basis. Whenever</mark> such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-3": "Since the tax situation of one or more persons liable to tax established in several Member States often is of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement and on</span></span> <mark>agreement. On</mark> a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>situation</span></span> <mark>position</mark> of one or more <mark>taxable</mark> persons <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liable to tax</span></span> established in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>several</span></span> <mark>different</mark> Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>common</span></span> <mark>joint</mark> or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible for simultaneous controls</span></span> <mark>importance. It is therefore necessary</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be carried out to such persons by</span></span> <mark>provide for the possibility that</mark> two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement</span></span> <mark>consent</mark> and on a voluntary basis, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>whenever</span></span> <mark>carry out simultaneous controls on the persons concerned, where</mark> such controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appear to be</span></span> <mark>are considered</mark> more effective than controls carried out by only one Member State.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>situation</span></span> <mark>position</mark> of one <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or</span></span> <mark>mixed</mark> more <mark>taxable</mark> persons <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liable to tax</span></span> established in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>several</span></span> <mark>different</mark> Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>common</span></span> <mark>joint</mark> or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible</span></span> <mark>importance. It is therefore necessary inducers provide</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>simultaneous controls to be carried out to such persons by</span></span> <mark>the application that</mark> two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement</span></span> <mark>consent</mark> and on a voluntary basis, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>whenever</span></span> <mark>carry several simultaneous controls on the persons concerned, where</mark> such controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appear to be</span></span> <mark>are considered</mark> more effective than controls carried out by only one Member State.",
            "Answer.end_timestamp": 1619724446.801,
            "Answer.fluency-1": 50,
            "Answer.fluency-2": 59,
            "Answer.fluency-3": 37,
            "Answer.fluency-4": 63,
            "Answer.fluency-5": 38,
            "Answer.start_timestamp": 1619724401.665,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-49",
            "Input.complex": "Since the tax situation of one or more persons liable to tax established in several Member States often is of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual agreement and on a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax situation of one or more persons liable to tax established in several Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of common or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible for</span></span> <mark>interest. Therefore,</mark> simultaneous controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>should</mark> be carried out to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>these</mark> persons by two or more Member States, by mutual agreement and on a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-2": "Since the tax situation of one or more persons liable to tax established in several Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual agreement and on a voluntary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis, whenever</span></span> <mark>basis. Whenever</mark> such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-3": "Since the tax situation of one or more persons liable to tax established in several Member States often is of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement and on</span></span> <mark>agreement. On</mark> a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>situation</span></span> <mark>position</mark> of one or more <mark>taxable</mark> persons <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liable to tax</span></span> established in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>several</span></span> <mark>different</mark> Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>common</span></span> <mark>joint</mark> or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible for simultaneous controls</span></span> <mark>importance. It is therefore necessary</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be carried out to such persons by</span></span> <mark>provide for the possibility that</mark> two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement</span></span> <mark>consent</mark> and on a voluntary basis, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>whenever</span></span> <mark>carry out simultaneous controls on the persons concerned, where</mark> such controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appear to be</span></span> <mark>are considered</mark> more effective than controls carried out by only one Member State.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>situation</span></span> <mark>position</mark> of one <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or</span></span> <mark>mixed</mark> more <mark>taxable</mark> persons <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liable to tax</span></span> established in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>several</span></span> <mark>different</mark> Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>common</span></span> <mark>joint</mark> or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible</span></span> <mark>importance. It is therefore necessary inducers provide</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>simultaneous controls to be carried out to such persons by</span></span> <mark>the application that</mark> two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement</span></span> <mark>consent</mark> and on a voluntary basis, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>whenever</span></span> <mark>carry several simultaneous controls on the persons concerned, where</mark> such controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appear to be</span></span> <mark>are considered</mark> more effective than controls carried out by only one Member State.",
            "Answer.end_timestamp": 1619724689.642,
            "Answer.fluency-1": 56,
            "Answer.fluency-2": 19,
            "Answer.fluency-3": 44,
            "Answer.fluency-4": 66,
            "Answer.fluency-5": 100,
            "Answer.start_timestamp": 1619724674.838,
            "Approve": null,
            "Reject": null
        },
        {
            "Input.cid": "bisect-49",
            "Input.complex": "Since the tax situation of one or more persons liable to tax established in several Member States often is of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual agreement and on a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.sid-1": "bisect-tf-bisect",
            "Input.sid-2": "bisect-custom-bisect",
            "Input.sid-3": "bisect-tf-wiki",
            "Input.sid-4": "bisect-ref-bisect",
            "Input.sid-5": "bisect-control",
            "Input.simple-1": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax situation of one or more persons liable to tax established in several Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of common or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible for</span></span> <mark>interest. Therefore,</mark> simultaneous controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>to</span></span> <mark>should</mark> be carried out to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>such</span></span> <mark>these</mark> persons by two or more Member States, by mutual agreement and on a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-2": "Since the tax situation of one or more persons liable to tax established in several Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual agreement and on a voluntary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>basis, whenever</span></span> <mark>basis. Whenever</mark> such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-3": "Since the tax situation of one or more persons liable to tax established in several Member States often is of common or complementary interest, it should be made possible for simultaneous controls to be carried out to such persons by two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement and on</span></span> <mark>agreement. On</mark> a voluntary basis, whenever such controls appear to be more effective than controls carried out by only one Member State.",
            "Input.simple-4": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>situation</span></span> <mark>position</mark> of one or more <mark>taxable</mark> persons <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liable to tax</span></span> established in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>several</span></span> <mark>different</mark> Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>common</span></span> <mark>joint</mark> or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible for simultaneous controls</span></span> <mark>importance. It is therefore necessary</mark> to <span class='tooltip' style='color:red'>^<span class='tooltiptext'>be carried out to such persons by</span></span> <mark>provide for the possibility that</mark> two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement</span></span> <mark>consent</mark> and on a voluntary basis, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>whenever</span></span> <mark>carry out simultaneous controls on the persons concerned, where</mark> such controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appear to be</span></span> <mark>are considered</mark> more effective than controls carried out by only one Member State.",
            "Input.simple-5": "<span class='tooltip' style='color:red'>^<span class='tooltiptext'>Since the</span></span> <mark>The</mark> tax <span class='tooltip' style='color:red'>^<span class='tooltiptext'>situation</span></span> <mark>position</mark> of one <span class='tooltip' style='color:red'>^<span class='tooltiptext'>or</span></span> <mark>mixed</mark> more <mark>taxable</mark> persons <span class='tooltip' style='color:red'>^<span class='tooltiptext'>liable to tax</span></span> established in <span class='tooltip' style='color:red'>^<span class='tooltiptext'>several</span></span> <mark>different</mark> Member States <span class='tooltip' style='color:red'>^<span class='tooltiptext'>often</span></span> is <mark>often</mark> of <span class='tooltip' style='color:red'>^<span class='tooltiptext'>common</span></span> <mark>joint</mark> or complementary <span class='tooltip' style='color:red'>^<span class='tooltiptext'>interest, it should be made possible</span></span> <mark>importance. It is therefore necessary inducers provide</mark> for <span class='tooltip' style='color:red'>^<span class='tooltiptext'>simultaneous controls to be carried out to such persons by</span></span> <mark>the application that</mark> two or more Member States, by mutual <span class='tooltip' style='color:red'>^<span class='tooltiptext'>agreement</span></span> <mark>consent</mark> and on a voluntary basis, <span class='tooltip' style='color:red'>^<span class='tooltiptext'>whenever</span></span> <mark>carry several simultaneous controls on the persons concerned, where</mark> such controls <span class='tooltip' style='color:red'>^<span class='tooltiptext'>appear to be</span></span> <mark>are considered</mark> more effective than controls carried out by only one Member State.",
            "Answer.end_timestamp": 1619730197.471,
            "Answer.fluency-1": 82,
            "Answer.fluency-2": 44,
            "Answer.fluency-3": 60,
            "Answer.fluency-4": 82,
            "Answer.fluency-5": 70,
            "Answer.start_timestamp": 1619730179.163,
            "Approve": null,
            "Reject": null
        }
    ]
}